
<html lang="en"     class="pb-page"  data-request-id="699234bd-ebac-4261-90c2-7b0da4d0cf75"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.7b00926;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2017.60.issue-17;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine–Guanine–(Xanthine) Phosphoribosyltransferase" /></meta><meta name="dc.Creator" content="Petr  Špaček" /></meta><meta name="dc.Creator" content="Dianne T.  Keough" /></meta><meta name="dc.Creator" content="Marina  Chavchich" /></meta><meta name="dc.Creator" content="Martin  Dračínský" /></meta><meta name="dc.Creator" content="Zlatko  Janeba" /></meta><meta name="dc.Creator" content="Lieve  Naesens" /></meta><meta name="dc.Creator" content="Michael D.  Edstein" /></meta><meta name="dc.Creator" content="Luke W.  Guddat" /></meta><meta name="dc.Creator" content="Dana  Hocková" /></meta><meta name="dc.Description" content="Acyclic nucleoside bisphosphonates (ANbPs) have previously been shown to be good inhibitors of human hypoxanthine–guanine phosphoribosyltransferase (HGPRT) and Plasmodium falciparum (Pf) hypoxanthi..." /></meta><meta name="Description" content="Acyclic nucleoside bisphosphonates (ANbPs) have previously been shown to be good inhibitors of human hypoxanthine–guanine phosphoribosyltransferase (HGPRT) and Plasmodium falciparum (Pf) hypoxanthi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 30, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00926" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00926" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00926" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00926" /></link>
        
    
    

<title>Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine–Guanine–(Xanthine) Phosphoribosyltransferase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00926" /></meta><meta property="og:title" content="Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine–Guanine–(Xanthine) Phosphoribosyltransferase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0018.jpeg" /></meta><meta property="og:description" content="Acyclic nucleoside bisphosphonates (ANbPs) have previously been shown to be good inhibitors of human hypoxanthine–guanine phosphoribosyltransferase (HGPRT) and Plasmodium falciparum (Pf) hypoxanthine–guanine–xanthine phosphoribosyltransferase (PfHGXPRT). On the basis of this scaffold, a new series of ANbPs was synthesized. One of these new ANbPs, [3-(guanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methylphosphonic acid, exhibited Ki values of 6 and 70 nM for human HGPRT and Pf HGXPRT, respectively. These low Ki values were achieved by inserting an extra carbon atom in the linker connecting the N9 atom of guanine to one of the phosphonate groups. The crystal structure of this ANbP in complex with human HGPRT was determined at 2.0 Å resolution and shows that it fills three key pockets in the active site. The most potent phosphoramidate prodrugs of these compounds have IC50 values in the low micromolar range in Pf lines and low toxicity in human A549 cells, demonstrating that these ANbPs are excellent antimalarial drug leads." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00926"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00926">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00926&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00926&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00926&amp;href=/doi/10.1021/acs.jmedchem.7b00926" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7539-7554</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00930" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00950" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of <i>Plasmodium falciparum</i> and Human Hypoxanthine–Guanine–(Xanthine) Phosphoribosyltransferase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Petr++%C5%A0pa%C4%8Dek">Petr Špaček</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dianne+T.++Keough">Dianne T. Keough</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marina++Chavchich">Marina Chavchich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Dra%C4%8D%C3%ADnsk%C3%BD">Martin Dračínský</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-4495-0070" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zlatko++Janeba">Zlatko Janeba</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lieve++Naesens">Lieve Naesens</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Edstein">Michael D. Edstein</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luke+W.++Guddat">Luke W. Guddat</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dana++Hockov%C3%A1">Dana Hocková</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-1673-8694" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, CZ-16610 Prague 6, Czech Republic</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4068, Australia</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Drug Evaluation, Australian Army Malaria Institute, Enoggera, Brisbane, Queensland 4051, Australia</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research—KU Leuven, Herestraat 49, B-3000 Leuven, Belgium</span></div><div class="corresp-info"><strong>*</strong>L.W.G.: e-mail, <a href="/cdn-cgi/l/email-protection#28445d434d064f5d4c4c495c685d59064d4c5d06495d"><span class="__cf_email__" data-cfemail="4f233a242a61283a2b2b2e3b0f3a3e612a2b3a612e3a">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>D.H.: e-mail, <a href="/cdn-cgi/l/email-protection#7a12151911150c1b3a0f1519121854191b09541900"><span class="__cf_email__" data-cfemail="86eee9e5ede9f0e7c6f3e9e5eee4a8e5e7f5a8e5fc">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00926&amp;href=/doi/10.1021%2Facs.jmedchem.7b00926" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7539–7554</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 16, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 June 2017</li><li><span class="item_label"><b>Published</b> online</span>30 August 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 September 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00926" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00926</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7539%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPetr%2B%25C5%25A0pa%25C4%258Dek%252C%2BDianne%2BT.%2BKeough%252C%2BMarina%2BChavchich%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D17%26contentID%3Dacs.jmedchem.7b00926%26title%3DSynthesis%2Band%2BEvaluation%2Bof%2BAsymmetric%2BAcyclic%2BNucleoside%2BBisphosphonates%2Bas%2BInhibitors%2Bof%2BPlasmodium%2Bfalciparum%2Band%2BHuman%2BHypoxanthine%25E2%2580%2593Guanine%25E2%2580%2593%2528Xanthine%2529%2BPhosphoribosyltransferase%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7554%26publicationDate%3DSeptember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00926"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1241</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00926" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine–Guanine–(Xanthine) Phosphoribosyltransferase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Petr&quot;,&quot;last_name&quot;:&quot;Špaček&quot;},{&quot;first_name&quot;:&quot;Dianne&quot;,&quot;last_name&quot;:&quot;T. Keough&quot;},{&quot;first_name&quot;:&quot;Marina&quot;,&quot;last_name&quot;:&quot;Chavchich&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Dračínský&quot;},{&quot;first_name&quot;:&quot;Zlatko&quot;,&quot;last_name&quot;:&quot;Janeba&quot;},{&quot;first_name&quot;:&quot;Lieve&quot;,&quot;last_name&quot;:&quot;Naesens&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Edstein&quot;},{&quot;first_name&quot;:&quot;Luke&quot;,&quot;last_name&quot;:&quot;W. Guddat&quot;},{&quot;first_name&quot;:&quot;Dana&quot;,&quot;last_name&quot;:&quot;Hocková&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;7539-7554&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00926&quot;},&quot;abstract&quot;:&quot;Acyclic nucleoside bisphosphonates (ANbPs) have previously been shown to be good inhibitors of human hypoxanthine–guanine phosphoribosyltransferase (HGPRT) and Plasmodium falciparum (Pf) hypoxanthine–guanine–xanthine phosphoribosyltransferase (PfHGXPRT). On the basis of this scaffold, a new series of ANbPs was synthesized. One of these new ANbPs, [3-(guanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methylphosphonic acid, exhibited Ki values of 6 and 70 nM for human HGPRT and Pf HGXPRT, respectively. These low Ki values were achieved by inserting an extra carbon atom in the linker connecting the N9 atom of guanine to one of the phosphonate groups. The crystal structure of this ANbP in complex with human HGPRT was determined at 2.0 Å resolution and shows that it fills three key pockets in the active site. The most potent phosphoramidate prodrugs of these compounds have IC50 values in the low micromolar range in Pf lines and low toxicity in human A549 cells, demonstrating that these ANbPs are excellent antimal&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00926&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00926" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00926&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00926" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00926&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00926" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00926&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00926&amp;href=/doi/10.1021/acs.jmedchem.7b00926" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00926" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00926" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00926%26sid%3Dliteratum%253Aachs%26pmid%3D28813147%26genre%3Darticle%26aulast%3D%25C5%25A0pa%25C4%258Dek%26date%3D2017%26atitle%3DSynthesis%2Band%2BEvaluation%2Bof%2BAsymmetric%2BAcyclic%2BNucleoside%2BBisphosphonates%2Bas%2BInhibitors%2Bof%2BPlasmodium%2Bfalciparum%2Band%2BHuman%2BHypoxanthine%25E2%2580%2593Guanine%25E2%2580%2593%2528Xanthine%2529%2BPhosphoribosyltransferase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D17%26spage%3D7539%26epage%3D7554%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=291157" title="Organophosphorus compounds">Organophosphorus compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/jmcmar.2017.60.issue-17/20170914/jmcmar.2017.60.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Acyclic nucleoside bisphosphonates (ANbPs) have previously been shown to be good inhibitors of human hypoxanthine–guanine phosphoribosyltransferase (HGPRT) and <i>Plasmodium falciparum (Pf)</i> hypoxanthine–guanine–xanthine phosphoribosyltransferase (<i>Pf</i>HGXPRT). On the basis of this scaffold, a new series of ANbPs was synthesized. One of these new ANbPs, [3-(guanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methylphosphonic acid, exhibited <i>K</i><sub>i</sub> values of 6 and 70 nM for human HGPRT and <i>Pf</i> HGXPRT, respectively. These low <i>K</i><sub>i</sub> values were achieved by inserting an extra carbon atom in the linker connecting the N<sup>9</sup> atom of guanine to one of the phosphonate groups. The crystal structure of this ANbP in complex with human HGPRT was determined at 2.0 Å resolution and shows that it fills three key pockets in the active site. The most potent phosphoramidate prodrugs of these compounds have IC<sub>50</sub> values in the low micromolar range in <i>Pf</i> lines and low toxicity in human A549 cells, demonstrating that these ANbPs are excellent antimalarial drug leads.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07870" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07870" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Malaria remains as one of the most lethal infectious diseases known to afflict mankind with 429 000 deaths and 212 million infections in 2015.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The causative agent of malaria is a protozoan parasite that belongs to <i>Plasmodium</i> genus and is spread by the bite of female Anopheles mosquito. Of the five <i>Plasmodium</i> species that can infect humans, <i>Plasmodium falciparum</i> (<i>Pf</i>) and <i>Plasmodium vivax</i> (<i>Pv</i>) are the most lethal and widespread.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Artemisinin based combination therapies (ACTs) are used worldwide for the treatment of malaria, but alarmingly ACT resistance has emerged in Southeast Asia with failure rates of 50% and 26% in Cambodia<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and Vietnam,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> with the use of dihydroartemisinin-piperaquine, respectively. On the basis that malarial infections remain as major cause of morbidity and mortality, the need to discover new antimalarial drug targets and new therapeutic agents with novel mechanisms is of the utmost importance.</div><div class="NLM_p">Hypoxanthine–guanine–xanthine phosphoribosyltransferase (HGXPRT) is an attractive drug target for antimalarial drug therapy, as its activity is essential for both the survival and reproduction of malarial parasites.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This is because it provides the only pathway for the synthesis of the 6-oxopurine nucleoside monophosphates required for DNA and RNA production (salvage pathway). HGXPRT is also indirectly responsible for the synthesis of the 6-amino nucleoside monophosphate, AMP, as this is produced in these parasites starting from IMP. The nucleotides, IMP, GMP and XMP, are therefore synthesized from hypoxanthine, guanine, and xanthine which are actively transported from their host cell. Though humans possess both a de novo pathway starting from simple precursors as well as the salvage pathway, the malarial parasites rely solely on the salvage pathway. Independent studies have shown that both purine starvation by inhibition of purine nucleoside phosphorylase<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and hypoxanthine depletion<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> have been effective routes to preventing the growth of malarial parasites, either in cell culture or in Aotus monkeys. These data provide further confirmation that purine metabolism is a major flaw in the parasitic armory that can be exploited for effective antimalarial drug discovery.</div><div class="NLM_p">HG(X)PRTs catalyze the formation of the 6-oxopurine nucleoside monophosphates from a nucleobase and from 5′-phospho-α-<span class="smallcaps smallerCapital">d</span>-ribosyl-1-pyrophosphate (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). The human and <i>Pv</i> enzymes use only hypoxanthine and guanine as substrates, whereas the <i>Pf</i> enzyme uses all three bases as substrates, hence the assignment of the enzymes as human HGPRT, <i>Pv</i>HGPRT and <i>Pf</i>HGXPRT. The presence of divalent metal ions, presumably magnesium in vivo, is essential for the reaction to proceed. Despite the fact that there is some redundancy in the salvage pathway (e.g., IMP dehydrogenase and GMP synthetase are present in the <i>Pf</i> genome), direct inhibition of HGXPRT<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> has been shown to be an efficient strategy for the development of novel lead antiparasitic and antibacterial agents.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14 ref15">(9-15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reaction catalyzed by HGPRT/HGXPRT. R = H (hypoxanthine), R = NH<sub>2</sub> (guanine), R = OH (xanthine).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The chemical structures of bisphosphonate HGPRT/HGXPRT inhibitors<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> previously characterized in a SAR study are given in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A and <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B. The basic structure of the newly synthesized ANbPs is shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General structures of ANbP-based HGPRT/HGXPRT inhibitors: (A, B) previously published bisphosphonates;<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (C) new asymmetric inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The design of new inhibitors presented in this paper (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C) is based on alterations to the scaffold of published acyclic nucleoside bisphosphonates (ANbPs, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A,B). These ANbPs have a 6-oxopurine base attached either to a symmetric moiety bearing two phosphonomethyloxy groups (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A) or to an asymmetric moiety with two phosphonoethyloxy groups (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The rationale for the design of new asymmetric ANbPs (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C) is based on the crystal structure of human HGPRT in complex with <b>1a</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In new series of compounds, five atoms<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> are contained in the linker connecting the N<sup>9</sup> atom of the purine base with one of the phosphonate groups. The crystal structure of human HGPRT in complex with <b>1a</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> shows that this particular phosphonate group is located in the 5′-phosphate binding pocket (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The second phosphonate group points down toward the PP<sub>i</sub> binding pocket, but this moiety is not located in this pocket. Instead, a sulfate ion, from the crystallization buffer, was found to occupy this site which is also the location where the second product of the reaction, PP<sub>i</sub>, binds. The crystal structure shows that a magnesium ion is coordinated to one of the sulfate oxygen atoms and one of the phosphonate oxygen atoms of <b>1a</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. [(2-[(Guanin-9-yl)methyl]propane-1,3-diyl)bis(oxy)]bis(methylene)diphosphonic acid (<b>1a</b>) bound in the active site of human HGPRT (Protein Data Bank code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IJQ">4IJQ</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> A sulfate ion from the crystallization media is present in the complex along with two magnesium ions (purple spheres).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Molecular docking suggested that lengthening one of the linkers by one atom may allow the second phosphonate group to be located in the PP<sub>i</sub> binding pocket leading to decreased <i>K</i><sub>i</sub> values (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> yellow structure). In addition, the chemical nature of the purine base was altered to examine the effects of such changes on the inhibition constants for human HGPRT and <i>Pf</i>HGXPRT.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the crystal structure of the human HGPRT·<b>1a</b> complex<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> with the docked structure of the new guanine derivative <b>20</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) overlaid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To test the antimalarial activity of the new inhibitors in erythrocyte cell culture infected by <i>Pf</i>, a prodrug approach was employed.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The highly polar bisphosphonates are unable to cross the cell membrane unless the phosphonate groups are masked by moieties which are cleaved enzymatically once the intact prodrug enters the cells. Phosphoramidate prodrugs bearing four nontoxic ethyl ester of <span class="smallcaps smallerCapital">l</span>-phenylalanine moieties<a onclick="showRef(event, 'ref14 ref16 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref16 ref19">(14, 16, 19)</a> were prepared, their IC<sub>50</sub> values were measured against <i>Pf</i> in cell culture, and their cytotoxicity in mammalian cells in tissue culture was determined.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10015" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10015" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The synthesis of this series of asymmetric ANbPs inhibitors can be described in three consecutive parts. The first part was to prepare the key hydroxy derivative <b>8</b>. This precursor contains two different functional groups (phosphonomethyl and phosphonoethyl) attached via ether bonds to the main scaffold (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The second part of the synthesis was the Mitsunobu reaction affording the connection of this bisphosphonate moiety to N-9 position of a purine base. The last part was a sequence of reactions transforming the preformed derivatives to the final inhibitors (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) BrCH<sub>2</sub>P(O)(O<i>i</i>Pr)<sub>2</sub>, NaH, DMF, 0°C; (b) DOWEX (50WX8 H<sup>+</sup>), 90% MeOH, 50°C; (c) TBDMSCl, imidazole, DMF, rt; (d) diethyl vinylphosphonate, Cs<sub>2</sub>CO<sub>3</sub>, <i>t</i>-BuOH, rt; (e) DOWEX (50WX8 H<sup>+</sup>), 90% MeOH, 50°C.</p></p></figure><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) DIAD, PPh<sub>3</sub>, 6-chloropurine, 2-amino-6-chloropurine or corresponding 7-deazapurines, THF, −30°C; (b) CF<sub>3</sub>COOH, H<sub>2</sub>O, rt; (c) K<sub>2</sub>CO<sub>3</sub>, DABCO, H<sub>2</sub>O, 120°C; (d) Br<sub>2</sub>, CCl<sub>4</sub>, DMF, rt; (e) BrSi(CH<sub>3</sub>)<sub>3</sub>, CH<sub>3</sub>CN, rt.</p></p></figure><div class="NLM_p">Starting material <b>3</b> (5-hydroxymethyl-2,2-dimethyl-1,3-dioxane) was prepared by simultaneous protection of two hydroxy groups of commercially available 2-hydroxymethyl-1,3-propanediol using reaction with dry acetone and acid catalyst.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Obtained alcohol <b>3</b> was transformed to a phosphonomethyloxy derivative <b>4</b> by the reaction with diisopropyl (bromomethyl)phosphonate and sodium hydride in DMF. Intermediate <b>4</b> was treated with DOWEX (50WX8 H<sup>+</sup>) in methanol to obtain dihydroxy derivative <b>5</b>, which was a key intermediate for the subsequent synthetic pathways (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">In the course of the first attempts to attach the second phosphonate group, dihydroxy derivative <b>5</b> was treated with various molar equivalents of diethyl vinylphosphonate under oxa-Michael reaction conditions.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, required alcohol <b>8</b> was not obtained in a sufficient quantity. Depending on the reaction conditions (using various bases and differing amounts of diethyl vinylphosphonate), we observed either product <b>9</b> with two attached phosphonoethoxy groups or the starting material <b>5</b> with a very small amount of desired product <b>8</b>. Therefore, we tried to protect one of the hydroxy groups of intermediate <b>5</b> using standard protecting groups. This would subsequently enable a selective introduction of only one phosphonoethoxy group. Experiments with several alkylating agents (benzyl halogenides or trityl chloride) under various reaction conditions (low temperature, various dry solvents, different bases) were carried out. Unfortunately, none of these methods to synthesize derivatives <b>6b</b> and <b>6c</b> were successful on a preparative scale.</div><div class="NLM_p">Another approach was to prepare a fully protected cyclic carbonate diester derivative from dihydroxy phosphonate <b>5</b> using ethyl chloroformate in THF with the addition of triethylamine and subsequently cleave this compound by an acid-catalyzed reaction with silica gel and corresponding alcohol to form carbonate esters <b>6d</b> and <b>6e</b>. Isopropyl alcohol and benzyl alcohol were chosen to diversify possible methods for later deprotection. Attempts were then made to attach a phosphonoethoxy functional group to intermediate <b>6d</b> or <b>6e</b>. Despite multiple attempts with reaction conditions of oxa-Michael addition, phosphonoethoxy derivatives <b>7b</b> and <b>7c</b> could not be obtained.</div><div class="NLM_p">Ultimately, a successful synthetic pathway was developed (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). This was via a <i>tert</i>-butyldimethylsilyl protected intermediate <b>6a</b>, which was prepared by the reaction of a 1.1 molar equiv of <i>tert-</i>butyldimethylsilyl chloride (TBDMSCl) and imidazole as a base in THF.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Protected alcohol <b>6a</b> further reacted with diethyl vinylphosphonate under standard reaction conditions of oxa-Michael addition to form bisphosphonate <b>7a</b>. Intermediate <b>7a</b> was treated with DOWEX (50WX8 H<sup>+</sup>) to obtain the final hydroxy derivative <b>8</b>, a key precursor for the synthesis of the inhibitors and their prodrugs.</div><div class="NLM_p">Further process leading to the synthesis of asymmetrical ANbPs was based on parallel reaction procedures (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). First, bisphosphonate moiety of alcohol <b>8</b> was introduced under Mitsunobu reaction conditions to the N-9 position of 2-amino-6-chloropurine, 6-chloropurine, 2-amino-6-chloro-7-deazapurine, and 6-chloro-7-deazapurine to form derivatives <b>10</b>, <b>11</b>, <b>12</b>, <b>13</b>. Transformation to the corresponding 6-oxopurine and 6-oxo-7-deazapurine analogues followed. 6-Chloropurine derivatives <b>10</b> and <b>11</b> were treated using standard conditions with a mixture of trifluoroacetic acid and water to obtain intermediates <b>14</b> and <b>15</b>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> For intermediates <b>12</b> and <b>13</b> with 7-deaza-modified heterocyclic bases a more vigorous method had to be applied. Thus, 7-deazapurine compounds <b>12</b> and <b>13</b> were hydrolyzed by the reaction with potassium carbonate and DABCO in water<a onclick="showRef(event, 'ref17 ref23'); return false;" href="javascript:void(0);" class="ref ref17 ref23">(17, 23)</a> to form 6-oxo-7-deazapurine derivatives <b>18</b> and <b>19</b>.</div><div class="NLM_p">Previously, an activity of several 8-bromoguanine derivatives was observed.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Therefore, we also decided to prepare bromo derivatives for testing. Thus, intermediates <b>14</b> and <b>15</b> were used for preparation of bromo derivatives <b>16</b> and <b>17</b> by bromination with elementary bromine in CCl<sub>4</sub> and DMF. Synthesis of bromo derivative <b>27</b> started from a previously published<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> diester of bisphosphonate <b>2c</b>, which was transformed to the corresponding 8-bromoguanine derivative <b>26</b> by the above-mentioned bromination method (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Br<sub>2</sub>, CCl<sub>4</sub>, DMF, rt; (b) BrSi(CH<sub>3</sub>)<sub>3</sub>, CH<sub>3</sub>CN, rt.</p></p></figure><div class="NLM_p">The last step for the preparation of the target ANbPs was the cleavage of phosphonate ester groups.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Esters <b>14</b>, <b>15</b>, <b>16</b>, <b>17</b>, <b>18</b>, <b>19</b>, and <b>26</b> were treated with bromotrimethylsilane in acetonitrile followed by hydrolysis to obtain free phosphonic acids <b>20</b>, <b>21</b>, <b>22</b>, <b>23</b>, <b>24</b>, <b>25</b>, and <b>27</b>.</div><div class="NLM_p">To improve cell penetration properties of the ANbP inhibitors, phosphoramidate prodrugs were prepared from corresponding esters (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Phosphonate ester precursors <b>14</b>, <b>15</b>, <b>18</b>, and <b>19</b> were transformed to the corresponding prodrugs <b>28</b>, <b>29</b>, <b>30</b>, and <b>31</b> by treatment with bromotrimethylsilane in acetonitrile, followed by the reaction of thus preformed silyl esters with <span class="smallcaps smallerCapital">l</span>-phenylalanine ethyl ester, 2,2′-dipyridyl disulfide, and triphenylphosphine in dry pyridine.<a onclick="showRef(event, 'ref16 ref26'); return false;" href="javascript:void(0);" class="ref ref16 ref26">(16, 26)</a></div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0015.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (1) BrSi(CH<sub>3</sub>)<sub>3</sub>, CH<sub>3</sub>CN, rt, (2) PPh<sub>3</sub>, aldrithiol, (<span class="smallcaps smallerCapital">l</span>)-NH<sub>2</sub>CH(Bn)COOEt·HCl, Et<sub>3</sub>N, pyridine, 70°C; (b) NBS, 1,4-dioxane, microwave, 100 °C.</p></p></figure><div class="NLM_p last">Direct preparation of phosphoramidate prodrugs of 8-bromo ANbPs from the corresponding esters is not possible.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Therefore, direct bromination of the final prodrugs with NBS and 1,4-dioxane in a microwave reactor was used. By use of this approach, prodrugs <b>28</b>, <b>29</b> and previously published<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> prodrug <b>34</b> were transformed to corresponding 8-bromopurine prodrugs <b>32</b>, <b>33</b>, and <b>35</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Inhibition of Human HGPRT and <i>Pf</i> HGXPRT</h3><div class="NLM_p">The <i>K</i><sub>i</sub> values of the newly synthesized ANbPs for human HGPRT and <i>Pf</i>HGXPRT are given in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> together for the data obtained with the previously published compounds (<b>1a</b>, <b>1b</b>, and <b>2a</b>; <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A and <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> to allow a direct comparison.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of <i>K</i><sub>i</sub> Values for ANbPs with Human HGPRT and <i>Pf</i> HGXPRT</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0016.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Data from ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>. <sup><i>b</i>,<i>c</i></sup>No inhibition for <b>2b</b> and <b>23</b> was observed when these compounds were tested at a concentration of 33 μM and 50 μM, respectively.</p></div></div><div></div></div><div class="NLM_p">Compound <b>1a</b> is a potent inhibitor of both the human and <i>Pf</i> enzymes (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Surprisingly, changing the attached purine base from guanine to hypoxanthine resulted in a large increase in <i>K</i><sub>i</sub> values (33-fold for human HGPRT and 71-fold for <i>Pf</i>HGXPRT). This is partly understandable for the human enzyme as guanine has a 2-fold lower <i>K</i><sub>m</sub> for guanine compared with hypoxanthine (1.9 μM for guanine compared with 3.4 μM for hypoxanthine). The <i>Pf</i> enzyme, on the other hand, has a lower <i>K</i><sub>m</sub> value for hypoxanthine compared with guanine (0.8 μM for guanine compared with 0.07 μM for hypoxanthine).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The significant increase in the <i>K</i><sub>i</sub> value due to the change in the base from guanine to hypoxanthine is evident when the <i>K</i><sub>i</sub> values of <b>20</b> and <b>21</b> are compared resulting in a 300-fold increase for human HGPRT and a 43-fold increase for <i>Pf</i>HGXPRT. Thus, for these two ANbP scaffolds, the nature of the purine base, whether hypoxanthine or guanine, has a significant influence on the <i>K</i><sub>i</sub> values.</div><div class="NLM_p">In series 2, substitution of guanine by hypoxanthine had little effect on the <i>K</i><sub>i</sub> values for the human enzyme (0.4–0.7 μM) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) though, once again, a large increase was observed for <i>Pf</i>HGXPRT. In this series, there was no change in the <i>K</i><sub>i</sub> value when guanine was replaced by 8-bromoguanine for either enzyme. The only difference in the structures in the ANbPs in series 2 compared with series 3 is the position of the oxygen atom in the linker (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Thus, the higher <i>K</i><sub>i</sub> values for the guanine containing compounds in series 2 compared with series 3 are attributed to the change in position of this oxygen atom. This atom is located in the linker connecting the N<sup>9</sup> atom of the base with the phosphonate group predicted to bind in the 5′-phosphate binding pocket. This prediction is based on the crystal structure of the human HGPRT·<b>1a</b> complex (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The location of the oxygen atom can influence the conformation of the linker and, thus, the location of the phosphonate group and the purine base in the active site. Therefore, it is clear that subtle chemical modifications can have a large effect on the orientation of the ANbPs in the active site.</div><div class="NLM_p last">In series 3, the attachment of 8-bromo or 7-deaza bases, either guanine or hypoxanthine derivatives, resulted in weak inhibition of both enzymes. Both these bases are very weak substrates, and this obviously influences the affinity of their ANbP. The crystal structure of <b>20</b> (series 3) in complex with human HGPRT was obtained and compared with that of the human HGPRT·<b>1a</b> structure to explain the decrease in the <i>K</i><sub>i</sub> values (cf. series 3 and series 1). This structure also provides an entry into the design of next generation compounds based on the structure and activity of these ANbPs.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Crystal Structure of the Human HGPRT·<b>20</b> Complex</h3><div class="NLM_p">To explain the potent binding of <b>20</b>, the crystal structure of the human HGPRT·<b>20</b> was determined to 2.03 Å resolution. The refinement statistics of this structure are given in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. The crystals contain a tetramer in the asymmetric unit (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), and <b>20</b> is bound in the active site of each subunit (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a> shows that the large mobile loop of ∼20 amino acid residues is disordered. This compares with its structure when ImmGP<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>/ImmHP<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>/acyclic immucillin phosphonate (AIP),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> PP<sub>i</sub>, and Mg<sup>2+</sup> are bound to human HGPRT or to <i>Pf</i>HGXPRT where this region becomes ordered and closes over the active site. The immucillins are compounds that are inert mimics for the predicted transition state of the reaction (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). When AIP binds, the large mobile loop becomes ordered and covers the active site of <i>Pf</i>HGXPRT. The ordering is due to the formation of hydrogen bonds between (i) the backbone amide S115 (<i>Pf</i> numbering) and a pyrophosphate oxygen, (ii) the backbone amide of Y116 (<i>Pf</i> numbering) and the same pyrophosphate oxygen, and (iii) the hydroxyl of Y116 and a phosphonate oxygen of AIP. Similar sets of stabilizing interactions have also been observed when ImmGP or ImmHP bind to human HGPRT or <i>Pf</i>HGXPRT.<a onclick="showRef(event, 'ref8 ref27'); return false;" href="javascript:void(0);" class="ref ref8 ref27">(8, 27)</a></div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of the tetrameric human HGPRT·<b>20</b> complex. Magenta highlights the location of the ordered regions adjacent to the large mobile loop, residues R100-D120, which are not visible in this complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Data Collection and Refinement Statistics for the Human HGPRT·<b>20</b> Complex<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><u class="uu">Crystal Data</u></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unit cell length <i>a</i>, <i>b</i>, <i>c</i> (Å)</td><td class="colsep0 rowsep0" align="left">56.67, 128.40, 65.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unit cell angle α, β, γ (deg)</td><td class="colsep0 rowsep0" align="left">90.0, 103.0, 90.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">space group</td><td class="colsep0 rowsep0" align="left"><i>P</i>2<sub>1</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">crystal size (mm)</td><td class="colsep0 rowsep0" align="left">0.3 × 0.1 × 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution range (Å)</td><td class="colsep0 rowsep0" align="left">47.30–2.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">observations</td><td class="colsep0 rowsep0" align="left">438 819 (31 172)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unique reflections</td><td class="colsep0 rowsep0" align="left">58 747 (4242)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">completeness (%)</td><td class="colsep0 rowsep0" align="left">99.7 (98.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>merge</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.081 (0.654)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>pim</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.038 (0.277)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">⟨<i>I</i>⟩/⟨σ(<i>I</i>)⟩</td><td class="colsep0 rowsep0" align="left">13.9 (2.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution limits (Å)</td><td class="colsep0 rowsep0" align="left">47.30–2.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>work</sub></td><td class="colsep0 rowsep0" align="left">0.1962</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>free</sub></td><td class="colsep0 rowsep0" align="left">0.2487</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Clashscore<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">11.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><u class="uu">Refinement Statistics</u></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution limits (Å)</td><td class="colsep0 rowsep0" align="left">47.30−2.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>work</sub></td><td class="colsep0 rowsep0" align="left">0.1962</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>free</sub></td><td class="colsep0 rowsep0" align="left">0.2487</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Clashscore<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">11.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RMSD bond lengths (Å)</td><td class="colsep0 rowsep0" align="left">0.0036</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RMSD bond angles (deg)</td><td class="colsep0 rowsep0" align="left">0.713</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tetramers</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">inhibitors</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">waters</td><td class="colsep0 rowsep0" align="left">521</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Mg<sup>2+</sup></td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">favored</td><td class="colsep0 rowsep0" align="left">96.91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">outliers</td><td class="colsep0 rowsep0" align="left">2.33</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Values in parentheses are for the outer resolution shell (2.08–2.03 Å). All data were collected at 100 K.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Calculated using <span class="NLM_inline-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/jm-2017-00926j_m001.gif" alt="" /></img></span>.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Calculated using <span class="NLM_inline-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/jm-2017-00926j_m002.gif" alt="" /></img></span>. <i>I</i><sub><i>i</i></sub>(<i>hkl</i>) is the observed intensity and <i>I</i>(<i>hkl</i>) is the average intensity obtained from multiple observations of symmetry related reflections.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Clashscore is defined as the number of bad overlaps of ≥0.4 Å per thousand atoms.</p></div></div></div><div class="NLM_p"><a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A shows the electron density for <b>20</b> in the active site, and <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B shows the superimposition of the structure of the inhibitor bound in each of the four subunits. The location of the three critical structural elements of <b>20</b>, i.e., the purine ring and the two phosphonate groups, is the same in each of the four subunits, though there are slight differences in the conformation of the linker (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). The only significant difference occurs in subunit B. In this subunit, the oxygen atom is pushed further back into the active site than in the other three subunits. In this position, it is located within 2.5 Å of a water molecule that forms a hydrogen bond to the N<sup>3</sup> of the purine ring (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). This water molecule also forms a hydrogen bond to one of the phosphonyl oxygen atoms. There are no interactions between either of the two linkers and active site residues or bridging waters.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Electron density map of [3-(guanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methylphosphonic acid (<b>20</b>) bound in subunit C. The pale blue sphere shows the location of the single magnesium ion in the active site. (B) Superimposition of subunits A, B, C, and D showing the location of <b>20</b> in each of the four active sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Interaction between the oxygen atom in one of the linkers and the bridging water molecule when <b>20</b> is bound in the active site of subunit B of human HGPRT. The hydrogen bond between the exocyclic amino group and the carbonyl of D193 occurs in all subunits.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> Comparison of the Crystal Structures of the Human HGPRT·<b>1a</b> and HGPRT·<b>20</b> Complexes</h4><div class="NLM_p">Superimposition of these two structures reveals that the location of the purine base and the location of the phosphonate group bound in the 5′-phosphate binding pocket are identical (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) and that the structures of the flexible loops that surround the active site are unchanged (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). The differences between the two structures is in the location of the second phosphonate group (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Comparison of the binding mode of <b>20</b> and <b>1a</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IJQ">4IJQ</a>) in the active site of human HGPRT. Compound <b>1a</b> with the associated sulfate ion: dark blue. Compound <b>20</b>: colored by element.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Thus, the differences in the <i>K</i><sub>i</sub> values between <b>20</b> and <b>1a</b> for human HGPRT are attributed to how the second phosphonate group, which points down into the PP<sub>i</sub> pocket, binds in the active site. In the human HGPRT·<b>20</b> complex, this group points back into the active site toward the PP<sub>i</sub> binding pocket, while in <b>1a</b> it points out of the active site, leaving room for a sulfate and magnesium ion to bind (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). It is, therefore, speculated that the higher <i>K</i><sub>i</sub> value for <i>Pf</i>HGXPRT compared to human HGPRT (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) may be due to differences in the mode of binding of this phosphonate group.</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Specific Interactions That the Phosphonyl Oxygens of the Second Phosphonate Group Form at the Active Site in the Human HGPRT·<b>20</b> Complex</h4><div class="NLM_p">A network of hydrogen bonds holds this phosphonate group in place when <b>20</b> is bound in the active site of human HGPRT (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). One of the phosphonyl oxygen atoms forms hydrogen bonds to three water molecules. These form hydrogen bonds with each other and with the highly conserved residues, D193 (OD), R199 (NH<sub>2</sub>), and G69 (backbone nitrogen). A second hydrogen bond is also evident between one of the other phosphonyl oxygen atoms and a water molecule that forms a hydrogen bond with the OD atom of D134 and is also coordinated to a magnesium ion (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). Thus, this network of bonds via bridging waters makes a strong contribution to anchoring <b>20</b> in position.</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0009.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Network of hydrogen bonds that the phosphonyl oxygen atoms of the phosphonate groups, which point into the PP<sub>i</sub> binding pocket, form at the active site of the human HGPRT·<b>20</b> complex. The green sphere is magnesium ion, and the red spheres are waters.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the human HGPRT·<b>20</b> complex, the phosphonate group (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>) is located in the same position as one of phosphate groups of pyrophosphate when this second product of the reaction is bound in the active site of human HGPRT together with ImmGP<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and magnesium ions (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>). The space in the active site occupied by the second phosphate group of PP<sub>i</sub> is instead occupied by water molecules when <b>20</b> binds (cf. <a class="ref internalNav" href="#fig9" aria-label="Figures 9">Figures 9</a> and <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). In the human HGPRT·<b>1a</b> complex, sulfate ions replaces one of the phosphate group of PP<sub>i</sub> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>). As there are no negatively charged ions in this vicinity in the human.<b>20</b> complex, i.e., phosphate or sulfate, the magnesium ion found in the HGPRT·ImmGP·PPi and HGPRT·<b>1a</b> complexes is not present.</div><figure id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0010.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Superimposition of the human HGPRT·<b>20</b> complex with the human enzyme in complex with (2-[(guanin-9-yl)methyl]propane-1,3-diyl)bis(oxy)]bis(methylene)diphosphonic acid (<b>1a</b>) and sulfate (yellow)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IJQ">4IJQ</a>) and ImmGP and pyrophosphate (dark blue)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BZY">1BZY</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The network of hydrogen bonds is a strongly contributing factor leading to the low <i>K</i><sub>i</sub> value of <b>20</b> for human HGPRT. It is unclear though why the hypoxanthine derivative binds much more weakly to both the human and <i>Pf</i> enzymes (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The absence of a single hydrogen bond between the backbone carbonyl of D193 and the exocyclic amino group seems unlikely to cause such a dramatic decrease if the ANbP was bound in exactly the same place as its guanine counterpart. Thus, the most logical conclusion is that this is not the case and when the base is hypoxanthine, this change influences the whole orientation of the ANbP in the active site and, thus, has a much higher <i>K</i><sub>i</sub> value.</div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vitro Antimalarial Study in Erythrocyte Cell Cultures Infected by <i>Plasmodium falciparum</i></h3><div class="NLM_p">Phosphoramidate prodrugs (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) for each inhibitor in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> were synthesized and tested for their ability to restrict the growth of <i>Pf</i> in cell culture. The results are given in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Antimalarial Activity and Cytotoxicity of ANbP Prodrugs in Cell Culture Assays<a class="ref internalNav" href="#tbl3-fn1" aria-label="e">e</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0017.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last"><i>Pf</i> strain sensitive to most drugs.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Chloroquine- and pyrimethamine-resistant <i>Pf</i> strain.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Human lung carcinoma cells.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Data from ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>.</p></div><div class="footnote" id="tbl3-fn1"><sup>Table e</sup><p class="last">B = purine base. ND = not determined. SI = selectivity index = CC<sub>50</sub>/IC<sub>50</sub>. IC<sub>50</sub> and CC<sub>50</sub> represent the concentrations of the drug where cell growth is reduced by 50% in <i>Pf</i> and human cells, respectively.</p></div></div><div></div></div><div class="NLM_p last">The IC<sub>50</sub> values range between 1.4 and 9.7 μM. The precise reason for the variability is unknown as it could be attributed to a number of factors. These include differences in transport across the plasmodial membrane and/or hydrolysis of the prodrug to its active component. The phosphoramidate prodrugs have several advantages: They have a long intracellular half-life that allows infrequent dosing; the nontoxic amino acid moieties serve as an attachment, and their properties can be fine-tuned; and there is no stereochemistry issue (in contrast to Pro-Tide approach). Thus, the phosphoramidates can serve as good model compounds to show the in vitro activity of inhibitors and to compare individual types of inhibitors with each other. An encouraging result is the fact that <b>28</b>, whose parent compound <b>20</b> is the most potent inhibitor of human HGPRT (<i>K</i><sub>i</sub> = 6 nM), has an extremely low cytotoxicity in human A549 cell line. This is also true for compound <b>36</b>. It confirms the assumption that HGXPRT is an excellent drug target based on the fact that the purine salvage pathway is much more important for the parasite than for its host. Further studies are in progress to investigate if modifications to these current prodrugs can improve antimalarial activity.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The new ANbPs exhibit a range of <i>K</i><sub>i</sub> values for human HGPRT (0.006–4.6 μM) and for <i>Pf</i>HGXPRT (0.07–6.0 μM). These values strongly depend on the nature of the purine base. The crystal structure of the most potent of these inhibitors in complex with human HGPRT has been obtained. This suggests that one of the factors that could contribute to the potency and/or the selectivity for human HGPRT and <i>Pf</i>HGXPRT could be the binding of one of the phosphonate groups in the binding pocket of the second product of the reaction, PP<sub>i</sub>. Variable micromolar antiparasitic activity of phosophoramidate prodrugs of these inhibitors in <i>Pf</i> infected erythrocyte cultures was observed. The toxicity data in human cell line show that even a prodrug (<b>28</b>) of potent inhibitor of human HGPRT (<b>20</b>) does not affect host cells but at the same time can be toxic to parasites.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37318" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37318" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Synthesis and Analytical Chemistry</h3><div class="NLM_p">Unless stated otherwise, solvents were evaporated at 40 °C/2 kPa, and compounds were dried in vacuum oven at 2 kPa. Tetrahydrofuran (THF) was distilled with lithium aluminum hydride pellets under argon. <i>tert</i>-Butanol was stored over annealed molecular sieves (4 Å).</div><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR spectra were measured on a Avance 500 spectrometer (500 and 126 MHz) in DMSO-<i>d</i><sub>6</sub>, D<sub>2</sub>O, or D<sub>2</sub>O (NaOD additive) and referenced to TMS, residual solvent signal, or added solvent (<sup><i>t</i></sup>BuOH or 1,4-dioxane). Complete assignment is based on heteronuclear correlation experiments HSQC and H,C HMBC. Chemical shifts (δ) are in ppm and coupling constants (<i>J</i>) in Hz. The numbering system for the assignment of NMR signals is described in <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>. GC/MS spectra were measured on Agilent 5975B MSD spectrometer coupled to 6890N gas chromatograph. Determination of low-resolution mass spectra is described below (procedure 1 and procedure 2). High resolution mass spectra were measured: on Q-Tof micro (Waters) using ESI technique for low-resolution mass spectra, followed by LTQ Orbitrap XL (Thermo Fisher Scientific) spectrometer using ESI technique for high-resolution mass spectra.</div><figure id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0011.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures and the numbering system for the assignment of NMR signals of compounds in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For flash chromatography, Teledyne ISCO CombiFlash Rf200 with dual λ absorbance detector and various types of columns were used: (a) original Teledyne ISCO columns RediSepRf variation “HP silica GOLD” in sizes 12 g, 40 g, 80 g, and 120 g; (b) original Teledyne ISCO columns RediSepRf variation “HP C18 Aq GOLD” in sizes 50 g and 100 g; (c) column CHROMABOND Flash DL 40, DL 80, DL 120, and DL 200, filled by Fluka silica gel 60. Separation of UV nonabsorbing substances was made (a) with internal UV absorption standard (like caffeine) with similar <i>R<sub>f</sub></i> as required substance or (b) by capturing all fractions followed by analysis.</div><div class="NLM_p last">Purity of target compounds was ≥95%. Purity was determined by the combination of UPLC–PDA-MS, NMR, and HR-MS.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> UPLC–MS</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Procedure 1</h4><div class="NLM_p">Analytical sample was prepared typically so that 50 μL of reaction mixture or chromatographic fraction was diluted in suitable solvent (MeOH or acetonitrile) to concentration of about 1 mg of sample in 1 mL of solution. Mixture was diluted to 1–2 mL volume and filtered over syringe filter (0.22 μM, membrane material of PVDF).</div><div class="NLM_p">Samples were tested by universal LC method (eluent H<sub>2</sub>O/CH<sub>3</sub>CN, gradient 0–100%, run length 7 min) and time-tested MS method (ESI+, cone voltage of 30 V, mass detector range of ∼100–1000 Da in standard case; 500–1600 Da for measurement of prodrugs).</div><div class="NLM_p last">Analytical arrangement contains Waters UPLC H-class core system (column Waters Acquity UPLC BEH C18 1.7 μm, 2.1 mm × 100 mm), Waters Acquity UPLC PDA detector, mass spectrometer Waters SQD2.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Procedure 2</h4><div class="NLM_p last">Procedure is almost identical as described above in procedure 1. There are differences in solvent for dilution of samples (water) and MS method (ESI-, detector range of ∼100–1000 Da). This procedure is suitable for measurement of free phosphonic acids or their sodium salts.</div></div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthetic Procedures. General Procedure for Mitsunobu Reaction (Method A)</h3><div class="NLM_p last">To a solution of triphenylphosphine (3.5 g, 13.4 mmol) in dry THF (50 mL) cooled to −30 °C under argon atmosphere diisopropyl azadicarboxylate (DIAD, 2.4 mL, 12.2 mmol) was added. The mixture was stirred for 30 min to form a complex. The solution of the corresponding alcohol (4 mmol) in dry THF (30 mL) and 6-chloropurine (1 g, 6.4 mmol = 1.6 equiv) or 6-chloro-7-deazapurine (1 g, 6.4 mmol = 1.6 equiv) was added to the preformed complex, and the reaction flask was filled with argon again. The resulting mixture was slowly warmed up to room temperature and stirred for 2 days. MeOH (30 mL) was added to dissolve all possible heterogeneous particles. Solvent was evaporated, and the crude mixture was purified by flash chromatography (silica gel; eluent CHCl<sub>3</sub>/MeOH, gradient 1–10%). The pure product was obtained as a yellowish solid or a foam.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure for the Mitsunobu Reaction (Method B)</h3><div class="NLM_p last">Starting from 2-amino-6-chloropurine or 2-amino-6-chloro-7-deazapurine and the corresponding alcohol, the procedure was identical as described above (Method A). Then after the stirring of the reaction mixture for 2 days, water (30 mL) and MeOH (30 mL) were added and the mixture was heated at 80 °C for 30 h. Solvent was evaporated, the residue was codistilled with toluene, and the crude mixture was purified by flash chromatography (silica gel; eluent CHCl<sub>3</sub>/MeOH, gradient 2–15%).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for Hydrolysis of 6-Chloropurine and 2-Amino-6-chloropurine Derivatives to Corresponding 6-Oxopurine and 2-Amino-6-oxopurine Derivatives (Method C)</h3><div class="NLM_p last">The 6-chloropurine or 2-amino-6-chloropurine derivative (4.13 mmol) was dissolved in aqueous trifluoroacetic acid (75%, 60 mL) and stirred overnight at room temperature. The solvent was evaporated, and the residue was codistilled with water (3×) and toluene (2×). The crude product was purified by flash chromatography (silica gel; eluent CHCl<sub>3</sub>/MeOH, gradient 2–15%). Pure product was obtained as a solidified oil.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure for Hydrolysis of 6-Chloro-7-deazapurine and 2-Amino-6-chloro-7-deazapurine Derivatives to Corresponding 6-Oxo-7-deazapurine and 2-Amino-6-oxo-7-deazapurine Derivatives (Method D)</h3><div class="NLM_p last">The appropriate 6-chloropurine derivative (3 mmol) was dissolved or suspended in water (40 mL) containing K<sub>2</sub>CO<sub>3</sub> (1.69 g, 12.2 mmol) and DABCO (0.69 g, 6.2 mmol). The reaction mixture was stirred and heated to 120 °C for 1–4 h. The resultant solution was cooled down, neutralized by 1 M HCl and a product extracted to CHCl<sub>3</sub> (3 × 50 mL). Organic phase was washed with water (2 × 100 mL), followed by brine (1 × 100 mL) and dried over MgSO<sub>4</sub>. Compounds were purified by flash chromatography (silica gel; CHCl<sub>3</sub>/MeOH, gradient 2–10%). Reaction was monitored by LC–MS (procedure 1).</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for Synthesis of Sodium Salts of Free Bisphosphonates (Method E)</h3><div class="NLM_p last">A mixture of bisphosphonic acid diester (diisopropyl or diethyl ester) (1 mmol), acetonitrile (20 mL), and BrSiMe<sub>3</sub> (2 mL) was stirred overnight at room temperature. After evaporation, the residue was stirred with MeOH/water (1:1, 20 mL) for 2 h at room temperature. The solvent was evaporated in vacuo. The residue was dissolved in solution of TEAB (5 mL of 2 M aqueous TEAB), evaporated in vacuo, and codistilled with water (3×). That TEAB salt was purified by flash chromatography (C18 silica gel, 0.125 M aqueous TEAB/MeOH, gradient 0–40%) and evaporated in vacuo and codistilled with water (3×). The residue was dissolved in small volume of water (5 mL) and percolated through DOWEX (50WX8 Na<sup>+</sup>, 5 g) to obtain sodium salt of the bisphosphonic acid. Filtrate was partially evaporated and prepared for following manipulation by lyophilization from water.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for Bromination of 6-Oxopurine Derivatives (Method F)</h3><div class="NLM_p last">To a solution of corresponding 6-oxopurine derivative (2 mmol) in DMF (10 mL), 0.3 M solution of bromine in CCl<sub>4</sub> (13 mL, 4 mmol of Br<sub>2</sub>, 2 equiv) was added. Reaction mixture was stirred for 2–12 h at room temperature. The mixture was evaporated in vacuo, codistilled with toluene (3×), and purified by flash chromatography (silica gel; CHCl<sub>3</sub>/MeOH, gradient 1–10%). Reaction was monitored by LC–MS (procedure 1). The product was obtained as colorless/yellowish solidified oil.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure for Synthesis of Tetra-(<span class="smallcaps smallerCapital">l</span>-phenylalanine ethyl ester) Prodrug of Bisphosphonates (Method G)</h3><div class="NLM_p last">Bisphosphonic acid tetraester (diisopropyl or diethyl ester) (1 mmol) was codistilled with dry acetonitrile (2×). Dry acetonitrile (20 mL) and bromotrimethylsilane (2 mL) were mixed with bisphosphonic acid tetraester and stirred overnight at room temperature under argon. After evaporation in vacuo and codistillation with dry acetonitrile (3×) (without any contact with air), the flask was purged with argon, and amino acid ester hydrochloride (2.5 g, 10.88 mmol, dried in vacuo at 30 °C and 0.1 mbar for 1 day), dry triethylamine (5 mL), and dry pyridine (15 mL) were added. This mixture was stirred and heated to 70 °C. Solution of 2,2′-dipyridyl disulfide (3.4 g, 15.4 mmol) and triphenylphosphine (4 g, 15.4 mmol) in 15 mL of dry pyridine under argon was added immediately. The resulting mixture was heated at 70 °C for 3 days to reach the full conversion. After cooling to room temperature, the richly yellow solution was evaporated in vacuo and the residue was purified first by flash chromatography (silica gel; CHCl<sub>3</sub>/MeOH, gradient 2–15%), followed by flash chromatography again (C18 silica gel, eluent H<sub>2</sub>O/MeOH, gradient 70–100%). The product was obtained as colorless/yellowish foam and prepared for following manipulation by lyophilization from dioxane.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure for Bromination of Tetra-(<span class="smallcaps smallerCapital">l</span>-phenylalanine ethyl ester) Prodrug of Bisphosphonates (Method H)</h3><div class="NLM_p last">The corresponding parent prodrug (0.15 mmol) and NBS (67 mg, 0.38 mmol, 2.5 equiv) were placed into 10 mL microwave reactor cuvette, and dioxane (6 mL) was added. Cuvette was filled with argon and sealed with a septum. Reaction mixture was stirred in microwave reactor at 100 °C for 20 min. The mixture was evaporated and purified first by flash chromatography (silica gel; eluent CHCl<sub>3</sub>/MeOH, gradient 2–15%), followed by flash chromatography again (C18 silica gel, eluent H<sub>2</sub>O/MeOH, gradient 70–100%). Compounds were prepared for following manipulation by lyophilization from dioxane.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Diisopropyl {[(2,2-Dimethyl-1,3-dioxan-5-yl)methoxy]methyl}phosphonate (<b>4</b>)</h3><div class="NLM_p last">To the solution of compound <b>3</b> (16.1 g, 110 mmol, 1 equiv) in dry DMF (600 mL) cooled to 0 °C under argon atmosphere NaH (60% suspension in mineral oil; 7.5 g, 188 mmol, 1.7 equiv) was added. Reaction flask was filled with argon again, and the mixture was stirred for 20 min to preform sodium salt of alcohol. Diisopropyl (bromomethyl)phosphonate (85% purity; 43.5 g, 143 mmol, 1.3 equiv) was added, and reaction flask was filled with argon again. The resulting mixture was slowly warmed up to room temperature and stirred overnight. Water (50 mL) was added, and mixture was stirred for 30 min. Solvent was evaporated in vacuo. Crude material was dissolved in EtOAc (250 mL), transferred to separatory funnel. The mixture of saturated solution of NH<sub>4</sub>Cl (20 mL) and H<sub>2</sub>O (180 mL) was added, and organic phase was separated. Aqueous phase was extracted witch EtOAc (2 × 150 mL). The organic phase was collected and washed by water (2 × 200 mL) followed by brine (1 × 200 mL) and dried over MgSO<sub>4</sub>. The solution was filtered and evaporated in vacuo. Crude product was obtained as brown oil and used in the next reaction step without purification. Reaction was monitored by LC–MS (procedure 1). MS (ESI+) <i>m</i>/<i>z</i> = 325.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Diisopropyl {[3-Hydroxy-2-(hydroxymethyl)propoxy]methyl}phosphonate (<b>5</b>)</h3><div class="NLM_p last">Crude material of <b>4</b> was dissolved in MeOH (500 mL) and H<sub>2</sub>O (50 mL). DOWEX (50WX8 H<sup>+</sup>, 10 g) was added, and mixture was heated at 50 °C and stirred overnight. Reaction mixture was cooled down to room temperature and filtered through the frit (S3) and evaporated in vacuo. Crude compound was purified by flash chromatography (silica gel; eluent hexane/EtOAc [6:4]/MeOH, gradient 1–10%) to give 12.54 g (the overall yield from compound <b>3</b> was 40%) of <b>5</b> as colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 4.59 [dsept, 2H, <i>J</i>(H,C,O,P) = 7.7 Hz, <i>J</i>(CH,CH<sub>3</sub>) = 6.2 Hz, CH <i>i</i>Pr]; 4.38 [t, 2H, <i>J</i>(OH,CH<sub>2</sub>) = 5.2 Hz, OH]; 3.68 [d, 2H, <i>J</i>(H,C,P) = 8.2 Hz, CH<sub>2</sub>P]; 3.49 [d, 2H, <i>J</i>(CH<sub>2</sub>,CH) = 6.0 Hz, HO-CH<sub>2</sub>CH<u class="uu">CH</u><sub><u class="uu">2</u></sub>]; 3.40 [m, 4H, <u class="uu">CH</u><sub><u class="uu">2</u></sub>-OH]; 1.74 [sept, 1H, <i>J</i>(CH,CH<sub>2</sub>) = 6.0 Hz, OCH<sub>2</sub><u class="uu">CH</u>]; 1.25 and 1.24 [d, 12H, <i>J</i>(CH<sub>3</sub>,CH) = 6.2 Hz, CH<sub>3</sub><i>i</i>Pr]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 71.64 [d, <i>J</i>(C,O,C,P) = 12.1 Hz, HO-CH<sub>2</sub>CH<u class="uu">CH</u><sub><u class="uu">2</u></sub>]; 70.30 [d, <i>J</i>(C,O,P) = 6.4 Hz, CH <i>i</i>Pr]; 65.25 [d, <i>J</i>(C,P) = 164.4 Hz, CH<sub>2</sub>P]; 59.40 [CH<sub>2</sub>OH]; 44.45 [OCH<sub>2</sub><u class="uu">CH</u>]; 24.05 and 23.93 [d, <i>J</i>(C,C,O,P) = 3.7 Hz, <i>J</i>(C,C,O,P) = 4.6 Hz, CH<sub>3</sub><i>i</i>Pr]. MS (ESI+) <i>m</i>/<i>z</i> = 285.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Diisopropyl {[3-(<i>tert</i>-Butyldimethylsilyloxy)-2-(hydroxymethyl)propoxy]methyl}phosphonate (<b>6a</b>)</h3><div class="NLM_p last">To the solution of <b>5</b> (2.34 g, 8.2 mmol, 1 equiv) in dry DMF (45 mL), imidazole (0.9 g, 12.3 mmol, 1.5 equiv) and TBDMSCl (1.26 g, 9 mmol, 1.1 equiv) were added. The mixture was stirred overnight at room temperature. Solvent was evaporated in vacuo and codistilled with toluene. Crude product was purified by flash chromatography (silica gel; eluent CHCl<sub>3</sub>/MeOH, gradient 0–8%) to give 3.9 g (41%) of <b>6a</b> as colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 4.54–4.63 [m, 2H, CH <i>i</i>Pr]; 4.42 [bs, 1H, OH]; 3.64–3.71 [m, 2H, CH<sub>2</sub>-P]; 3.58 [d, 2H, <i>J</i>(3,2) = 5.8 Hz, H-3]; 3.46–3.52 [m, 2H, H-1]; 3.37–3.43 [m, 2H, <u class="uu">CH</u><sub><u class="uu">2</u></sub>-OH]; 1.79 [septet, 1H, <i>J</i>(2,CH<sub>2</sub>) = 5.9 Hz, H-2]; 1.24 and 1.24 [d, 12H, <i>J</i>(CH<sub>3</sub>,CH) = 6.2 Hz, CH<sub>3</sub><i>i</i>Pr]; 0.86 [s, 9H, C-<u class="uu">(CH</u><sub><u class="uu">3</u></sub><u class="uu">)</u><sub><u class="uu">3</u></sub>]; 0.02 [s, 6H, Si-<u class="uu">CH</u><sub><u class="uu">3</u></sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 71.27 [d, <i>J</i>(1,P) = 12.1 Hz, C-1]; 70.21 [d, <i>J</i>(C,O,P) = 6.3 Hz, CH <i>i</i>Pr]; 65.32 [d, <i>J</i>(C,P) = 164.5 Hz, CH<sub>2</sub>-P]; 60.94 [C-3]; 59.03 [<u class="uu">CH</u><sub><u class="uu">2</u></sub>-OH]; 44.39 [C-2]; 25.97 [C-<u class="uu">(CH</u><sub><u class="uu">3</u></sub><u class="uu">)</u><sub><u class="uu">3</u></sub>]; 24.01 and 23.90 [d, <i>J</i>(C,C,O,P) = 3.7 Hz, <i>J</i>(C,C,O,P) = 4.5 Hz, CH<sub>3</sub><i>i</i>Pr]; 18.14 [<u class="uu">C</u>-(CH<sub>3</sub>)<sub>3</sub>]; −5.30 [Si-<u class="uu">CH</u><sub><u class="uu">3</u></sub>]. MS (ESI+) <i>m</i>/<i>z</i> = 399.05 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Diisopropyl {[3-(<i>tert</i>-Butyldimethylsilyloxy)-2-((2-diethoxyphosphorylethoxy)methyl)propoxy]methyl}phosphonate (<b>7a</b>)</h3><div class="NLM_p last">Alcohol <b>6a</b> (7.5 g, 18.8 mmol, 1 equiv) and cesium carbonate (6.4 g, 19.7 mmol, 1.05 equiv) were placed into 25 mL reaction flask. Dry <i>tert</i>-butanol (15 mL) was added, and the flask was sealed with a septum and filled with argon. Diethyl vinylphosphonate (5.5 mL, 35.8 mmol, 1.9 equiv) was added into the flask, and the mixture was vigorously stirred for 2 days. The reaction mixture was diluted with H<sub>2</sub>O and extracted with EtOAc (3 × 100 mL). The organic phase was collected, washed with H<sub>2</sub>O (2 × 100 mL), followed by brine (1 × 100 mL), and dried over MgSO<sub>4</sub>. The solution was filtered and evaporated in vacuo. Crude product was obtained as colorless solidified oil and used in the next reaction step without purification. Reaction was monitored by LC–MS (procedure 1). Small amount of crude product was purified by flash chromatography (silica gel; eluent hexane/EtOAc [6:4]/MeOH, gradient 1–10%) to obtain an analytical sample. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 4.54–4.63 [m, 2H, CH <i>i</i>Pr]; 3.93–4.02 [m, 4H, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.65–3.72 [m, 2H, CH<sub>2</sub>-P]; 3.48–3.61 [m, 6H, H-2, H-5, H-6]; 3.37 [m, 2H, H-3]; 1.99–2.05 [m, 2H, H-1]; 1.93 [m, H-4]; 1.20–1.25 [m, 18H, CH<sub>3</sub><i>i</i>Pr, CH<sub>2</sub><u class="uu">CH</u><sub><u class="uu">3</u></sub>]; 0.86 [s, 9H, C(CH<sub>3</sub>)<sub>3</sub>]; 0.02 [s, 6H, Si-CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 71.01 [d, <i>J</i>(3,P) = 12.0 Hz, C-5]; 70.22 and 70.21 [d, <i>J</i>(C,O,P) = 6.4 Hz, CH <i>i</i>Pr]; 68.11 [C-3]; 65.28 [d, <i>J</i>(CH<sub>2</sub>-P,P) = 164.4 Hz, CH<sub>2</sub>-P]; 64.74 [d, <i>J</i>(2,P) = 1.5 Hz, C-2]; 61.10 [d, <i>J</i>(C,O,P) = 6.1 Hz, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 60.67 [C-6]; 41.93 [C-4]; 26.11 [d, <i>J</i>(1,P) = 137.1 Hz, C-1]; 25.94 [C<u class="uu">(CH</u><sub><u class="uu">3</u></sub><u class="uu">)</u><sub><u class="uu">3</u></sub>]; 24.00 and 23.89 [d, <i>J</i>(C,O,O,P) = 3.7 Hz, <i>J</i>(C,O,O,P) = 4.5 Hz, CH<sub>3</sub><i>i</i>Pr]; 18.11 [<u class="uu">C</u>(CH<sub>3</sub>)<sub>3</sub>]; 16.42 [d, <i>J</i>(C,O,O,P) = 5.9 Hz, CH<sub>2</sub><u class="uu">CH</u><sub><u class="uu">3</u></sub>]; −5.35 and −5.36 [Si-CH<sub>3</sub>]. MS (ESI+) <i>m</i>/<i>z</i> = 563.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Diisopropyl {[3-Hydroxy-2-((2-diethoxyphosphorylethoxy)methyl)propoxy]methyl}phosphonate (<b>8</b>)</h3><div class="NLM_p last">Crude product <b>7a</b> was dissolved in MeOH/H<sub>2</sub>O (100 + 10 mL). DOWEX (50WX8 H<sup>+</sup>; 10 g) was added, and reaction mixture was heated at 50 °C and stirred overnight. The mixture was filtered, and filtrate was evaporated in vacuo. Resulting residue was purified by flash chromatography (silica gel; eluent CHCl<sub>3</sub>/MeOH, gradient 0–10%) to give 5.1 g (overall yield from compound <b>6a</b>, 31%) of <b>8</b> as colorless oil. Reaction was monitored by LC–MS (procedure 1) and TLC (eluent CHCl<sub>3</sub>, 10% MeOH). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 4.59 [dsept, 2H, <i>J</i>(H,C,O,P) = 7.7 Hz, <i>J</i>(CH,CH<sub>3</sub>) = 6.2 Hz, CH <i>i</i>Pr]; 4.47 [t, <i>J</i>(OH,CH<sub>2</sub>) = 5.3 Hz, OH]; 3.94–4.02 [m, 4H, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.69 [d, 2H, <i>J</i>(H,C,P) = 8.2 Hz, P-CH<sub>2</sub>O]; 3.46–3.55 [m, 4H, H-2, H-5]; 3.35–3.41 [m, 4H, H-6, H-3]; 2.03 [dt, 2H, <i>J</i>(1,P) = 18.2 Hz, <i>J</i>(1,2) = 7.3 Hz, H-1]; 1.87 [sept, 1H, <i>J</i>(4,3) = <i>J</i>(4,5) = <i>J</i>(4,6) = 6.0 Hz, H-4]; 1.21–1.25 [m, 18H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 71.38 [d, <i>J</i>(5,P) = 12.1 Hz, C-5]; 70.27 [d, <i>J</i>(C,O,P) = 6.4 Hz, CH <i>i</i>Pr]; 68.52 [C-3]; 65.23 [d, <i>J</i>(C,P) = 164.4 Hz, P-CH<sub>2</sub>O]; 64.67 [d, <i>J</i>(2,P) = 1.6 Hz, C-2]; 64.14 [d, <i>J</i>(C,O,P) = 6.2 Hz, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 59.22 [C-6]; 42.12 [C-4]; 26.06 [d, <i>J</i>(1,P) = 137.0 Hz, C-1]; 24.03 and 23.92 [d, <i>J</i>(C,C,O,P) = 3.8 Hz, <i>J</i>(C,C,O,P) = 4.5 Hz, CH<sub>3</sub><i>i</i>Pr]; 16.45 [d, <i>J</i>(C,C,O,P) = 5.9 Hz, <u class="uu">CH</u><sub><u class="uu">3</u></sub>CH<sub>2</sub>]. MS (ESI+) <i>m</i>/<i>z</i> = 449.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Diisopropyl {[3-(2-Amino-6-chloropurin-9-yl)-2-((2-diethoxyphosphorylethoxy)methyl)propoxy]methyl}phosphonate (<b>10</b>)</h3><div class="NLM_p last">From compound <b>8</b> (1.55 g, 3.46 mmol) according to method B, afforded 1.53 g (74%) of <b>10</b>, as yellowish solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 8.10 [s, H-8]; 6.91 [bs, 2H, NH<sub>2</sub>]; 4.54–4.63 [m, 2H, CH <i>i</i>Pr]; 4.07–4.12 [m, 2H, H-1′]; 3.93–4.01 [m, 4H, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.68–3.75 [m, 2H, H-4′]; 3.44–3.55 [m, 4H, H-3′, H-6′]; 3.29–3.41 [m, 2H, H-5′]; 2.45 [m, 1H, H-2′]; 1.97–2.06 [m, 2H, H-7′]; 1.20–1.24 [m, 18H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 159.97 [C-2]; 154.54 [C-4]; 149.47 [C-6]; 143.93 [C-8]; 123.49 [C-5]; 71.12 [d, <i>J</i>(3′,P) = 11.1 Hz, C-3′]; 70.37 and 70.34 [d, <i>J</i>(C,O,P) = 6.4 Hz, CH <i>i</i>Pr]; 68.38 [C-5′]; 65.25 [d, <i>J</i>(4′,P) = 163.9 Hz, C-4′]; 64.70 [C-6′]; 61.17–61.24 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 42.36 [C-1′]; 38.92 [C-2′]; 25.88 [d, <i>J</i>(7′,P) = 137.2 Hz, C-7′]; 24.00 and 23.91 [d, <i>J</i>(C,C,O,P) = 3.7 Hz, <i>J</i>(C,C,O,P) = 4.5 Hz, CH<sub>3</sub><i>i</i>Pr]; 16.44 [d, <i>J</i>(C,C,O,P) = 5.8 Hz, CH<sub>2</sub><u class="uu">CH</u><sub><u class="uu">3</u></sub>]. MS (ESI+) <i>m</i>/<i>z</i> = 600.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Diisopropyl {[3-(6-Chloropurin-9-yl)-2-((2-diethoxyphosphorylethoxy)methyl)propoxy]methyl}phosphonate (<b>11</b>)</h3><div class="NLM_p last">From compound <b>8</b> (2.17 g, 4.8 mmol) according to method A, afforded 820 mg (29%) of <b>11</b> as colorless solidified oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 8.77 [s, 1H, H-2]; 8.70 [s, 1H, H-8]; 4.54–4.63 [m, 2H, CH <i>i</i>Pr]; 4.35 [d, 2H, <i>J</i>(1′,2′) = 7.0 Hz, H-1′]; 3.92–4.01 [m, 4H, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.68–3.74 [m, 2H, H-4′]; 3.50–3.55 [m, 2H, H-3′]; 3.42–3.49 [m, 2H, H-6′]; 3.33–3.39 [m, 2H, H-5′]; 2.52 [m, 1H, H-2′]; 1.95 [dt, 2H, <i>J</i>(7′,P) = 18.2 Hz, <i>J</i>(7′,6′) = 7.2 Hz, H-7′]; 1.19–1.24 [m, 18H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 152.45 [C-6]; 151.62 [C-2]; 149.10 [C-4]; 148.24 [C-8]; 131.03 [C-5]; 71.24 [d, <i>J</i>(3′,P) = 11.3 Hz, C-3′]; 70.36 and 70.34 [d, <i>J</i>(C,O,P) = 6.4 Hz, CH <i>i</i>Pr]; 68.61 [C-5′]; 65.21 [d, <i>J</i>(4′,P) = 164.1 Hz, C-4′]; 64.73 [d, <i>J</i>(6′,P) = 1.6 Hz, C-6′]; 61.18 and 61.16 [d, <i>J</i>(C,O,P) = 6.2 Hz, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 43.35 [C-1′]; 39.14 [C-2′]; 25.84 [d, <i>J</i>(7′,P) = 137.0 Hz, C-7′]; 24.00 and 23.91 [d, <i>J</i>(C,C,O,P) = 3.8 Hz, <i>J</i>(C,C,O,P) = 4.5 Hz, CH<sub>3</sub><i>i</i>Pr]; 16.44 [d, <i>J</i>(C,C,O,P) = 5.9 Hz, CH<sub>2</sub><u class="uu">CH</u><sub><u class="uu">3</u></sub>]. MS (ESI+) <i>m</i>/<i>z</i> = 585.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Diisopropyl {[3-(2-Amino-6-chloro-7-deazapurin-9-yl)-2-((2-diethoxyphosphorylethoxy)methyl)propoxy]methyl}phosphonate (<b>12</b>)</h3><div class="NLM_p last">From compound <b>8</b> (1.3 g, 2.9 mmol) according to method B, afforded 1.2 g (69%) of <b>12</b> as yellowish foam. Presence of product was confirmed by LC–MS (procedure 1). Pure product was used in the next reaction step without additional characterization. MS (ESI) <i>m</i>/<i>z</i> = 599.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Diisopropyl {[3-(6-Chloro-7-deazapurin-9-yl)-2-((2-diethoxyphosphorylethoxy)methyl)propoxy]methyl}phosphonate (<b>13</b>)</h3><div class="NLM_p last">From compound <b>8</b> (2.63 g, 5.9 mmol) according to method A, afforded 2.83 g (82%) of <b>13</b> as yellowish solidified oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 8.62 [s, 1H, H-2]; 7.79 [d, 1H, <i>J</i>(8,7) = 3.6 Hz, H-8]; 6.66 [d, 1H, <i>J</i>(7,8) = 3.6 Hz, H-7]; 4.54–4.63 [m, 2H, CH <i>i</i>Pr]; 4.30–4.39 [m, 2H, H-1′]; 3.93–4.01 [m, 4H, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.66–3.74 [m, 2H, H-4′]; 3.43–3.53 [m, 4H, H-3′, H-6′]; 3.28–3.34 [m, 2H, H-5′]; 2.46 [m, 1H, H-2′] ; 1.95–2.04 [m, 2H, H-7′]; 1.17–1.24 [m, 18H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 151.05 [C-4]; 150.80 [C-6]; 150.45 [C-2]; 132.29 [C-8]; 116.96 [C-5]; 98.67 [C-7]; 71.20 [d, <i>J</i>(3′,P) = 11.3 Hz, C-3′]; 70.38 and 70.36 [d, <i>J</i>(C,O,P) = 6.4 Hz, CH <i>i</i>Pr]; 68.52 [C-5′]; 65.21 [d, <i>J</i>(4′,P) = 164.0 Hz, C-4′]; 64.81 [d, <i>J</i>(6′,P) = 1.6 Hz, C-6′]; 61.16–61.24 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 43.98 [C-1′]; 39.5 [C-2′]; 25.90 [d, <i>J</i>(7′,P) = 137.2 Hz, C-7′]; 24.06 and 23.96 [d, <i>J</i>(C,C,O,P) = 3.7 Hz, <i>J</i>(C,C,O,P) = 4.5 Hz, CH<sub>3</sub><i>i</i>Pr]; 16.50 [d, <i>J</i>(C,C,O,P) = 5.9 Hz, CH<sub>2</sub><u class="uu">CH</u><sub><u class="uu">3</u></sub>]. MS (ESI+) <i>m</i>/<i>z</i> = 584.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Diisopropyl {[3-(Guanine-9-yl)-2-((2-diethoxyphosphorylethoxy)methyl)propoxy]methyl}phosphonate (<b>14</b>)</h3><div class="NLM_p last">From compound <b>10</b> (1.53 g, 2.55 mmol) according to method C, afforded 1.47 g (99%) of <b>14</b> as colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 10.56 [bs, 1H, H-1]; 7.65 [s, 1H, H-8]; 6.46 [bs, 2H, NH<sub>2</sub>]; 4.56–4.63 [m, 2H, CH <i>i</i>Pr]; 3.92–4.02 [m, 6H, H-1′, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.68–3.75 [m, 2H, H-4′]; 3.45–3.55 [m, 4H, H-3′, H-6′]; 3.32 [dd, 1H, <i>J</i>(gem) = 9.6 Hz, <i>J</i>(5′a,2′) = 5.4 Hz, H-5′a]; 3.32 [dd, 1H, <i>J</i>(gem) = 9.6 Hz, <i>J</i>(5′b,2′) = 5.2 Hz, H-5′b]; 2.37 [m, 1H, H-2′]; 2.03 [dm, 2H, <i>J</i>(7′,P) = 18.2 Hz, H-7′]; 1.20–1.25 [m, 18H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 157.00 [C-6]; 153.71 [C-2]; 151.57 [C-4]; 138.17 [C-8]; 116.72 [C-5]; 71.03 [d, <i>J</i>(3′,P) = 11.3 Hz, C-3′]; 70.37 and 70.35 [d, <i>J</i>(C,O,P) = 6.4 Hz, CH <i>i</i>Pr]; 68.20 [C-5′]; 65.27 [d, <i>J</i>(4′,P) = 164.2 Hz, C-4′]; 64.71 [d, <i>J</i>(6′,P) = 1.5 Hz, C-6′]; 61.22 and 61.20 [d, <i>J</i>(C,O,P) = 6.2 Hz, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 41.82 [C-1′]; 39.27 [C-2′]; 25.91 [d, <i>J</i>(7′,P) = 137.1 Hz, C-7′]; 23.91–24.04 [m, CH<sub>3</sub><i>i</i>Pr]; 16.45 [d, <i>J</i>(C,C,O,P) = 5.9 Hz, CH<sub>2</sub><u class="uu">CH</u><sub><u class="uu">3</u></sub>]. MS (ESI+) <i>m</i>/<i>z</i> = 582.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Diisopropyl {[3-(Hypoxanthine-9-yl)-2-((2-diethoxyphosphorylethoxy)methyl)propoxy]methyl}phosphonate (<b>15</b>)</h3><div class="NLM_p last">From compound <b>11</b> (820 mg, 1.4 mmol) according to method C, afforded 515 mg (65%) of <b>15</b> as yellowish oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 12.30 [bs, 1H, H-1]; 8.06 [s, 1H, H-8]; 8.02 [s, 1H, H-2]; 4.54–4.64 [m, 2H, CH <i>i</i>Pr]; 4.14–4.21 [m, 2H, H-1′]; 3.92–4.02 [m, 4H, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.67–3.75 [m, 2H, H-4′]; 3.45–3.51 [m, 4H, H-3′, H-6′]; 3.33 [dd, 1H, <i>J</i>(gem) = 9.6 Hz, <i>J</i>(5′a,2′) = 5.6 Hz, H-5′a]; 3.30 [dd, 1H, <i>J</i>(gem) = 9.6 Hz, <i>J</i>(5′b,2′) = 5.2 Hz, H-5′b]; 2.42 [m, 1H, H-2′]; 1.97–2.03 [m, 2H, H-7′]; 1.20–1.25 [m, 18H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 156.91 [C-6]; 148.81 [C-4]; 145.68 [C-2]; 141.07 [C-8]; 124.13 [C-5]; 71.11 [d, <i>J</i>(3′,P) = 11.2 Hz, C-3′]; 70.42 and 70.40 [d, <i>J</i>(C,O,P) = 6.4 Hz, <i>J</i>(C,O,P) = 6.3 Hz, CH <i>i</i>Pr]; 68.41 [C-5′]; 65.23 [d, <i>J</i>(4′,P) = 164.0 Hz, C-4′]; 64.79 [d, <i>J</i>(6′,P) = 1.6 Hz, C-6′]; 61.23 and 61.21 [d, <i>J</i>(C,O,P) = 6.2 Hz, <u class="uu">CH</u><sub><u class="uu">2</u></sub>-CH<sub>3</sub>]; 42.63 [C-1′]; 39.59 [C-2′]; 25.90 [d, <i>J</i>(7′,P) = 137.1 Hz, C-7′]; 24.04 and 23.95 [d, <i>J</i>(C,C,O,P) = 3.7 Hz, <i>J</i>(C,C,O,P) = 4.5 Hz, CH<sub>3</sub> iPr]; 16.47 [d, <i>J</i>(C,C,O,P) = 5.9 Hz, CH<sub>2</sub>–<u class="uu">CH</u><sub><u class="uu">3</u></sub>]. MS (ESI+) <i>m</i>/<i>z</i> = 567.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Diisopropyl {[3-(8-Bromoguanine-9-yl)-2-((2-diethoxyphosphorylethoxy)methyl)propoxy]methyl}phosphonate (<b>16</b>)</h3><div class="NLM_p last">From compound <b>14</b> (656 mg, 1.1 mmol) according to method F, afforded 325 mg (45%) of <b>16</b> as yellowish-orange oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 10.67 [s, 1H, H-1]; 6.58 [bs, 2H, NH<sub>2</sub>]; 4.54–4.63 [m, 2H, CH <i>i</i>Pr]; 3.87–4.05 [m, 6H, H-1′, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.75 and 3.68 [dd, 2H, <i>J</i>(gem) = 14.0 Hz, <i>J</i>(4′,P) = 8.0, <i>J</i>(gem) = 14.0 Hz, <i>J</i>(4′,P) = 7.8, H-4′]; 3.32–3.60 [m, 6H, H-3′, H-5′, H-6′]; 2.43 [m, 1H, H-2′]; 1.95–2.05 [m, 2H, H-7′]; 1.19–1.25 [m, 18H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 155.78 and 154.00 [C-2, C-6]; 152.94 [C-4]; 121.25 [C-8]; 116.97 [C-5]; 71.11 [d, <i>J</i>(3′,P) = 10.8 Hz, C-3′]; 70.36, 70.34 [d, <i>J</i>(C,O,P) = 6.4 Hz, CH <i>i</i>Pr]; 68.51 [C-5′]; 65.27 [d, <i>J</i>(4′,P) = 163.8 Hz, C-4′]; 64.64 [C-6′]; 61.17–61.27 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 43.30 [C-1′]; 39.02 [C-2′]; 25.91 [d, <i>J</i>(7′,P) = 137.0 Hz, C-7′]; 23.92–24.05 [m, CH<sub>3</sub><i>i</i>Pr]; 16.47 [d, <i>J</i>(C,C,O,P) = 5.9 Hz, CH<sub>2</sub><u class="uu">CH</u><sub><u class="uu">3</u></sub>]. MS (ESI+) <i>m</i>/<i>z</i> = 660.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Diisopropyl {[3-(8-Bromohypoxanthine-9-yl)-2-((2-diethoxyphosphorylethoxy)methyl)propoxy]methyl}phosphonate (<b>17</b>)</h3><div class="NLM_p last">From compound <b>15</b> (499 mg, 0.89 mmol) according to method F, afforded 155 mg (27%) of <b>17</b> as yellowish orange oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 12.46 [bs, 1H, H-1]; 8.05 [d, 1H, <i>J</i>(2,1) = 3.0 Hz, H-2]; 4.53–4.62 [m, 2H, CH<i>i</i>Pr]; 4.13–4.21 [m, 2H, H-1′]; 3.87–4.00 [m, 4H, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.65–3.75 [m, 2H, H-4′]; 3.36–3.57 [m, 6H, H-3′, H-5′, H-6′]; 2.47 [m, 1H, H-2′]; 1.90–2.00 [m, 2H, H-7′]; 1.18–1.24 [m, 18H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 155.56 [C-6]; 150.26 [C-4]; 146.34 [C-2] ; 125.79 [C-8]; 124.45 [C-5]; 71.19 [d, <i>J</i>(3′,P) = 11.0 Hz, C-3′]; 70.35 [d, <i>J</i>(C,O,P) = 6.4 Hz, CH <i>i</i>Pr]; 68.76 [C-5′]; 65.23 [d, <i>J</i>(4′,P) = 163.9 Hz, C-4′]; 64.73 [C-6′]; 61.15–61.20 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 44.29 [C-1′]; 39.0 [C-2′]; 25.90 [d, <i>J</i>(7′,P) = 137.0 Hz, C-7′]; 23.92–24.05 [m, CH<sub>3</sub><i>i</i>Pr]; 16.46 [d, <i>J</i>(C,C,O,P) = 5.9 Hz, CH<sub>2</sub><u class="uu">CH</u><sub><u class="uu">3</u></sub>]. MS (ESI+) <i>m</i>/<i>z</i> = 645.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Diisopropyl {[3-(7-Deazaguanine-9-yl)-2-((2-diethoxyphosphorylethoxy)methyl)propoxy]methyl}phosphonate (<b>18</b>)</h3><div class="NLM_p last">From compound <b>12</b> (1139 mg, 1.9 mmol) according to method D, afforded 256 mg (23%) of <b>18</b> as colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 10.28 [bs, 1H, H-1]; 6.71 [d, 1H, <i>J</i>(8,7) = 3.4 Hz, H-8]; 6.22 [bs, 2H, NH<sub>2</sub>]; 6.21 [d, 1H, <i>J</i>(7,8) = 3.4 Hz, H-7]; 4.56–4.63 [m, 2H, CH <i>i</i>Pr]; 3.87–4.01 [m, 6H, H-1′, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.66–3.74 [m, 2H, H-4′]; 3.42–3.58 [m, 4H, H-3′, H-6′]; 3.24–3.30 [m, 2H, H-5′]; 2.32 [m, 1H, H-2′]; 2.01–2.09 [m, 2H, H-7′]; 1.20–1.25 [m, 18H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 158.90 [C-6]; 152.57 [C-2]; 150.61 [C-4]; 120.98 [C-8]; 101.36 [C-7]; 100.07 [C-5]; 71.13 [d, <i>J</i>(3′,P) = 11.3 Hz, C-3′]; 70.38 d and 70.35 [d, <i>J</i>(C,O,P) = 6.4 Hz, CH <i>i</i>Pr]; 68.26 [C-5′]; 65.27 [d, <i>J</i>(4′,P) = 164.0 Hz, C-4′]; 64.72 [C-6′]; 61.20–61.27 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 42.94 [C-1′]; 39.7 [C-2′]; 23.96–24.09 [m, CH<sub>3</sub><i>i</i>Pr]; 16.51 [d, <i>J</i>(C,C,O,P) = 5.9 Hz, CH<sub>2</sub><u class="uu">CH</u><sub><u class="uu">3</u></sub>]. MS (ESI+) <i>m</i>/<i>z</i> = 581.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Diisopropyl {[3-(7-Deazahypoxanthine-9-yl)-2-((2-diethoxyphosphorylethoxy)methyl)propoxy]methyl}phosphonate (<b>19</b>)</h3><div class="NLM_p last">From compound <b>13</b> (2.83 g, 4.85 mmol) according to method D, afforded 1.19 g (43%) of <b>19</b> as white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 11.90 [bs, 1H, H-1]; 7.87 [s, 1H, H-2]; 7.14 [d, <i>J</i>(8,7) = 3.4 Hz, H-8]; 6.46 [d, <i>J</i>(7,8) = 3.4 Hz, H-7]; 4.54–4.64 [m, 2H, CH <i>i</i>Pr]; 4.13–4.16 [m, 2H, H-1′]; 3.93–4.02 [m, 4H, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.68–3.78 [m, 2H, H-4′]; 3.42–3.51 [m, 4H, H-3′, H-6′]; 3.26–3.32 [m, 2H, H-5′]; 2.37 [m, 1H, H-2′]; 1.99–2.07 [m, 2H, H-7′]; 1.20–1.25 [m, 18H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 158.48 [C-6]; 147.50 [C-4]; 143.56 [C-2]; 124.57 [C-8]; 107.99 [C-5]; 101.66 [C-7]; 71.15 [d, <i>J</i>(3′,P) = 11.3 Hz, C-3′]; 70.37 and 70.35 [d, <i>J</i>(C,O,P) = 6.3 Hz, <i>J</i>(C,O,P) = 6.4 Hz, CH <i>i</i>Pr]; 68.38 [C-5′]; 65.23 [d, <i>J</i>(4′,P) = 164.1 Hz, C-4′]; 64.82 [d, <i>J</i>(6′,P) = 1.6 Hz, C-6′]; 61.16–61.23 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 43.26 [C-1′]; 40.30 [C-2′]; 25.94 [d, <i>J</i>(7′,P) = 137.0 Hz, H-7′]; 24.06 and 23.96 [d, <i>J</i>(C,O,O,P) = 3.6 Hz, <i>J</i>(C,O,O,P) = 4.5 Hz, CH<sub>3</sub><i>i</i>Pr]; 16.49 [d, <i>J</i>(C,O,O,P) = 5.9 Hz, CH<sub>2</sub><u class="uu">CH</u><sub><u class="uu">3</u></sub>]. MS (ESI+) <i>m</i>/<i>z</i> = 566.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Sodium Salt of {[3-(Guanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methyl}phosphonic Acid (<b>20</b>)</h3><div class="NLM_p last">From compound <b>14</b> (597 mg, 1.02 mmol) according to method E, afforded 160 mg (30%) of <b>20</b> as yellowish lyophilisate. <sup>1</sup>H NMR (D<sub>2</sub>O): 7.83 [s, 1H, H-8]; 4.09–4.19 [m, 2H, H-1′]; 3.58–3.67 [m, 4H, H-4′, H-6′]; 3.53 [d, 2H, <i>J</i>(3′,2′) = 5.8 Hz, H-3′]; 3.45–3.51 [m, 2H, H-5′]; 2.46 [m, 1H, H-2′]; 1.85–1.92 [m, 2H, H-7′]. <sup>13</sup>C NMR (D<sub>2</sub>O): 159.17 [C-6]; 154.19 [C-2]; 152.21 [C-4]; 141.12 [C-8]; 115.93 [C-5]; 71.59 [d, <i>J</i>(3′,P) = 12.2 Hz, H-3′]; 69.40 [C-5′]; 67.80 [d, <i>J</i>(4′,P) = 156.7 Hz, C-4′]; 67.04 [C-6′]; 43.22 [C-1′]; 39.56 [C-2′]; 29.34 [d, <i>J</i>(7′,P) = 130.0 Hz, C-7′]. HR-MS (ESI−) <i>m</i>/<i>z</i>: calcd for C<sub>12</sub>H<sub>17</sub>N<sub>5</sub>Na<sub>4</sub>O<sub>9</sub>P<sub>2</sub> 440.07417 [M – 4Na + 3H]<sup>−</sup>, found 440.07349 [M – 4Na + 3H]<sup>−</sup>.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Sodium Salt of {[3-(Hypoxanthine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methyl}phosphonic Acid (<b>21</b>)</h3><div class="NLM_p last">From compound <b>15</b> (84 mg, 0.15 mmol) according to method E, afforded 30 mg (39%) of <b>21</b> as yellowish lyophilisate. <sup>1</sup>H NMR (D<sub>2</sub>O): 8.20 [s, H-2]; 8.18 [s, H-8]; 4.35–4.45 [m, 2H, H-1′]; 3.49–3.63 [m, 8H, H-3′, H-4′, H-5′, H-6′]; 2.56 [m, H-2′]; 1.77–1.84 [m, 2H, H-7′]. <sup>13</sup>C NMR (D<sub>2</sub>O): 159.30 [C-6]; 149.87 [C-4]; 146.23 [C-2]; 143.59 [C-8]; 123.82 [C-5]; 71.59 [d, <i>J</i>(3′,P) = 12.0 Hz, C-3′]; 69.56 [C-5′]; 67.90 [d, <i>J</i>(4′,P) = 156.6 Hz, C-4′]; 67.15 [d, <i>J</i>(6′,P) = 1.7 Hz, C-6′]; 43.99 [C-1′]; 39.87 [C-2′]; 29.32 [d, <i>J</i>(7′,P) = 129.7 Hz, C-7′]. HR-MS (ESI−) <i>m</i>/<i>z</i>: calcd for C<sub>12</sub>H<sub>16</sub>N<sub>4</sub>Na<sub>4</sub>O<sub>9</sub>P<sub>2</sub> 425.06327 [M – 4Na + 3H]<sup>−</sup>, found 425.06244 [M – 4Na + 3H]<sup>−</sup>.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Sodium Salt of {[3-(8-Bromoguanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methyl}phosphonic Acid (<b>22</b>)</h3><div class="NLM_p last">From compound <b>16</b> (294 mg, 0.45 mmol) according to method E, afforded 27 mg (10%) of <b>22</b> as white lyophilisate. <sup>1</sup>H NMR (D<sub>2</sub>O): 4.13–4.21 [m, 2H, H-1′]; 3.50–3.67 [m, 8H, H-3′, H-4′, H-5′, H-6′]; 2.58 [m, 1H, H-2′]; 1.71–1.85 [m, 2H, H-7′]. <sup>13</sup>C NMR (D<sub>2</sub>O): 158.41 [C-6]; 154.33 [C-2]; 153.66 [C-4]; 125.76 [C-8]; 116.88 [C-5]; 71.94 [d, <i>J</i>(3′,P) = 11.7 Hz, C-3′]; 70.08 [C-5′]; 67.25–68.57 [m, C-4′]; 67.13 [C-6′]; 44.78 [C-1′]; 38.92 [C-2′]; 29.38 [d, <i>J</i>(7′,P) = 129.6 Hz, C-7′]. HR-MS (ESI−) <i>m</i>/<i>z</i>: calcd for C<sub>12</sub>H<sub>16</sub>BrN<sub>5</sub>Na<sub>4</sub>O<sub>9</sub>P<sub>2</sub> 517.98469 [M – 4Na + 3H]<sup>−</sup>, found 517.98420 [M – 4Na + 3H]<sup>−</sup>.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Sodium Salt of {[3-(8-Bromohypoxanthine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methyl}phosphonic Acid (<b>23</b>)</h3><div class="NLM_p last">From compound <b>17</b> (135 mg, 0.21 mmol) according to method E, afforded 37 mg (31%) of <b>23</b> as yellowish lyophilisate. <sup>1</sup>H NMR (D<sub>2</sub>O): 8.19 [s, 1H, H-2]; 4.35–4.43 [m, 2H, H-1′]; 3.45–3.67 [m, 8H, H-3′, H-4′, H-5′, H-6′]; 2.64 [m, 1H, H-2′]; 1.61–1.77 [m, 2H, H-7′]. <sup>13</sup>C NMR (D<sub>2</sub>O): 158.07 [C-6]; 151.14 [C-4]; 146.61 [C-2]; 129.42 [C-8]; 124.35 [C-5]; 71.92 [d, <i>J</i>(3′,P) = 11.5 Hz, C-3′]; 70.22 [C-5′]; 68.43 [d, <i>J</i>(4′,P) = 154.9 Hz, C-4′]; 67.46 [d, <i>J</i>(6′,P) = 2.6 Hz, C-6′]; 45.78 [C-1′]; 39.19 [C-2′]; 29.55 [d, <i>J</i>(7′,P) = 128.6 Hz, C-7′]. HR-MS (ESI−) <i>m</i>/<i>z</i>: calcd for C<sub>12</sub>H<sub>15</sub>BrN<sub>4</sub>Na<sub>4</sub>O<sub>9</sub>P<sub>2</sub> 502.97379 [M – 4Na + 3H]<sup>−</sup>, found 502.97318 [M – 4Na + 3H]<sup>−</sup>.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Sodium Salt of {[3-(7-Deazaguanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methyl}phosphonic Acid (<b>24</b>)</h3><div class="NLM_p last">From compound <b>18</b> (110 mg, 0.19 mmol) according to method E, afforded 29 mg (35%) of <b>24</b> as yellowish lyophilisate. <sup>1</sup>H NMR (D<sub>2</sub>O): 6,89 [d, 1H, <i>J</i>(8,7) = 3.6 Hz, H-8]; 6.48 [d, 1H, <i>J</i>(7,8) = 3.6 Hz, H-7]; 4.08–4.16 [m, 2H, H-1′]; 3.54–3.64 [m, 4H, H-4′, H-6′]; 3.52 [m, 2H, H-3′]; 3.47 [m, 2H, H-5′]; 2.45 [m, 1H, H-2′]; 1.83–1.89 [m, 2H, H-7′]. <sup>13</sup>C NMR (D<sub>2</sub>O): 162.11 [C-6]; 152.87 [C-2]; 151.49 [C-4]; 124.46 [C-8]; 101.38 [H-7]; 100.44 [H-5]; 71.83 [d, <i>J</i>(3′,P) = 12.1 Hz, H-3′]; 69.50 [C-5′]; 68.0 [C-4′]; 67.2 [C-6′]; 44.09 [C-1′]; 40.16 [C-2′]; 29.45 [m, C-7′]. HR-MS (ESI−) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>18</sub>N<sub>4</sub>Na<sub>4</sub>O<sub>9</sub>P<sub>2</sub> 461.06087 [M – 3Na + 2H]<sup>−</sup>, found 461.06025 [M – 3Na + 2H]<sup>−</sup>.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Sodium Salt of {[3-(7-Deazahypoxanthine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methyl}phosphonic Acid (<b>25</b>)</h3><div class="NLM_p last">From compound <b>19</b> (649 mg, 1.15 mmol) according to method E, afforded 38 mg (6%) of <b>25</b> as yellowish lyophilisate. <sup>1</sup>H NMR (D<sub>2</sub>O): 8.05 [s, 1H, H-2]; 7.22 [d, 1H, <i>J</i>(8,7) = 3.5 Hz, H-8]; 6.68 [d, 1H, <i>J</i>(7.8) = 3.5 Hz, H-7]; 4.26–4.34 [m, 2H, H-1′]; 3.51–3.61 [m, 6H, H-3′, H-4′, H-6′]; 3.43–3.49 [m, 2H, H-5′]; 2.49 [m, 1H, H-2′]; 1.77–1.87 [m, 2H, H-7′]. <sup>13</sup>C NMR (D<sub>2</sub>O): 161.46 [C-6]; 148.46 [C-4]; 143.47 [C-2]; 127.22 [C-8]; 108.08 [C-5]; 102.01 [C-7]; 71.81 [d, <i>J</i>(3′,P) = 11.4 Hz, C-3′]; 69.51 [C-5′]; 67.88 [m, C-4′]; 67.12 [C-6′]; 44.74 [C-1′]; 40.41 [C-2′]; 29.31 [d, <i>J</i>(7′,P) = 129.6 Hz, C-7′]. HR-MS (ESI−) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>17</sub>N<sub>3</sub>Na<sub>4</sub>O<sub>9</sub>P<sub>2</sub> 424.06803 [M – 4Na + 3H]<sup>−</sup>, found 424.06732 [M – 4Na + 3H]<sup>−</sup>.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Diethyl {2-[3-(8-Bromoguanine-9-yl)-2-(2-(diethoxyphosphoryl)ethoxy)propoxy]ethyl}phosphonate (<b>26</b>)</h3><div class="NLM_p last">From compound <b>2c</b> (1.3 g, 2.35 mmol) according to method F, afforded 1.2 g (81%) of <b>26</b> as yellowish-orange solidified oil. Presence of product was confirmed by LC–MS (procedure 1). Pure product was used in the next reaction step without additional characterization. HR-MS (ESI+) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>36</sub>BrN<sub>5</sub>O<sub>9</sub>P<sub>2</sub> 632.12444 [M + H]<sup>+</sup>, found 632.12445 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> {2-[3-(8-Bromoguanin-9-yl)-2-(2-(bishydroxyphosphoryl)ethoxy)propoxy]ethyl}phosphonic Acid (<b>27</b>)</h3><div class="NLM_p last">From compound <b>26</b> (1.1 g, 1.74 mmol) according to method E, afforded 434 mg (41%) of <b>27</b> as white lyophilisate. <sup>1</sup>H NMR (D<sub>2</sub>O): 4.25 [dd, 1H, <i>J</i>(gem) = 15.0 Hz, <i>J</i>(1′a,2′) = 5.1 Hz, H-1′a]; 4.19 [dd, 1H, <i>J</i>(gem) = 15.0 Hz, <i>J</i>(1′b,2′) = 7.1 Hz, H-1′b]; 3.99 [m, 1H, H-2′]; 3.70–3.79 [m, 4H, H-3′a, H-6′a, H-4′]; 3.64 [m, 1H, H-6′b]; 3.55 [dd, 1H, <i>J</i>(gem) = 10.9 Hz, <i>J</i>(3′b,2′) = 4.9 Hz, H-3′b]; 1.94–2.00 [m, 2H, H-5′]; 1.69–1.83 [m, 2H, H-7′]. <sup>13</sup>C NMR (D<sub>2</sub>O): 158.48 [C-6]; 154.47 [C-2]; 153.73 [C-4]; 125.80 [C-8]; 116.97 [C-5]; 76.61 [C-2′]; 70.07 [C-3′]; 67.63 [d, <i>J</i>(4′,P) = 1.6 Hz, C-4′]; 66.94 [d, <i>J</i>(6′,P) = 3.0 Hz, C-6′]; 45.54 [C-1′]; 29.75 [d, <i>J</i>(7′,P) = 128.7 Hz, H-7′]; 29.49 [d, <i>J</i>(5′,P) = 129.7 Hz, C-5′]. HR-MS (ESI−) <i>m</i>/<i>z</i>: calcd for C<sub>12</sub>H<sub>16</sub>BrN<sub>5</sub>Na<sub>4</sub>O<sub>9</sub>P<sub>2</sub> 517.98469 [M – 4Na + 3H]<sup>−</sup>, found 517.98401 [M – 4Na + 3H]<sup>−</sup>.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Tetra-(<span class="smallcaps smallerCapital">l</span>-phenylalanine ethyl ester) Prodrug of {[3-(Guanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methyl}phosphonic Acid (<b>28</b>)</h3><div class="NLM_p last">From compound <b>14</b> (608 mg, 1.05 mmol) according to method to method G, afforded 274 mg (62%) of <b>28</b> as brilliantly white lyophilisate. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 10.57 [bs, H-1]; 7.59 and 7.57 [s, 1 H, H-8]; 7.09–7.27 [m, 20H, H-2″, H-3″, H-4″]; 6.54 [bs, 2H, NH<sub>2</sub>]; 4.47–4.58 and 4.12–4.25 [m, 4H, <u class="uu">NH</u>-CH]; 3.82–4.05 [m, 14H, H-1′, NH-<u class="uu">CH</u>, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.08–3.32 [m, 8H, H-3′, H-4′, H-5′, H-6′]; 2.70–2.93 [m, 8H, 1″-<u class="uu">CH</u><sub><u class="uu">2</u></sub>]; 2.16 [m, H-2′]; 1.55 [m, 2H, H-7′]; 1.03–1.13 [m, 12H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 172.88–173.37 [m, COO]; 157.07 [C-6]; 153.78 [C-2]; 151.67 and 151.63 [C-4]; 138.35 and 138.31 [C-8]; 137.24–137.52 [m, C-1″]; 129.63–129.71 [m, C-2″]; 128.31–128.37 [m, C-3″]; 126.67–126.76 [m, C-4″]; 116.65 [C-5]; 70.55–70.75 [m, C-3′]; 67.28–68.43 [m, C-4′, C-5′]; 65.08 and 65.02 [C-6′]; 60.53–60.72 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 53.98–54.49 [m, <u class="uu">CH</u>-NH]; 41.25 [C-1′]; 39.9 [1″-<u class="uu">CH</u><sub><u class="uu">2</u></sub>]; 39.1 [C-2′]; 30.14 [d, <i>J</i>(7′,P) = 111.9 Hz, C-7′]; 14.10–14.18 [m, CH<sub>3</sub>]. HR-MS (ESI+) <i>m</i>/<i>z</i>: calcd for C<sub>56</sub>H<sub>73</sub>N<sub>9</sub>O<sub>13</sub>P<sub>2</sub> 1164.46953 [M + Na]<sup>+</sup>, found 1164.47004 [M + Na]<sup>+</sup>.</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Tetra-(<span class="smallcaps smallerCapital">l</span>-phenylalanine ethyl ester) Prodrug of {[3-(Hypoxanthine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methyl}phosphonic Acid (<b>29</b>)</h3><div class="NLM_p last">From compound <b>15</b> (888 mg, 1.6 mmol) according to method G, afforded 449 mg (25%) of <b>29</b> as white lyophilizate. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 12.32 [bs, H-1]; 8.02 and 8.00 [s, 1H, H-2]; 7.99 and 7.96 [s, 1H, H-8]; 7.11–7.27 [m, 20H, H-2″, H-3″, H-4″]; 4.46–4.64 [m, 2H, <u class="uu">NH</u>-CH]; 4.24 [m, 1H, <u class="uu">NH</u>-CH]; 3.82–4.12 [m, 15H, <u class="uu">NH</u>-CH, NH-<u class="uu">CH</u>, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>, H-1′]; 2.99–3.28 [m, 8H, H-3′, H-4′, H-5′, H-6′]; 2.69–2.94 [m, 8H, 1″-<u class="uu">CH</u><sub><u class="uu">2</u></sub>]; 2.09–2.25 [m, 1H, H-2′]; 1.48–1.57 [m, 2H, H-7′]; 1.04–1.15 [m, 12H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 172.96–173.41 [m, COO]; 156.92 and 156.90 [C-6]; 148.78 and 148.69 [C-4]; 145.80 and 145.73 [C-2]; 141.23 and 141.06 [C-8]; 137.30–137.52 [m, C-1″]; 129.68–129.72 [m, C-2″]; 128.31–128.36 [m, C-3″]; 126.66–126.74 [m, C-4″]; 124.04 and 124.01 [C-5]; 70.21–70.63 [m, C-3′]; 67.11–68.59 [m, C-4′, C-5′]; 65.36 [C-6′]; 60.53–60.73 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 53.86–54.45 [m, <u class="uu">CH</u>-NH]; 42.00 and 41.89 [C-1′]; 39.7 [1″-<u class="uu">CH</u><sub><u class="uu">2</u></sub>]; 39.4 [C-2′]; 30.00 [d, <i>J</i>(7′,P) = 112.3 Hz, C-7′]; 14.12–14.20 [m, CH<sub>3</sub>]. HR-MS (ESI+) <i>m</i>/<i>z</i>: calcd for C<sub>56</sub>H<sub>72</sub>N<sub>8</sub>O<sub>13</sub>P<sub>2</sub> 1127.47668 [M + H]<sup>+</sup>, found 1127.47724 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Tetra-(<span class="smallcaps smallerCapital">l</span>-phenylalanine ethyl ester) Prodrug of {[3-(7-Deazaguanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methyl}phosphonic Acid (<b>30</b>)</h3><div class="NLM_p last">From compound <b>18</b> (110 mg, 0.19 mmol) according to method G, afforded 49 mg (23%) of <b>30</b> as white lyophilisate. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 10.32 [bs, 1H, H-1]; 7.08–7.27 [m, 20H, H-2″, H-3″, H-4″]; 6.61 and 6.60 [d, 1H, <i>J</i>(8,7) = 3.4 Hz, H-8]; 6.30 [bs, 2H, NH<sub>2</sub>]; 6.22 and 6.21 [d, 1H, <i>J</i>(7,8) = 3.4 Hz, H-7]; 4.42–4.56 and 4.09–4.21 [m, 4H, NH]; 3.78–4.04 [m, 14H, H-1′, NH-<u class="uu">CH</u>, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.07–3.35 [m, 8H, H-3′, H-4′, H-5′, H-6′]; 2.70–2.93 [m, 8H, 1″-CH<sub>2</sub>]; 2.14 [m, 1H, H-2′]; 1.51–1.60 [m, 2H, H-7′]; 1.03–1.13 [m, 12H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 172.81–173.33 [m, COO]; 158.93 [C-6]; 152.59 [C-2]; 150.65 and 150.63 [C-4]; 137.18–137.50 [m, C-1″]; 129.59–129.68 [m, C-2″]; 128.29–128.34 [m, C-3″]; 126.65–126.73 [m, C-4″]; 121.07 and 121.03 [C-8]; 101.27 [C-7]; 99.98 [C-5]; 70.87–71.06 [m, C-3′]; 67.35–68.50 [m, C-4′, C-5′]; 65.07 and 65.01 [C-6′]; 60.49–60.70 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 53.99–54.47 [m, NH-<u class="uu">CH</u>]; 42.59 [C-1′]; 39.8 [1″-CH<sub>2</sub>]; 39.6 [C-2′]; 30.15 [d, <i>J</i>(7′,P) = 113.7 Hz, C-7′]; 14.08–14.16 [m, CH<sub>3</sub>]. HR-MS (ESI+) <i>m</i>/<i>z</i>: calcd for C<sub>57</sub>H<sub>74</sub>N<sub>8</sub>O<sub>13</sub>P<sub>2</sub> 1163.47428 [M + Na]<sup>+</sup>, found 1163.47445 [M + Na]<sup>+</sup>.</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Tetra-(<span class="smallcaps smallerCapital">l</span>-phenylalanine ethyl ester) Prodrug of {[3-(7-Deazahypoxanthine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methyl}phosphonic Acid (<b>31</b>)</h3><div class="NLM_p last">From compound <b>19</b> (508 mg, 0.9 mmol) according to method G, afforded 108 mg (11%) of <b>31</b> as white lyophilisate. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 11.92 [bs, 1H, H-1]; 7.90 and 7.87 [s, 1H, H-2]; 7.10–7.27 [m, 20H, H-2″, H-3″, H-4″]; 7.03 and 7.00 [d, 1H, <i>J</i>(8,7) = 3.4 Hz, H-8]; 6.48 and 6.47 [d, 1H, <i>J</i>(7,8) = 3.4 Hz, H-7]; 4.46–4.62 [m, 2H, NH]; 4.20 [m, 1H, NH]; 3.81–4.12 [m, 15H, NH, NH-<u class="uu">CH</u>, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>, H-1′]; 2.98–3.32 [m, 8H, H-3′, H-4′, H-5′, H-6′]; 2.69–2.94 [m, 8H, 1″-<u class="uu">CH</u><sub><u class="uu">2</u></sub>]; 2.19 and 2.10 [m, 1H, H-2′]; 1.48–1.59 [m, 2H, H-7′]; 1.04–1.14 [m, 12H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 173.12–173.60 [m, COO]; 158.72 and 158.70 [C-6]; 147.72 and 147.64 [C-4]; 143.93 and 143.83 [C-2]; 137.52–137.74 [m, C-1″]; 129.87–129.94 [m, C-2″]; 128.53–128.57 [m, C-3″]; 126.89–126.96 [m, C-4″]; 124.91 and 124.71 [C-8]; 108.15 and 108.10 [C-5]; 101.97 and 101.89 [C-7]; 71.09 and 70.72 [d, <i>J</i>(3′,P) = 13.0 Hz, <i>J</i>(3′,P) = 13.5 Hz, C-3′]; 67.42–68.91 [m, C-4′, C-5′]; 65.56 [C-6′]; 60.74–60.95 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 54.14–54.67 [m, <u class="uu">CH</u>-NH]; 43.46 and 43.33 [C-1′]; 39.8 [1″-<u class="uu">CH</u><sub><u class="uu">2</u></sub>]; 29.84–30.77 [m, C-7′]; 14.34–14.42 [m, CH<sub>3</sub>]. HR-MS (ESI+) <i>m</i>/<i>z</i>: calcd for C<sub>57</sub>H<sub>73</sub>N<sub>7</sub>O<sub>13</sub>P<sub>2</sub> 1148.46338 [M + Na]<sup>+</sup>, found 1148.46358 [M + Na]<sup>+</sup>.</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Tetra-(<span class="smallcaps smallerCapital">l</span>-phenylalanine ethyl ester) Prodrug of {[3-(8-Bromoguanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methyl}phosphonic Acid (<b>32</b>)</h3><div class="NLM_p last">From compound <b>28</b> (160 mg, 0.14 mmol) according to method H, afforded 21 mg (12%) of <b>32</b> as colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 10.73 [bs, 1H, H-1]; 7.06–7.27 [m, 20H, H-2″, H-3″, H4″]; 6.73 [bs, 2H, NH<sub>2</sub>]; 4.08–4.61 [m, 4H, NH]; 3.79–4.05 [m, 12H, NH-<u class="uu">CH</u>, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.08–3.38 [m, 8H, H-3′, H-4′, H-5′, H-6′]; 2.67–2.93 [m, 8H, 1″-<u class="uu">CH</u><sub><u class="uu">2</u></sub>]; 2.23 [m, 1H, H-2′]; 1.50–1.60 [m, 2H, H-7′]; 1.01–1.14 [m, 12H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 172.78–173.36 [m, COO]; 155.85 and 154.13 [C-2, C-6]; 152.93 [C-4]; 137.17–137.55 [m, C-1″]; 129.56–129.69 [m, C-2″]; 128.26–128.35 [m, C-3″]; 126.61–126.75 [m, C-4″]; 121.21 and 121.19 [C-8]; 116.89 [C-5]; 70.86–71.03 [m, C-3′]; 67.38–68.43 [m, C-4′, C-5′]; 65.01 and 64.89 [C-6′]; 60.47–60.75 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 53.94–54.54 [m, <u class="uu">CH</u>-NH]; 42.54 and 42.45 [C-1′]; 39.8 [1″-<u class="uu">CH</u><sub><u class="uu">2</u></sub>]; 38.7 [C-2′]; 29.8 [C-7′]; 14.50–14.17 [m, CH<sub>3</sub>]. HR-MS (ESI+) <i>m</i>/<i>z</i>: calcd for C<sub>56</sub>H<sub>72</sub>BrN<sub>9</sub>O<sub>13</sub>P<sub>2</sub> 1220.39810 [M + H]<sup>+</sup>, found 1220.39888 [M + H]<sup>+</sup>.</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Tetra-(<span class="smallcaps smallerCapital">l</span>-phenylalanine ethyl ester) Prodrug of {[3-(8-Bromohypoxanthine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methyl}phosphonic Acid (<b>33</b>)</h3><div class="NLM_p last">From compound <b>29</b> (153 mg, 0.136 mmol) according to method H, afforded 24 mg (15%) of <b>33</b> as white lyophilisate. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 12.49 [bs, 1H, H-1]; 8.05, 8.01 [s, 1H, H-2]; 7.09–7.27 [m, 20H, H-2″, H-3″, H-4″]; 4.14–4.59 [m, 4H, NH]; 3.80–4.11 [m, 14H, H-1′, NH-<u class="uu">CH</u>, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 3.07–3.33 [m, 8H, H-3′, H-4′, H-5′, H-6′]; 2.67–2.92 [m, 8H, 1″-CH<sub>2</sub>]; 2.21–2.32 [m, 1H, H-2′]; 1.43–1.56 [m, 2H, H-7′]; 1.03–1.17 [m, 12H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 172.91–173.30 [m, COO]; 155.70 [C-6]; 150.20 and 150.09 [C-4]; 146.4 [C-2]; 137.20–137.49 [m, C-1″]; 129.61–129.70 [m, C-2″]; 128.25–128.35 [m, C-3″]; 126.64–126.72 [m, C-4″]; 125.76 and 125.65 [C-8]; 124.45 and 124.43 [C-5]; 70.29–71.00 [m, C-3′]; 67.16–68.66 [m, C-4′, C-5′]; 65.37 [C-6′]; 60.49–60.73 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 53.72–54.40 [m, <u class="uu">CH</u>-NH]; 43.76 [C-1′]; 39.7 [1″-CH<sub>2</sub>]; 39.0 [C-2′]; 29.7 [C-7′]; 14.09–14.19 [m, CH<sub>3</sub>]. HR-MS (ESI+) <i>m</i>/<i>z</i>: calcd for C<sub>56</sub>H<sub>71</sub>BrN<sub>8</sub>O<sub>13</sub>P<sub>2</sub> 1227.36914 [M + Na]<sup>+</sup>, found 1227.36938 [M + Na]<sup>+</sup>.</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Tetra-(<span class="smallcaps smallerCapital">l</span>-phenylalanine ethyl ester) Prodrug of {2-[3-(8-Bromoguanin-9-yl)-2-(2-(bishydroxyphosphoryl)ethoxy)propoxy]ethyl}phosphonic Acid (<b>35</b>)</h3><div class="NLM_p last">From compound <b>34</b> (171 mg, 0.15 mmol) according to method H, afforded 24 mg (13%) of <b>35</b> as white lyophilisate. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 10.71 [bs, 1H, H-1]; 7.09–7.28 [m, 20H, H-2″, H-3″, H-4″]; 6.71 [bs, 2H, NH<sub>2</sub>]; 4.42–4.57 [m, 2H, NH]; 4.06–4.18 [m, 2H, NH]; 3.78–4.04 [m, 14H, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>, H-1′; NH-<u class="uu">CH</u>]; 3.60 [m, 1H, H-2′]; 3.18–3.42 [m, 6H, H-3′, H-4′, H-6′]; 2.67–2.92 [m, 8H, 1″-CH<sub>2</sub>]; 1.57–1.65 [m, 2H, H-5′]; 1.43–1.51 [m, 2H, H-7′]; 1.03–1.13 [m, 12H, CH<sub>3</sub>]. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 173.06–173.28 [m, COO]; 155.83 and 154.06 [C-2, C-6]; 152.87 [C-4]; 137.38–137.46 [m, C-1″]; 129.55–129.61 [m, C-2″]; 128.26–128.33 [m, C-3″]; 126.64–126.71 [m, C-4″]; 121.60 and 121.57 [C-8]; 116.85 and 116.82 [C-5]; 75.66 and 75.55 [C-2′]; 69.64 and 69.43 [C-3′]; 65.46 and 65.32 [C-4′]; 64.48 and 64.42 [C-6′]; 60.44–60.60 [m, <u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>]; 53.89–54.46 [m, NH-<u class="uu">CH</u>]; 44.82 and 44.76 [C-1′]; 39.9 [1″-CH<sub>2</sub>]; 29.63–30.77 [m, C-5′, C-7′]; 14.04–14.14 [m, CH<sub>3</sub>]. HR-MS (ESI+) <i>m</i>/<i>z</i>: calcd for C<sub>56</sub>H<sub>72</sub>BrN<sub>9</sub>O<sub>13</sub>P<sub>2</sub> 1242.38004 [M + Na]<sup>+</sup>, found 1242.38030 [M + Na]<sup>+</sup>.</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Biological Activity Testing. Determination of <i>K</i><sub>i</sub> Values</h3><div class="NLM_p last">The <i>K</i><sub>i</sub> values for the human and <i>Pf</i> enzymes were determined as previously described.<a onclick="showRef(event, 'ref16 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref20">(16, 20)</a> All assays were performed in 0.1 M Tris-HCl, 10 mM MgCl<sub>2</sub> at pH 7.4. Hanes’ plots were determined at a fixed concentration of inhibitor and the nonvariable substrate, guanine (49 μM). The concentration of <i>P</i>Rib-<i>PP</i> was varied between 20 and 1400 μM so that the maximum concentration of this substrate was at least 4 times that of <i>K</i><sub>m</sub>(app). The <i>K</i><sub>i</sub> was calculated using the equation, <i>v</i><sub>o</sub> = <i>V</i><sub>max</sub>[S]<sub>o</sub>/[S]<sub>o</sub> + <i>K</i><sub>m(app)</sub> and <i>K</i><sub>m(app)</sub> = <i>K</i><sub>m</sub>[1 + [I]/<i>K</i><sub>i</sub>]. At [I] = 0 and the concentration of inhibitor used in the assay, <i>V</i><sub>max</sub> was unchanged and the <i>K</i><sub>m</sub> increased consistent with competitive inhibition. For inhibitors with low <i>K</i><sub>i</sub> values (<2 μM), the <i>K</i><sub>m(app)</sub> was calculated at three different concentrations of inhibitor. These are single rates. The approximate <i>K</i><sub>i</sub> values were calculated and were consistent with the final numbers. For these compounds, all of the plots are linear and parallel. The errors in <i>K</i><sub>i</sub> value were calculated using GraphPad Prism. Standard deviations were derived by fitting all of the exeprimental data to <i>K</i><sub>m</sub>(app) = <i>K</i><sub>m</sub>[1 + [I]/<i>K</i><sub>i</sub>].</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Crystallization and Structure Determination of Human HGPRT in Complex with <b>20</b></h3><div class="NLM_p last">For crystallization experiments, human HGPRT was concentrated to 11.1 mg/mL (0.44 mM in terms of subunits). After concentration, the enzyme is stored at −70 °C in 0.1 M Tris-HCl, 0.01 M MgCl<sub>2</sub>, 1 mM DTT, and 300 μM PRib-PP, pH 7.4. Prior to crystallization, the enzyme was incubated with <b>20</b> for ∼5 min to give a final concentration of the compound of 4.8 mM. For crystallization, the hanging drop method was used where 1 μL of reservoir solution and 1 μL of human HGPRT in complex with the inhibitor were combined in the drops and incubated at 18 °C. The reservoir solution for the complex was 20% PEG 3350, 0.2 M sodium bromide, 0.1 M Bis-Tris propane, pH 7.5. Crystals were cryocooled in liquid nitrogen for shipment to the Australian Synchrotron where they were robotically placed in a cryostream (100 K) on beamline MX1. X-ray data were collected remotely using BLU-ICE.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> All data sets were scaled and merged with XDS.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The structure was solved by molecular replacement using the program PHASER within PHENIX 1.8.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The protein coordinates of human HGPRT in complex with 9-[(<i>N</i>-phosphonoethyl-<i>N</i>-phosphonoethoxyethyl)-2-aminoethyl]-8-bromoguanine was the starting model (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RAB">4RAB</a>). Subsequent refinement and initial model building were with PHENIX 1.8 and COOT 0.8,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> respectively.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> In Vitro Antimalarial Activity of ANbP Prodrugs</h3><div class="NLM_p last"><i>P. falciparum</i> D6 (Sierra-Leone) laboratory line, sensitive to most antimalarial drugs and W2 (Indochina) line and resistant to chloroquine and pyrimethamine, were maintained as previously described<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> in RPMI-1640-LPLF complete medium, containing 10.4 g/L RPMI-1640-LPLF powder (Gibco BRL), 5.97 g/L HEPES buffer (MP Biomedicals, USA), 2.0 g/L <span class="smallcaps smallerCapital">d</span>-glucose (BDH Chemicals, Australia), 0.05 g/L hypoxanthine (Sigma, USA), and 40 mg/L gentamycin (Pfizer, Australia) with pH adjusted to 6.9. The sodium bicarbonate solution (0.21% final concentration) and human plasma (10% final) were added prior to use. Cultures were maintained at 4% hematocrit (O(<sup>+</sup>) RBC) and 1–8% parasitemia at 37 °C in a special gas mixture (5% O<sub>2</sub>, 5% CO<sub>2</sub>, and 90% N<sub>2</sub>). Cultures were routinely synchronized using <span class="smallcaps smallerCapital">d</span>-sorbitol.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The antimalarial activity of the ANbPs was evaluated using the [<sup>3</sup>H]-hypoxanthine growth inhibition assay.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> For these assays, stock solutions of ANbPs were made to concentrations of 20–40 mM in DMSO or water and subsequently diluted in hypoxanthine-free complete media prior to assay. The assays (in 96-well plate format) were initiated when most of the parasites (>90%) were at early trophozoite (ring) stage. Parasite cultures (100 μL per well) at 0.5% initial parasitemia and 2% hematocrit in hypoxanthine-free RPMI1640-LPLF medium were exposed to 10 2-fold serial dilutions of the ANbPs for 96 h, with [<sup>3</sup>H]-hypoxanthine (0.2 μCi/well) added ∼48 h after beginning of the experiment. The [<sup>3</sup>H]-hypoxanthine incorporation data were analyzed, and sigmoidal growth inhibition curves were produced by nonlinear regression analysis of the [<sup>3</sup>H]-hypoxanthine incorporation data versus log-transformed concentrations of the compounds using GraphPad Prism version 5.0 software (GraphPad Software Inc., USA), from which the inhibitory concentration (IC<sub>50</sub>) that causes 50% of parasite growth was determined. The IC<sub>50</sub> values were based on at least two independent experiments with mean (±SD) calculated.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Cytotoxicity Assays in Human Cell Lines</h3><div class="NLM_p last">Human lung carcinoma A549 cells were seeded in 96-well plates at 7500 cells per well, and on the next day the compounds were added in serial dilutions. After 4 days incubation at 37 °C, the cells were trypsinized, then counted with a Coulter counter apparatus. The CC<sub>50</sub> or 50% cytostatic concentration, defined as the compound concentration producing 50% inhibition of cell proliferation as compared to the no compound control, was calculated by extrapolation assuming a semilog dose–response effect.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00926">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00926" class="ext-link">10.1021/acs.jmedchem.7b00926</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SMILES strings of target ANbPs and their prodrugs (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00926/suppl_file/jm7b00926_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00926/suppl_file/jm7b00926_si_001.csv">jm7b00926_si_001.csv (3.26 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors of human HGPRT in complex with compound <b>20</b> have been deposited with the Protein Data Bank as entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W8V">5W8V</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b00926" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luke W. Guddat</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4068, Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fe928b959bd0998b9a9a9f8abe8b8fd09b9a8bd09f8b"><span class="__cf_email__" data-cfemail="a0ccd5cbc58ec7d5c4c4c1d4e0d5d18ec5c4d58ec1d5">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dana Hocková</span> - <span class="hlFld-Affiliation affiliation">The
Institute of Organic Chemistry and Biochemistry of the Czech Academy
of Sciences, Flemingovo
nám. 2, CZ-16610 Prague 6, Czech Republic</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1673-8694" title="Orcid link">http://orcid.org/0000-0003-1673-8694</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bad2d5d9d1d5ccdbfacfd5d9d2d894d9dbc994d9c0"><span class="__cf_email__" data-cfemail="d0b8bfb3bbbfa6b190a5bfb3b8b2feb3b1a3feb3aa">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Petr Špaček</span> - <span class="hlFld-Affiliation affiliation">The
Institute of Organic Chemistry and Biochemistry of the Czech Academy
of Sciences, Flemingovo
nám. 2, CZ-16610 Prague 6, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dianne T. Keough</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4068, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marina Chavchich</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Evaluation, Australian Army Malaria
Institute, Enoggera, Brisbane, Queensland 4051, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Dračínský</span> - <span class="hlFld-Affiliation affiliation">The
Institute of Organic Chemistry and Biochemistry of the Czech Academy
of Sciences, Flemingovo
nám. 2, CZ-16610 Prague 6, Czech Republic</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4495-0070" title="Orcid link">http://orcid.org/0000-0002-4495-0070</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zlatko Janeba</span> - <span class="hlFld-Affiliation affiliation">The
Institute of Organic Chemistry and Biochemistry of the Czech Academy
of Sciences, Flemingovo
nám. 2, CZ-16610 Prague 6, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lieve Naesens</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Virology and Chemotherapy, Rega Institute
for Medical Research—KU Leuven, Herestraat 49, B-3000 Leuven, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Edstein</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Evaluation, Australian Army Malaria
Institute, Enoggera, Brisbane, Queensland 4051, Australia</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d237e5810-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Initial crystallographic conditions were determined using the University of Queensland Remote-Operation Crystallization and X-ray Diffraction facility (UQROCX). X-ray measurements were performed at the Australian Synchrotron. We thank Kerryn Rowcliffe for in vitro drug testing and the Australian Red Cross Blood Service for human blood. The views expressed here are those of the authors and not necessarily those of the Australian Synchrotron or the Australian Defence Organisation. This work was supported by NHMRC (Grant 1030353 to L.W.G., D.H., and M.D.E.), the Institute of Organic Chemistry and Biochemistry, RVO 61388963, the Czech Science Foundation (Grant 16-06049S to D.H.), and Gilead Sciences (Foster City, CA, U.S.).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i63" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i63"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i64" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i64"> Abbreviations Used</h2><tr><td class="NLM_term">A549</td><td class="NLM_def"><p class="first last">human lung carcinoma cells</p></td></tr><tr><td class="NLM_term">ACT</td><td class="NLM_def"><p class="first last">artemisinin based combination therapy</p></td></tr><tr><td class="NLM_term">ANbP</td><td class="NLM_def"><p class="first last">acyclic nucleoside bisphosphonate</p></td></tr><tr><td class="NLM_term">D6</td><td class="NLM_def"><p class="first last"><i>Plasmodium falciparum</i> strain sensitive to most drugs</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr><tr><td class="NLM_term">HGPRT</td><td class="NLM_def"><p class="first last">hypoxanthine–guanine phosphoribosyltransferase</p></td></tr><tr><td class="NLM_term">HGXPRT</td><td class="NLM_def"><p class="first last">hypoxanthine–guanine–xanthine phosphoribosyltransferase</p></td></tr><tr><td class="NLM_term">HR</td><td class="NLM_def"><p class="first last">high resolution</p></td></tr><tr><td class="NLM_term">IMP</td><td class="NLM_def"><p class="first last">inosine 5′-monophosphate</p></td></tr><tr><td class="NLM_term">PDA</td><td class="NLM_def"><p class="first last">photodiode array</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term"><i>Pf</i></td><td class="NLM_def"><p class="first last"><i>Plasmodium falciparum</i></p></td></tr><tr><td class="NLM_term"><i>Pv</i></td><td class="NLM_def"><p class="first last"><i>Plasmodium vivax</i></p></td></tr><tr><td class="NLM_term">PP<sub>i</sub></td><td class="NLM_def"><p class="first last">pyrophosphate</p></td></tr><tr><td class="NLM_term">RBC</td><td class="NLM_def"><p class="first last">red blood cell</p></td></tr><tr><td class="NLM_term">RPMI1640-LPLF</td><td class="NLM_def"><p class="first last">Roswell Park Memorial Institute 1640 medium with low <i>p</i>-aminobenzoic acid and low folic acid</p></td></tr><tr><td class="NLM_term"><i>P</i>Rib-<i>PP</i></td><td class="NLM_def"><p class="first last">5-phospho-α-<span class="smallcaps smallerCapital">d</span>-ribosyl-1-pyrophosphate</p></td></tr><tr><td class="NLM_term">TEAB</td><td class="NLM_def"><p class="first last">triethylammonium bicarbonate</p></td></tr><tr><td class="NLM_term">Tris</td><td class="NLM_def"><p class="first last">2-amino-2-(hydroxymethyl)propane-1,3-diol</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultraperformance liquid chromatography</p></td></tr><tr><td class="NLM_term">W2</td><td class="NLM_def"><p class="first last">chloroquine- and pyrimethamine-resistant <i>Plasmodium falciparum</i> strain</p></td></tr><tr><td class="NLM_term">XMP</td><td class="NLM_def"><p class="first last">xanthosine 5′-monophosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span> <span class="citation_source-book">World Malaria Report 2016</span>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Malaria+Report+2016%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DWorld%2520Malaria%2520Report%25202016%26pub%3DWorld%2520Health%2520Organization%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Venkatesh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shastri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochar, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patankar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span> </span><span class="NLM_article-title">Proteomics of <i>Plasmodium Vivax</i> Malaria: New Insights, Progress and Potential</span> <span class="citation_source-journal">Expert Rev. Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">782</span><span class="refDoi"> DOI: 10.1080/14789450.2016.1210515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1080%2F14789450.2016.1210515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=27389635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Krtb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=771-782&issue=8&author=A.+Venkateshauthor=S.+K.+Patelauthor=S.+Rayauthor=J.+Shastriauthor=G.+Chatterjeeauthor=S.+K.+Kocharauthor=S.+Patankarauthor=S.+Srivastava&title=Proteomics+of+Plasmodium+Vivax+Malaria%3A+New+Insights%2C+Progress+and+Potential&doi=10.1080%2F14789450.2016.1210515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomics of Plasmodium vivax malaria: new insights, progress and potential</span></div><div class="casAuthors">Venkatesh, Apoorva; Patel, Sandip K.; Ray, Sandipan; Shastri, Jayanthi; Chatterjee, Gangadhar; Kochar, Sanjay K.; Patankar, Swati; Srivastava, Sanjeeva</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Proteomics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">771-782</span>CODEN:
                <span class="NLM_cas:coden">ERPXA3</span>;
        ISSN:<span class="NLM_cas:issn">1478-9450</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Plasmodium vivax has accounted for an enormous share of the global malaria burden in recent years, along with Plasmodium falciparum.  The wide distribution of P. vivax and recent evidences of severe and complicated vivax malaria across several endemic regions of the world suggest that this disease may have been more overlooked than benign.  While P. falciparum has been extensively studied, P. vivax has received limited research attention owing to its complex nature and absence of a continuous culture system.  This review briefly describes the epidemiol. of vivax malaria, analyzes challenges towards effective control and summarizes major insights provided by genomics and transcriptomics research in the area.  Subsequently, the review provides a detailed description of the applications of proteomics in vivax malaria research, focusing on both host responses and parasite proteomics studies to understand P. vivax biol.  In recent years, proteomics technologies are being used effectively to understand P. vivax biol. and the underlying pathogenesis.  Technol. advances in mass spectrometry configurations, multiomics investigations and emerging strategies such as targeted proteomics may also immensely aid in studying disease severity, improving existing diagnosis and identifying new drug and vaccine targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQsw7cGxQKHLVg90H21EOLACvtfcHk0li10vgLm6HGvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Krtb7E&md5=58859c5cc44360c85904b0bea281bdf3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1080%2F14789450.2016.1210515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14789450.2016.1210515%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatesh%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DS.%2BK.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DShastri%26aufirst%3DJ.%26aulast%3DChatterjee%26aufirst%3DG.%26aulast%3DKochar%26aufirst%3DS.%2BK.%26aulast%3DPatankar%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DS.%26atitle%3DProteomics%2520of%2520Plasmodium%2520Vivax%2520Malaria%253A%2520New%2520Insights%252C%2520Progress%2520and%2520Potential%26jtitle%3DExpert%2520Rev.%2520Proteomics%26date%3D2016%26volume%3D13%26issue%3D8%26spage%3D771%26epage%3D782%26doi%3D10.1080%2F14789450.2016.1210515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Spring, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanachayangkul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somethy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Se, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittiverakul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sia-ngam, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntawunginn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arsanok, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buathong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaorattanakawee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ta-aksorn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanarat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundrakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teja-isavadharm, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichyangkul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phann, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshnick, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chour, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanteri, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, D. L.</span><span> </span><span class="NLM_article-title">Dihydroartemisinin-piperaquine Failure Associated with a Triple Mutant Including <i>Kelch13 C580Y</i> in Cambodia: An Observational Cohort Study</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1016/S1473-3099(15)70049-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2FS1473-3099%2815%2970049-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=25877962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFSgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=683-691&author=M.+D.+Springauthor=J.+T.+Linauthor=J.+E.+Manningauthor=P.+Vanachayangkulauthor=S.+Somethyauthor=R.+Bunauthor=Y.+Seauthor=S.+Channauthor=M.+Ittiverakulauthor=P.+Sia-ngamauthor=W.+Kuntawunginnauthor=M.+Arsanokauthor=N.+Buathongauthor=S.+Chaorattanakaweeauthor=P.+Gosiauthor=W.+Ta-aksornauthor=N.+Chanaratauthor=S.+Sundrakesauthor=N.+Kongauthor=T.+K.+Hengauthor=S.+Nouauthor=P.+Teja-isavadharmauthor=S.+Pichyangkulauthor=S.+T.+Phannauthor=S.+Balasubramanianauthor=J.+J.+Julianoauthor=S.+R.+Meshnickauthor=C.+M.+Chourauthor=S.+Promauthor=C.+A.+Lanteriauthor=C.+Lonauthor=D.+L.+Saunders&title=Dihydroartemisinin-piperaquine+Failure+Associated+with+a+Triple+Mutant+Including+Kelch13+C580Y+in+Cambodia%3A+An+Observational+Cohort+Study&doi=10.1016%2FS1473-3099%2815%2970049-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study</span></div><div class="casAuthors">Spring, Michele D.; Lin, Jessica T.; Manning, Jessica E.; Vanachayangkul, Pattaraporn; Somethy, Sok; Bun, Rathvicheth; Se, Youry; Chann, Soklyda; Ittiverakul, Mali; Sia-ngam, Piyaporn; Kuntawunginn, Worachet; Arsanok, Montri; Buathong, Nillawan; Chaorattanakawee, Suwanna; Gosi, Panita; Ta-aksorn, Winita; Chanarat, Nitima; Sundrakes, Siratchana; Kong, Nareth; Heng, Thay Kheang; Nou, Samon; Teja-isavadharm, Paktiya; Pichyangkul, Sathit; Phann, Sut Thang; Balasubramanian, Sujata; Juliano, Jonathan J.; Meshnick, Steven R.; Chour, Char Meng; Prom, Satharath; Lanteri, Charlotte A.; Lon, Chanthap; Saunders, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">683-691</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Dihydroartemisinin-piperaquine has been adopted as first-line artemisinin combination therapy (ACT) for multidrug-resistant Plasmodium falciparum malaria in Cambodia because of few remaining alternatives.  We aimed to assess the efficacy of std. 3 day dihydroartemisinin-piperaquine treatment of uncomplicated P falciparum malaria, with and without the addn. of primaquine, focusing on the factors involved in drug resistance.  In this observational cohort study, we assessed 107 adults aged 18-65 years presenting to Anlong Veng District Hospital, Oddar Meanchey Province, Cambodia, with uncomplicated P falciparum or mixed P falciparum/Plasmodium vivax infection of between 1000 and 200 000 parasites per μL of blood, and participating in a randomized clin. trial in which all had received dihydroartemisinin-piperaquine for 3 days, after which they had been randomly allocated to receive either primaquine or no primaquine.  The trial was halted early due to poor dihydroartemisinin-piperaquine efficacy, and we assessed day 42 PCR-cor. therapeutic efficacy (proportion of patients with recurrence at 42 days) and evidence of drug resistance from the initial cohort.  We did analyses on both the intention to treat (ITT), modified ITT (withdrawals, losses to follow-up, and those with secondary outcomes [eg, new non-recrudescent malaria infection] were censored on the last day of follow-up), and per-protocol populations of the original trial.  The original trial was registered with ClinicalTrials.gov, no. NCT01280162.  Between Dec 10, 2012, and Feb 18, 2014, we had enrolled 107 patients in the original trial.  Enrolment was voluntarily halted on Feb 16, 2014, before reaching planned enrollment (n=150) because of poor efficacy.  We had randomly allocated 50 patients to primaquine and 51 patients to no primaquine groups.  PCR-adjusted Kaplan-Meier risk of P falciparum 42 day recrudescence was 54% (95% CI 45-63) in the modified ITT anal. population.  We found two kelch13 propeller gene mutations assocd. with artemisinin resistance-a non-synonymous Cys580Tyr substitution in 70 (65%) of 107 participants, an Arg539Thr substitution in 33 (31%), and a wild-type parasite in four (4%).  Unlike Arg539Thr, Cys580Tyr was accompanied by two other mutations assocd. with extended parasite clearance (MAL10:688956 and MAL13:1718319).  This combination triple mutation was assocd. with a 5·4 times greater risk of treatment failure (hazard ratio 5·4 [95% CI 2·4-12]; p<0·0001) and higher piperaquine 50% inhibitory concn. (triple mutant 34 nM [28-41]; non-triple mutant 24 nM [1-27]; p=0·003) than other infections had.  The drug was well tolerated, with gastrointestinal symptoms being the most common complaints.  The dramatic decline in efficacy of dihydroartemisinin-piperaquine compared with what was obsd. in a study at the same location in 2010 was strongly assocd. with a new triple mutation including the kelch13 Cys580Tyr substitution.  3 Days of artemisinin as part of an artemisinin combination therapy regimen might be insufficient.  Strict regulation and monitoring of antimalarial use, along with non-pharmacol. approaches to malaria resistance containment, must be integral parts of the public health response to rapidly accelerating drug resistance in the region.  Armed Forces Health Surveillance Center/Global Emerging Infections Surveillance and Response System, Military Infectious Disease Research Program, National Institute of Allergy and Infectious Diseases, and American Society of Tropical Medicine and Hygiene/Burroughs Wellcome Fund.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFjkvNekrUMrVg90H21EOLACvtfcHk0livsKz4ca5gXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFSgu78%253D&md5=6150b25babe19f91eb5971e030327681</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2815%2970049-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252815%252970049-6%26sid%3Dliteratum%253Aachs%26aulast%3DSpring%26aufirst%3DM.%2BD.%26aulast%3DLin%26aufirst%3DJ.%2BT.%26aulast%3DManning%26aufirst%3DJ.%2BE.%26aulast%3DVanachayangkul%26aufirst%3DP.%26aulast%3DSomethy%26aufirst%3DS.%26aulast%3DBun%26aufirst%3DR.%26aulast%3DSe%26aufirst%3DY.%26aulast%3DChann%26aufirst%3DS.%26aulast%3DIttiverakul%26aufirst%3DM.%26aulast%3DSia-ngam%26aufirst%3DP.%26aulast%3DKuntawunginn%26aufirst%3DW.%26aulast%3DArsanok%26aufirst%3DM.%26aulast%3DBuathong%26aufirst%3DN.%26aulast%3DChaorattanakawee%26aufirst%3DS.%26aulast%3DGosi%26aufirst%3DP.%26aulast%3DTa-aksorn%26aufirst%3DW.%26aulast%3DChanarat%26aufirst%3DN.%26aulast%3DSundrakes%26aufirst%3DS.%26aulast%3DKong%26aufirst%3DN.%26aulast%3DHeng%26aufirst%3DT.%2BK.%26aulast%3DNou%26aufirst%3DS.%26aulast%3DTeja-isavadharm%26aufirst%3DP.%26aulast%3DPichyangkul%26aufirst%3DS.%26aulast%3DPhann%26aufirst%3DS.%2BT.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DJuliano%26aufirst%3DJ.%2BJ.%26aulast%3DMeshnick%26aufirst%3DS.%2BR.%26aulast%3DChour%26aufirst%3DC.%2BM.%26aulast%3DProm%26aufirst%3DS.%26aulast%3DLanteri%26aufirst%3DC.%2BA.%26aulast%3DLon%26aufirst%3DC.%26aulast%3DSaunders%26aufirst%3DD.%2BL.%26atitle%3DDihydroartemisinin-piperaquine%2520Failure%2520Associated%2520with%2520a%2520Triple%2520Mutant%2520Including%2520Kelch13%2520C580Y%2520in%2520Cambodia%253A%2520An%2520Observational%2520Cohort%2520Study%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2015%26volume%3D15%26spage%3D683%26epage%3D691%26doi%3D10.1016%2FS1473-3099%2815%2970049-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Thanh, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuy-Nhien, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuyen, N. T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nha-Ca, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quang, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thwaites, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolbers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hien, T. T.</span><span> </span><span class="NLM_article-title">Rapid Decline in the Susceptibility of <i>Plasmodium falciparum</i> to Dihydroartemisinin-piperaquine in the South of Vietnam</span> <span class="citation_source-journal">Malar. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="refDoi"> DOI: 10.1186/s12936-017-1680-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1186%2Fs12936-017-1680-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=28086775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A280%3ADC%252BC1c7ls1Oltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=27&author=N.+V.+Thanhauthor=N.+Thuy-Nhienauthor=N.+T.+K.+Tuyenauthor=N.+T.+Tongauthor=N.+T.+Nha-Caauthor=L.+T.+Dongauthor=H.+H.+Quangauthor=J.+Farrarauthor=G.+Thwaitesauthor=N.+J.+Whiteauthor=M.+Wolbersauthor=T.+T.+Hien&title=Rapid+Decline+in+the+Susceptibility+of+Plasmodium+falciparum+to+Dihydroartemisinin-piperaquine+in+the+South+of+Vietnam&doi=10.1186%2Fs12936-017-1680-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam</span></div><div class="casAuthors">Thanh Ngo Viet; Thuy-Nhien Nguyen; Tuyen Nguyen Thi Kim; Tong Nguyen Thanh; Nha-Ca Nguyen Thuy; Farrar Jeremy; Thwaites Guy; Wolbers Marcel; Hien Tran Tinh; Dong Le Thanh; Quang Huynh Hong; Farrar Jeremy; Thwaites Guy; White Nicholas J; Wolbers Marcel; Hien Tran Tinh; White Nicholas J</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Artemisinin resistant Plasmodium falciparum has emerged in the countries of the Greater Mekong sub-region posing a serious threat to global malaria elimination efforts.  The relationship of artemisinin resistance to treatment failure has been unclear.  METHODS:  In annual studies conducted in three malaria endemic provinces in the south of Vietnam (Binh Phuoc, Ninh Thuan and Gia Lai) between 2011 and 2015, 489 patients with uncomplicated P. falciparum malaria were enrolled in detailed clinical, parasitological and molecular therapeutic response assessments with 42 days follow up.  Patients received the national recommended first-line treatment dihydroartemisinin-piperaquine for three days.  RESULTS:  Over the 5 years the proportion of patients with detectable parasitaemia on day 3 rose steadily from 38 to 57% (P < 0.001).  In Binh Phuoc province, the parasite clearance half-life increased from 3.75 h in 2011 to 6.60 h in 2015 (P < 0.001), while treatment failures rose from 0% in 2012 and 2013, to 7% in 2014 and 26% in 2015 (P < 0.001).  Recrudescence was associated with in vitro evidence of artemisinin and piperaquine resistance.  In the treatment failures cases of 2015, all 14 parasite isolates carried the C580Y Pfkelch 13 gene, marker of artemisinin resistance and 93% (13/14) of them carried exoE415G mutations, markers of piperaquine resistance.  CONCLUSIONS:  In the south of Vietnam recent emergence of piperaquine resistant P. falciparum strains has accelerated the reduced response to artemisinin and has led to treatment failure rates of up to 26% to dihydroartemisinin-piperaquine, Vietnam's current first-line ACT.  Alternative treatments are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGj2vwuYNqs7FU0A1HOshhfW6udTcc2eYLf0JqJJdyKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7ls1Oltg%253D%253D&md5=cd3e7d89b8166b18acf7760d80073963</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2Fs12936-017-1680-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-017-1680-8%26sid%3Dliteratum%253Aachs%26aulast%3DThanh%26aufirst%3DN.%2BV.%26aulast%3DThuy-Nhien%26aufirst%3DN.%26aulast%3DTuyen%26aufirst%3DN.%2BT.%2BK.%26aulast%3DTong%26aufirst%3DN.%2BT.%26aulast%3DNha-Ca%26aufirst%3DN.%2BT.%26aulast%3DDong%26aufirst%3DL.%2BT.%26aulast%3DQuang%26aufirst%3DH.%2BH.%26aulast%3DFarrar%26aufirst%3DJ.%26aulast%3DThwaites%26aufirst%3DG.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DWolbers%26aufirst%3DM.%26aulast%3DHien%26aufirst%3DT.%2BT.%26atitle%3DRapid%2520Decline%2520in%2520the%2520Susceptibility%2520of%2520Plasmodium%2520falciparum%2520to%2520Dihydroartemisinin-piperaquine%2520in%2520the%2520South%2520of%2520Vietnam%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26spage%3D27%26doi%3D10.1186%2Fs12936-017-1680-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Cassera, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazleton, K. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">Purine and Pyrimidine Pathways as Targets in Plasmodium falciparum</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">2103</span><span class="NLM_x">–</span> <span class="NLM_lpage">2115</span><span class="refDoi"> DOI: 10.2174/156802611796575948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.2174%2F156802611796575948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=21619511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=2103-2115&issue=16&author=M.+B.+Casseraauthor=Y.+Zhangauthor=K.+Z.+Hazletonauthor=V.+L.+Schramm&title=Purine+and+Pyrimidine+Pathways+as+Targets+in+Plasmodium+falciparum&doi=10.2174%2F156802611796575948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Purine and pyrimidine pathways as targets in Plasmodium falciparum</span></div><div class="casAuthors">Cassera, Maria Belen; Zhang, Yong; Hazleton, Keith Z.; Schramm, Vern L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2103-2115</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria is a leading cause of morbidity and mortality in the tropics.  Chemotherapeutic and vector control strategies have been applied for more than a century but have not been efficient in disease eradication.  Increased resistance of malaria parasites to drug treatment and of mosquito vectors to insecticides requires the development of novel chemotherapeutic agents.  Malaria parasites exhibit rapid nucleic acid synthesis during their intraerythrocytic growth phase.  Plasmodium purine and pyrimidine metabolic pathways are distinct from those of their human hosts.  Thus, targeting purine and pyrimidine metabolic pathways provides a promising route for novel drug development.  Recent developments in enzymic transition state anal. have provided an improved route to inhibitor design targeted to specific enzymes, including those of purine and pyrimidine metab.  Modern transition state analog drug discovery has resulted in transition state analogs capable of binding to target enzymes with unprecedented affinity and specificity.  These agents can provide specific blocks in essential pathways.  The combination of tight binding with the high specificity of these logically designed inhibitors, results in low toxicity and minor side effects.  These features reduce two of the major problems with the current antimalarials.  Transition state analog design is being applied to generate new lead compds. to treat malaria by targeting purine and pyrimidine pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYWQhqSwJfg7Vg90H21EOLACvtfcHk0li5Iu3GkAvmDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3F&md5=bbab95b24e5f86134ceb7aa7f9473bde</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F156802611796575948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611796575948%26sid%3Dliteratum%253Aachs%26aulast%3DCassera%26aufirst%3DM.%2BB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHazleton%26aufirst%3DK.%2BZ.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DPurine%2520and%2520Pyrimidine%2520Pathways%2520as%2520Targets%2520in%2520Plasmodium%2520falciparum%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26issue%3D16%26spage%3D2103%26epage%3D2115%26doi%3D10.2174%2F156802611796575948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Berman, P. A.; Human, L.</span><span> </span><span class="NLM_article-title">Hypoxanthine Depletion Induced by Xanthine Oxidase Inhibits Malaria Parasite Growth in Vitro</span>.  <span class="citation_source-book">Purine and Pyrimidine Metabolism in Man VII: Part A: Chemotherapy, ATP Depletion, and Gout</span>; <span class="NLM_contrib-group">Harkness, R. A.; Elion, G. B.; Zöllner, N.</span>, Eds.; <span class="NLM_publisher-name">Plenum Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1991</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1007%2F978-1-4899-2638-8_37" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1991&pages=165-168&author=P.+A.+Berman&author=L.+Humanauthor=R.+A.+Harkness&author=G.+B.+Elion&author=N.+Z%C3%B6llner&title=Purine+and+Pyrimidine+Metabolism+in+Man+VII%3A+Part+A%3A+Chemotherapy%2C+ATP+Depletion%2C+and+Gout"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2F978-1-4899-2638-8_37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4899-2638-8_37%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DP.%2BA.%26atitle%3DHypoxanthine%2520Depletion%2520Induced%2520by%2520Xanthine%2520Oxidase%2520Inhibits%2520Malaria%2520Parasite%2520Growth%2520in%2520Vitro%26btitle%3DPurine%2520and%2520Pyrimidine%2520Metabolism%2520in%2520Man%2520VII%253A%2520Part%2520A%253A%2520Chemotherapy%252C%2520ATP%2520Depletion%252C%2520and%2520Gout%26aulast%3DHarkness%26aufirst%3DR.%2BA.%26pub%3DPlenum%2520Press%26date%3D1991%26spage%3D165%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holý, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner-Adams, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Inhibition of Hypoxanthine-Guanine Phosphoribosyltransferase by Acyclic Nucleoside Phosphonates: A New Class of Antimalarial Therapeutics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4391</span><span class="NLM_x">–</span> <span class="NLM_lpage">4399</span><span class="refDoi"> DOI: 10.1021/jm900267n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900267n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Ons7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4391-4399&issue=14&author=D.+T.+Keoughauthor=D.+Hockov%C3%A1author=A.+Hol%C3%BDauthor=L.+M.+J.+Naesensauthor=T.+S.+Skinner-Adamsauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Inhibition+of+Hypoxanthine-Guanine+Phosphoribosyltransferase+by+Acyclic+Nucleoside+Phosphonates%3A+A+New+Class+of+Antimalarial+Therapeutics&doi=10.1021%2Fjm900267n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hypoxanthine-Guanine Phosphoribosyltransferase by Acyclic Nucleoside Phosphonates: A New Class of Antimalarial Therapeutics</span></div><div class="casAuthors">Keough, Dianne T.; Hockova, Dana; Holy, Antonin; Naesens, Lieve M. J.; Skinner-Adams, Tina S.; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4391-4399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The purine salvage enzyme hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT) is essential for purine nucleotide and hence nucleic acid synthesis in the malaria parasite, Plasmodium falciparum.  Acyclic nucleoside phosphonates (ANPs) are analogs of the nucleotide product of the reaction, comprising a purine base joined by a linker to a phosphonate moiety.  Ki values for 19 ANPs were detd. for Pf HGXPRT and the corresponding human enzyme, HGPRT.  Values for Pf HGXPRT were as low as 100 nM, with selectivity for the parasite enzyme of up to 58.  Structures of human HGPRT in complex with three ANPs are reported.  On binding, a large mobile loop in the free enzyme moves to partly cover the active site.  For three ANPs, the IC50 values for Pf grown in cell culture were 1, 14, and 46 μM, while the cytotoxic concn. for the first compd. was 489 μM.  These results provide a basis for the design of potent and selective ANP inhibitors of Pf HGXPRT as antimalarial drug leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn8rPcoy0EBbVg90H21EOLACvtfcHk0li5Iu3GkAvmDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Ons7w%253D&md5=76746f78ec791a08ba2376beba86fa2b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm900267n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900267n%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DNaesens%26aufirst%3DL.%2BM.%2BJ.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DInhibition%2520of%2520Hypoxanthine-Guanine%2520Phosphoribosyltransferase%2520by%2520Acyclic%2520Nucleoside%2520Phosphonates%253A%2520A%2520New%2520Class%2520of%2520Antimalarial%2520Therapeutics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D14%26spage%3D4391%26epage%3D4399%26doi%3D10.1021%2Fjm900267n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Li, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furneaux, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kicska, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubmeyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girvin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">Transition-State Analogs as Inhibitors of Human and Malarial Hypoxanthine-Guanine Phosphoribosyltransferases</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">582</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span><span class="refDoi"> DOI: 10.1038/9367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1038%2F9367" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=582-587&author=C.+M.+Liauthor=P.+C.+Tylerauthor=R.+H.+Furneauxauthor=G.+Kicskaauthor=Y.+Xuauthor=C.+Grubmeyerauthor=M.+E.+Girvinauthor=V.+L.+Schramm&title=Transition-State+Analogs+as+Inhibitors+of+Human+and+Malarial+Hypoxanthine-Guanine+Phosphoribosyltransferases&doi=10.1038%2F9367"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F9367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F9367%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BM.%26aulast%3DTyler%26aufirst%3DP.%2BC.%26aulast%3DFurneaux%26aufirst%3DR.%2BH.%26aulast%3DKicska%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DGrubmeyer%26aufirst%3DC.%26aulast%3DGirvin%26aufirst%3DM.%2BE.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DTransition-State%2520Analogs%2520as%2520Inhibitors%2520of%2520Human%2520and%2520Malarial%2520Hypoxanthine-Guanine%2520Phosphoribosyltransferases%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D582%26epage%3D587%26doi%3D10.1038%2F9367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ducati, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namanja-Magliano, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">Transition-State Inhibitors of Purine Salvage and Other Prospective Enzyme Targets in Malaria</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1341</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span><span class="refDoi"> DOI: 10.4155/fmc.13.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.4155%2Ffmc.13.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=23859211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFWktL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1341-1360&issue=11&author=R.+G.+Ducatiauthor=H.+A.+Namanja-Maglianoauthor=V.+L.+Schramm&title=Transition-State+Inhibitors+of+Purine+Salvage+and+Other+Prospective+Enzyme+Targets+in+Malaria&doi=10.4155%2Ffmc.13.51"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria</span></div><div class="casAuthors">Ducati, Rodrigo G.; Namanja-Magliano, Hilda A.; Schramm, Vern L.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1341-1360</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria is a leading cause of human death within the tropics.  The gradual generation of drug resistance imposes an urgent need for the development of new and selective antimalarial agents.  Kinetic isotope effects coupled to computational chem. have provided the relevant details on geometry and charge of enzymic transition states to facilitate the design of transition-state analogs.  These features have been reproduced into chem. stable mimics through synthetic chem., generating inhibitors with dissocn. consts. in the pico- to femto-molar range.  Transition-state analogs are expected to contribute to the control of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1jm7Iu-SN7bVg90H21EOLACvtfcHk0li2ktjzlngGNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFWktL%252FK&md5=a7f6768ef89b03de28fa984f7f153f93</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.51%26sid%3Dliteratum%253Aachs%26aulast%3DDucati%26aufirst%3DR.%2BG.%26aulast%3DNamanja-Magliano%26aufirst%3DH.%2BA.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DTransition-State%2520Inhibitors%2520of%2520Purine%2520Salvage%2520and%2520Other%2520Prospective%2520Enzyme%2520Targets%2520in%2520Malaria%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26issue%3D11%26spage%3D1341%26epage%3D1360%26doi%3D10.4155%2Ffmc.13.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Clinch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazleton, K. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, P. C.</span><span> </span><span class="NLM_article-title">Acyclic Phosph(on)ate Inhibitors of <i>Plasmodium Falciparum</i> Hypoxanthine-Guanine-Xanthine Phosphoribosyltransferase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5629</span><span class="NLM_x">–</span> <span class="NLM_lpage">5646</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.02.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2Fj.bmc.2013.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=23810424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWls73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=5629-5646&issue=17&author=K.+Clinchauthor=D.+R.+Crumpauthor=G.+B.+Evansauthor=K.+Z.+Hazletonauthor=J.+M.+Masonauthor=V.+L.+Schrammauthor=P.+C.+Tyler&title=Acyclic+Phosph%28on%29ate+Inhibitors+of+Plasmodium+Falciparum+Hypoxanthine-Guanine-Xanthine+Phosphoribosyltransferase&doi=10.1016%2Fj.bmc.2013.02.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Acyclic phosph(on)ate inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase</span></div><div class="casAuthors">Clinch, Keith; Crump, Douglas R.; Evans, Gary B.; Hazleton, Keith Z.; Mason, Jennifer M.; Schramm, Vern L.; Tyler, Peter C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5629-5646</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The pathogenic protozoa responsible for malaria lack enzymes for the de novo synthesis of purines and rely on purine salvage from the host.  In Plasmodium falciparum (Pf), hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT) converts hypoxanthine to inosine monophosphate and is essential for purine salvage making the enzyme an anti-malarial drug target.  We have synthesized a no. of simple acyclic aza-C-nucleosides and shown that some are potent inhibitors of Pf HGXPRT while showing excellent selectivity for the Pf vs. the human enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUUjPr4oHetrVg90H21EOLACvtfcHk0li2ktjzlngGNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWls73I&md5=1a7be25d17441e003e48c568a3ba231c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DClinch%26aufirst%3DK.%26aulast%3DCrump%26aufirst%3DD.%2BR.%26aulast%3DEvans%26aufirst%3DG.%2BB.%26aulast%3DHazleton%26aufirst%3DK.%2BZ.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26aulast%3DTyler%26aufirst%3DP.%2BC.%26atitle%3DAcyclic%2520Phosph%2528on%2529ate%2520Inhibitors%2520of%2520Plasmodium%2520Falciparum%2520Hypoxanthine-Guanine-Xanthine%2520Phosphoribosyltransferase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D17%26spage%3D5629%26epage%3D5646%26doi%3D10.1016%2Fj.bmc.2013.02.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Terán, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Česnek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zíková, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Crystal Structures and Inhibition of <i>Trypanosoma brucei</i> Hypoxanthine–Guanine Phosphoribosyltransferase</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">35894</span><span class="refDoi"> DOI: 10.1038/srep35894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1038%2Fsrep35894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=27786284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKntrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=35894&author=D.+Ter%C3%A1nauthor=D.+Hockov%C3%A1author=M.+%C4%8Cesnekauthor=A.+Z%C3%ADkov%C3%A1author=L.+Naesensauthor=D.+T.+Keoughauthor=L.+W.+Guddat&title=Crystal+Structures+and+Inhibition+of+Trypanosoma+brucei+Hypoxanthine%E2%80%93Guanine+Phosphoribosyltransferase&doi=10.1038%2Fsrep35894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures and inhibition of Trypanosoma brucei hypoxanthine-guanine phosphoribosyltransferase</span></div><div class="casAuthors">Teran, David; Hockova, Dana; Cesnek, Michal; Zikova, Alena; Naesens, Lieve; Keough, Dianne T.; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35894</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human African Trypanosomiasis (HAT) is a life-threatening infectious disease caused by the protozoan parasite, Trypanosoma brucei (Tbr).  Due to the debilitating side effects of the current therapeutics and the emergence of resistance to these drugs, new medications for this disease need to be developed.  One potential new drug target is 6-oxopurine phosphoribosyltransferase (PRT), an enzyme central to the purine salvage pathway and whose activity is crit. for the prodn. of the nucleotides (GMP and IMP) required for DNA/RNA synthesis within this protozoan parasite.  Here, the first crystal structures of this enzyme have been detd., these in complex with GMP and IMP and with three acyclic nucleoside phosphonate (ANP) inhibitors.  The Ki values for GMP and IMP are 30.5 μM and 77 μM, resp.  Two of the ANPs have Ki values considerably lower than for the nucleotides, 2.3 μM (with guanine as base) and 15.8 μM (with hypoxanthine as base).  The crystal structures show that when two of the ANPs bind, they induce an unusual conformation change to the loop where the reaction product, pyrophosphate, is expected to bind.  This and other structural differences between the Tbr and human enzymes suggest selective inhibitors for the Tbr enzyme can be designed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe7k6Mh75xB7Vg90H21EOLACvtfcHk0li2ktjzlngGNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKntrnN&md5=5704d506e6373d4de9e3a49b441162e0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fsrep35894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep35894%26sid%3Dliteratum%253Aachs%26aulast%3DTer%25C3%25A1n%26aufirst%3DD.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3D%25C4%258Cesnek%26aufirst%3DM.%26aulast%3DZ%25C3%25ADkov%25C3%25A1%26aufirst%3DA.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DCrystal%2520Structures%2520and%2520Inhibition%2520of%2520Trypanosoma%2520brucei%2520Hypoxanthine%25E2%2580%2593Guanine%2520Phosphoribosyltransferase%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D35894%26doi%3D10.1038%2Fsrep35894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Eng, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Špaček, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">First Crystal Structures of <i>Mycobacterium Tuberculosis</i> 6-Oxopurine Phosphoribosyltransferase: Complexes with GMP and Pyrophosphate and with Acyclic Nucleoside Phosphonates Whose Prodrugs Have Antituberculosis Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">4822</span><span class="NLM_x">–</span> <span class="NLM_lpage">4838</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00611</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00611" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4822-4838&issue=11&author=W.+S.+Engauthor=D.+Hockov%C3%A1author=P.+%C5%A0pa%C4%8Dekauthor=Z.+Janebaauthor=N.+P.+Westauthor=K.+Woodsauthor=L.+M.+J.+Naesensauthor=D.+T.+Keoughauthor=L.+W.+Guddat&title=First+Crystal+Structures+of+Mycobacterium+Tuberculosis+6-Oxopurine+Phosphoribosyltransferase%3A+Complexes+with+GMP+and+Pyrophosphate+and+with+Acyclic+Nucleoside+Phosphonates+Whose+Prodrugs+Have+Antituberculosis+Activity&doi=10.1021%2Facs.jmedchem.5b00611"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00611%26sid%3Dliteratum%253Aachs%26aulast%3DEng%26aufirst%3DW.%2BS.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DWest%26aufirst%3DN.%2BP.%26aulast%3DWoods%26aufirst%3DK.%26aulast%3DNaesens%26aufirst%3DL.%2BM.%2BJ.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DFirst%2520Crystal%2520Structures%2520of%2520Mycobacterium%2520Tuberculosis%25206-Oxopurine%2520Phosphoribosyltransferase%253A%2520Complexes%2520with%2520GMP%2520and%2520Pyrophosphate%2520and%2520with%2520Acyclic%2520Nucleoside%2520Phosphonates%2520Whose%2520Prodrugs%2520Have%2520Antituberculosis%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D11%26spage%3D4822%26epage%3D4838%26doi%3D10.1021%2Facs.jmedchem.5b00611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krečmerová, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Česnek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holý, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brereton, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzor, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title"><i>Plasmodium Vivax</i> Hypoxanthine-Guanine Phosphoribosyltransferase: A Target for Anti-Malarial Chemotherapy</span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span><span class="refDoi"> DOI: 10.1016/j.molbiopara.2010.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2Fj.molbiopara.2010.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=20595032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVCmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2010&pages=165-169&issue=2&author=D.+T.+Keoughauthor=D.+Hockov%C3%A1author=M.+Kre%C4%8Dmerov%C3%A1author=M.+%C4%8Cesnekauthor=A.+Hol%C3%BDauthor=L.+Naesensauthor=I.+M.+Breretonauthor=D.+J.+Winzorauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Plasmodium+Vivax+Hypoxanthine-Guanine+Phosphoribosyltransferase%3A+A+Target+for+Anti-Malarial+Chemotherapy&doi=10.1016%2Fj.molbiopara.2010.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium vivax hypoxanthine-guanine phosphoribosyltransferase: A target for anti-malarial chemotherapy</span></div><div class="casAuthors">Keough, Dianne T.; Hockova, Dana; Krecmerova, Marcela; Cesnek, Michal; Holy, Antonin; Naesens, Lieve; Brereton, Ian M.; Winzor, Donald J.; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-169</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">The malarial parasite, Plasmodium vivax (Pv), causes a serious infectious disease found primarily in Asia and the Americas.  For protozoan parasites, 6-oxopurine phosphoribosyltransferases (PRTases) provide the only metabolic pathway to synthesize the purine nucleoside monophosphates essential for DNA/RNA prodn.  We have purified the recombinant Pv 6-oxopurine (PRTase) and compared its properties with the human and Pf enzymes.  The Pv enzyme uses hypoxanthine and guanine with similar catalytic efficiency to the Pf enzyme but xanthine is not a substrate, hence we identify this enzyme as PvHGPRT.  Mass spectrometry suggests that PvHGPRT contains bound magnesium ions that are removed by EDTA resulting in loss of activity.  However, the addn. of Mg2+ restores activity.  Acyclic nucleoside phosphonates (ANPs) are good inhibitors of PvHGPRT having Ki values as low as 3 μM.  These compds. can form the basis for the design of new drugs aimed at combating malaria caused by Pv.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1uFwfI8LK6LVg90H21EOLACvtfcHk0lhh-LHd7oe0bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVCmt7o%253D&md5=027d3207a8530ca9c113412a0a976d6e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2010.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2010.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DKre%25C4%258Dmerov%25C3%25A1%26aufirst%3DM.%26aulast%3D%25C4%258Cesnek%26aufirst%3DM.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DBrereton%26aufirst%3DI.%2BM.%26aulast%3DWinzor%26aufirst%3DD.%2BJ.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DPlasmodium%2520Vivax%2520Hypoxanthine-Guanine%2520Phosphoribosyltransferase%253A%2520A%2520Target%2520for%2520Anti-Malarial%2520Chemotherapy%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2010%26volume%3D173%26issue%3D2%26spage%3D165%26epage%3D169%26doi%3D10.1016%2Fj.molbiopara.2010.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edstein, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavchich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Aza-Acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group as Inhibitors of the Human, <i>Plasmodium Falciparum</i> and <i>Vivax</i> 6-Oxopurine Phosphoribosyltransferases and Their Prodrugs as Antimalarial Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span><span class="refDoi"> DOI: 10.1021/jm501416t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501416t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=827-846&issue=2&author=D.+T.+Keoughauthor=D.+Hockov%C3%A1author=Z.+Janebaauthor=T.+H.+Wangauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=M.+Chavchichauthor=L.+W.+Guddat&title=Aza-Acyclic+Nucleoside+Phosphonates+Containing+a+Second+Phosphonate+Group+as+Inhibitors+of+the+Human%2C+Plasmodium+Falciparum+and+Vivax+6-Oxopurine+Phosphoribosyltransferases+and+Their+Prodrugs+as+Antimalarial+Agents&doi=10.1021%2Fjm501416t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Aza-acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group As Inhibitors of the Human, Plasmodium falciparum and vivax 6-Oxopurine Phosphoribosyltransferases and Their Prodrugs As Antimalarial Agents</span></div><div class="casAuthors">Keough, Dianne T.; Hockova, Dana; Janeba, Zlatko; Wang, Tzu-Hsuan; Naesens, Lieve; Edstein, Michael D.; Chavchich, Marina; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">827-846</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxanthine-guanine-[xanthine] phosphoribosyltransferase (HG[X]PRT) is considered an important target for antimalarial chemotherapy as it is the only pathway for the synthesis of the purine nucleoside monophosphates required for DNA/RNA prodn.  Thus, inhibition of this enzyme should result in cessation of replication.  The aza-acyclic nucleoside phosphonates (aza-ANPs) are good inhibitors of Plasmodium falciparum HGXPRT (PfHGXPRT), with Ki values as low as 0.08 and 0.01 μM for Plasmodium vivax HGPRT (PvHGPRT).  Prodrugs of these aza-ANPs exhibit antimalarial activity against Pf lines with IC50 values (0.8-6.0 μM) and have low cytotoxicity against human cells.  Crystal structures of six of these compds. in complex with human HGPRT have been detd.  These suggest that the different affinities of these aza-ANPs could be due to the flexibility of the loops surrounding the active site as well as the flexibility of the inhibitors, allowing them to adapt to fit into three binding pockets of the enzyme(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9eXB3S3z3v7Vg90H21EOLACvtfcHk0lhh-LHd7oe0bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrzF&md5=c7d1dad69f99a1b4928b2a65fa411670</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm501416t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501416t%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DT.%2BH.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DAza-Acyclic%2520Nucleoside%2520Phosphonates%2520Containing%2520a%2520Second%2520Phosphonate%2520Group%2520as%2520Inhibitors%2520of%2520the%2520Human%252C%2520Plasmodium%2520Falciparum%2520and%2520Vivax%25206-Oxopurine%2520Phosphoribosyltransferases%2520and%2520Their%2520Prodrugs%2520as%2520Antimalarial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D2%26spage%3D827%26epage%3D846%26doi%3D10.1021%2Fjm501416t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Špaček, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrbková, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krečmerová, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eng, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jans, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Inhibition of the <i>Escherichia Coli</i> 6-Oxopurine Phosphoribosyltransferases by Nucleoside Phosphonates: Potential for New Antibacterial Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">6967</span><span class="NLM_x">–</span> <span class="NLM_lpage">6984</span><span class="refDoi"> DOI: 10.1021/jm400779n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400779n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1ChsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6967-6984&issue=17&author=D.+T.+Keoughauthor=D.+Hockov%C3%A1author=D.+Rejmanauthor=P.+%C5%A0pa%C4%8Dekauthor=S.+Vrbkov%C3%A1author=M.+Kre%C4%8Dmerov%C3%A1author=W.+S.+Engauthor=H.+Jansauthor=N.+P.+Westauthor=L.+M.+J.+Naesensauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Inhibition+of+the+Escherichia+Coli+6-Oxopurine+Phosphoribosyltransferases+by+Nucleoside+Phosphonates%3A+Potential+for+New+Antibacterial+Agents&doi=10.1021%2Fjm400779n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Escherichia coli 6-Oxopurine Phosphoribosyltransferases by Nucleoside Phosphonates: Potential for New Antibacterial Agents</span></div><div class="casAuthors">Keough, Dianne T.; Hockova, Dana; Rejman, Dominik; Spacek, Petr; Vrbkova, Silvie; Krecmerova, Marcela; Eng, Wai Soon; Jans, Harmen; West, Nicholas P.; Naesens, Lieve M. J.; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6967-6984</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Escherichia coli (Ec) cells possess two purine salvage enzymes: xanthine-guanine phosphoribosyltransferase (XGPRT) and hypoxanthine phosphoribosyltransferase (HPRT).  EcXGPRT shares a common structural feature with other members of this family, a flexible loop that closes over the active site during catalysis.  The replacement of six of these amino acids by alanine has no effect on the Km for the two substrates.  However, the Ki for the nucleoside monophosphate increases by 27-fold, and the kcat is reduced by ∼200-fold.  Nucleoside phosphonates (NP) are good inhibitors of EcXGPRT and EcHPRT, with Ki values as low as 10 nM.  In the absence of the flexible loop, these values increase by 5- to 30-fold, indicating the importance of the loop for high-affinity inhibition.  Crystal structures of two NPs in complex with EcXGPRT explain the tight binding.  Prodrugs of NPs with low Ki values for EcXGPRT or EcHPRT exhibit IC50 values between 5 and 23 μM against Mycobacterium tuberculosis in cell-based assays, suggesting that these compds. are therapeutic leads against pathogenic bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjJGY9KeZWpbVg90H21EOLACvtfcHk0lhh-LHd7oe0bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1ChsL7M&md5=bc8016299374898032e7311d054ec883</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm400779n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400779n%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DRejman%26aufirst%3DD.%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DVrbkov%25C3%25A1%26aufirst%3DS.%26aulast%3DKre%25C4%258Dmerov%25C3%25A1%26aufirst%3DM.%26aulast%3DEng%26aufirst%3DW.%2BS.%26aulast%3DJans%26aufirst%3DH.%26aulast%3DWest%26aufirst%3DN.%2BP.%26aulast%3DNaesens%26aufirst%3DL.%2BM.%2BJ.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DInhibition%2520of%2520the%2520Escherichia%2520Coli%25206-Oxopurine%2520Phosphoribosyltransferases%2520by%2520Nucleoside%2520Phosphonates%253A%2520Potential%2520for%2520New%2520Antibacterial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D17%26spage%3D6967%26epage%3D6984%26doi%3D10.1021%2Fjm400779n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Špaček, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichý, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrbková, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slavětínská, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edstein, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavchich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group Are Potent Inhibitors of 6-Oxopurine Phosphoribosyltransferases and Have Antimalarial Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2513</span><span class="NLM_x">–</span> <span class="NLM_lpage">2526</span><span class="refDoi"> DOI: 10.1021/jm301893b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301893b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2513-2526&issue=6&author=D.+T.+Keoughauthor=P.+%C5%A0pa%C4%8Dekauthor=D.+Hockov%C3%A1author=T.+Tich%C3%BDauthor=S.+Vrbkov%C3%A1author=L.+Slav%C4%9Bt%C3%ADnsk%C3%A1author=Z.+Janebaauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=M.+Chavchichauthor=T.+H.+Wangauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Acyclic+Nucleoside+Phosphonates+Containing+a+Second+Phosphonate+Group+Are+Potent+Inhibitors+of+6-Oxopurine+Phosphoribosyltransferases+and+Have+Antimalarial+Activity&doi=10.1021%2Fjm301893b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group Are Potent Inhibitors of 6-Oxopurine Phosphoribosyltransferases and Have Antimalarial Activity</span></div><div class="casAuthors">Keough, Dianne T.; Spacek, Petr; Hockova, Dana; Tichy, Tomas; Vrbkova, Silvie; Slavetinska, Lenka; Janeba, Zlatko; Naesens, Lieve; Edstein, Michael D.; Chavchich, Marina; Wang, Tzu-Hsuan; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2513-2526</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyclic nucleoside phosphonates (ANPs) that contain a 6-oxopurine base are good inhibitors of the Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) 6-oxopurine phosphoribosyltransferases (PRTs).  Chem. modifications based on the crystal structure of 2-(phosphonoethoxy)ethylguanine (PEEG) in complex with human HGPRT have led to the design of new ANPs.  These novel compds. contain a second phosphonate group attached to the ANP scaffold.  {[(2-[(Guanine-9H-yl)methyl]propane-1,3-diyl)bis(oxy)]bis(methylene)}diphosphonic acid (I) exhibited a Ki value of 30 nM for human HGPRT and 70 nM for Pf HGXPRT.  The crystal structure of this compd. in complex with human HGPRT shows that it fills or partially fills three crit. locations in the active site: the binding sites of the purine base, the 5'-phosphate group, and pyrophosphate.  This is the first HG(X)PRT inhibitor that has been able to achieve this result.  Prodrugs have been synthesized resulting in IC50 values as low as 3.8 μM for Pf grown in cell culture, up to 25-fold lower compared to the parent compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOIyMCQRsPnrVg90H21EOLACvtfcHk0lhrvtoj3Xdg3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWgsrw%253D&md5=f57c4cfd4f9bcb94e6ce93894bfd4d0f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm301893b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301893b%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DTich%25C3%25BD%26aufirst%3DT.%26aulast%3DVrbkov%25C3%25A1%26aufirst%3DS.%26aulast%3DSlav%25C4%259Bt%25C3%25ADnsk%25C3%25A1%26aufirst%3DL.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DT.%2BH.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DAcyclic%2520Nucleoside%2520Phosphonates%2520Containing%2520a%2520Second%2520Phosphonate%2520Group%2520Are%2520Potent%2520Inhibitors%2520of%25206-Oxopurine%2520Phosphoribosyltransferases%2520and%2520Have%2520Antimalarial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D6%26spage%3D2513%26epage%3D2526%26doi%3D10.1021%2Fjm301893b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Česnek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holý, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dračínský, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baszczyňski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Synthesis of 9-Phosphonoalkyl and 9-Phosphonoalkoxyalkyl Purines: Evaluation of Their Ability to Act as Inhibitors of <i>Plasmodium Falciparum, Plasmodium Vivax</i> and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">1076</span><span class="NLM_x">–</span> <span class="NLM_lpage">1089</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.11.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2Fj.bmc.2011.11.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=22178188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFSisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1076-1089&issue=2&author=M.+%C4%8Cesnekauthor=D.+Hockov%C3%A1author=A.+Hol%C3%BDauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=O.+Baszczy%C5%88skiauthor=J.+de+Jerseyauthor=D.+T.+Keoughauthor=L.+W.+Guddat&title=Synthesis+of+9-Phosphonoalkyl+and+9-Phosphonoalkoxyalkyl+Purines%3A+Evaluation+of+Their+Ability+to+Act+as+Inhibitors+of+Plasmodium+Falciparum%2C+Plasmodium+Vivax+and+Human+Hypoxanthine-Guanine-%28Xanthine%29+Phosphoribosyltransferases&doi=10.1016%2Fj.bmc.2011.11.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 9-phosphonoalkyl and 9-phosphonoalkoxyalkyl purines: Evaluation of their ability to act as inhibitors of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases</span></div><div class="casAuthors">Cesnek, Michal; Hockova, Dana; Holy, Antonin; Dracinsky, Martin; Baszczynski, Ondrej; de Jersey, John; Keough, Dianne T.; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1076-1089</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purine salvage enzyme, hypoxanthine-guanine-(xanthine) phosphoribosyltransferase [HG(X)PRT], catalyzes the synthesis of the purine nucleoside monophosphates, IMP, GMP or XMP essential for DNA/RNA prodn.  In protozoan parasites, such as Plasmodium, this is the only route available for their synthesis as they lack the de novo pathway which is present in human cells.  Acyclic nucleoside phosphonates (ANPs), analogs of the purine nucleoside monophosphates, have been found to inhibit Plasmodium falciparum (Pf) HGXPRT and Plasmodium vivax (Pv) HGPRT with Ki values as low as 100 nM.  They arrest parasitemia in cell based assays with IC50 values of the order of 1-10 μM.  ANPs with phosphonoalkyl and phosphonoalkoxyalkyl moieties linking the purine base and phosphonate group were designed and synthesized to evaluate the influence of this linker on the potency and/or selectivity of the ANPs for the human and malarial enzymes.  This data shows that variability in the linker, as well as the positioning of the oxygen in this linker, influences binding.  The human enzyme binds the ANPs with Ki values of 0.5 μM when the no. of atoms in the linker was 5 or 6 atoms.  However, the parasite enzymes have little affinity for such long chains unless oxygen is included in the three-position.  In comparison, all three enzymes have little affinity for ANPs where the no. of atoms linking the base and the phosphonate group is of the order of 2-3 atoms.  The chem. nature of the purine base also effects the Ki values.  This data shows that both the linker and the purine base play an important role in the binding of the ANPs to these three enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpquLDpWV2ftrVg90H21EOLACvtfcHk0lhrvtoj3Xdg3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFSisA%253D%253D&md5=9e75cc4dcd0fd16d1c34844fc00cf818</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.11.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.11.034%26sid%3Dliteratum%253Aachs%26aulast%3D%25C4%258Cesnek%26aufirst%3DM.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DBaszczy%25C5%2588ski%26aufirst%3DO.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DSynthesis%2520of%25209-Phosphonoalkyl%2520and%25209-Phosphonoalkoxyalkyl%2520Purines%253A%2520Evaluation%2520of%2520Their%2520Ability%2520to%2520Act%2520as%2520Inhibitors%2520of%2520Plasmodium%2520Falciparum%252C%2520Plasmodium%2520Vivax%2520and%2520Human%2520Hypoxanthine-Guanine-%2528Xanthine%2529%2520Phosphoribosyltransferases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26issue%3D2%26spage%3D1076%26epage%3D1089%26doi%3D10.1016%2Fj.bmc.2011.11.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Thornton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miccoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehellou, Y.</span><span> </span><span class="NLM_article-title">Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">10400</span><span class="NLM_x">–</span> <span class="NLM_lpage">10410</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00523</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00523" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWntLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10400-10410&issue=23&author=P.+J.+Thorntonauthor=H.+Kadriauthor=A.+Miccoliauthor=Y.+Mehellou&title=Nucleoside+Phosphate+and+Phosphonate+Prodrug+Clinical+Candidates&doi=10.1021%2Facs.jmedchem.6b00523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates</span></div><div class="casAuthors">Thornton, Peter J.; Kadri, Hachemi; Miccoli, Ageo; Mehellou, Youcef</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10400-10410</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nucleoside monophosphates and monophosphonates have been known for a long time to exert favorable pharmacol. effects upon intracellular delivery.  However, their development as drug mols. has been hindered by the inherent poor druglike properties of the monophosphate and monophosphonate groups.  These include inefficient cellular uptake and poor in vivo stability, with this latter drawback being most relevant to monophosphates than monophosphonates.  To address these limitations, numerous monophosphate and monophosphonate prodrug strategies have been developed and applied in the discovery of nucleoside monophosphate and monophosphonate prodrugs that can treat viral infections and cancer.  The approval of sofosbuvir, a nucleoside monophosphate prodrug, highlighted the success to be had by employing these prodrug technologies in the discovery of nucleotide therapeutics.  In this Miniperspective, we discuss the different key monophosphate and monophosphonate nucleoside prodrugs that entered clin. development, some of which may in the future be approved to treat various human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps_oIoE-3R_rVg90H21EOLACvtfcHk0liv2HsMzkYiWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWntLjE&md5=f00f13fb82caa27b88a87d2d337dcad4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00523%26sid%3Dliteratum%253Aachs%26aulast%3DThornton%26aufirst%3DP.%2BJ.%26aulast%3DKadri%26aufirst%3DH.%26aulast%3DMiccoli%26aufirst%3DA.%26aulast%3DMehellou%26aufirst%3DY.%26atitle%3DNucleoside%2520Phosphate%2520and%2520Phosphonate%2520Prodrug%2520Clinical%2520Candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D23%26spage%3D10400%26epage%3D10410%26doi%3D10.1021%2Facs.jmedchem.6b00523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edstein, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavchich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Antimalarial Activity of Prodrugs of N-Branched Acyclic Nucleoside Phosphonate Inhibitors of 6-Oxopurine Phosphoribosyltransferases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5502</span><span class="NLM_x">–</span> <span class="NLM_lpage">5510</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2Fj.bmc.2015.07.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5502-5510&issue=17&author=D.+Hockov%C3%A1author=Z.+Janebaauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=M.+Chavchichauthor=D.+T.+Keoughauthor=L.+W.+Guddat&title=Antimalarial+Activity+of+Prodrugs+of+N-Branched+Acyclic+Nucleoside+Phosphonate+Inhibitors+of+6-Oxopurine+Phosphoribosyltransferases&doi=10.1016%2Fj.bmc.2015.07.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.038%26sid%3Dliteratum%253Aachs%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DAntimalarial%2520Activity%2520of%2520Prodrugs%2520of%2520N-Branched%2520Acyclic%2520Nucleoside%2520Phosphonate%2520Inhibitors%2520of%25206-Oxopurine%2520Phosphoribosyltransferases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26issue%3D17%26spage%3D5502%26epage%3D5510%26doi%3D10.1016%2Fj.bmc.2015.07.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Špaček, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavchich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dračínský, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edstein, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Symmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of the <i>Plasmodium Falciparum, Plasmodium Vivax</i> and Human 6-Oxopurine Phosphoribosyltransferases and the Antimalarial Activity of Their Prodrugs</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4008</span><span class="NLM_x">–</span> <span class="NLM_lpage">4030</span><span class="refDoi"> DOI: 10.1016/j.bmc.2017.05.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2Fj.bmc.2017.05.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=28601510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslGnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=4008-4030&author=P.+%C5%A0pa%C4%8Dekauthor=D.+T.+Keoughauthor=M.+Chavchichauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=Z.+Janebaauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=L.+W.+Guddatauthor=D.+Hockov%C3%A1&title=Synthesis+and+Evaluation+of+Symmetric+Acyclic+Nucleoside+Bisphosphonates+as+Inhibitors+of+the+Plasmodium+Falciparum%2C+Plasmodium+Vivax+and+Human+6-Oxopurine+Phosphoribosyltransferases+and+the+Antimalarial+Activity+of+Their+Prodrugs&doi=10.1016%2Fj.bmc.2017.05.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of symmetric acyclic nucleoside bisphosphonates as inhibitors of the Plasmodium falciparum, Plasmodium vivax and human 6-oxopurine phosphoribosyltransferases and the antimalarial activity of their prodrugs</span></div><div class="casAuthors">Spacek, Petr; Keough, Dianne T.; Chavchich, Marina; Dracinsky, Martin; Janeba, Zlatko; Naesens, Lieve; Edstein, Michael D.; Guddat, Luke W.; Hockova, Dana</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4008-4030</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two new series of sym. acyclic nucleoside bisphosphonates (ANbPs) have been synthesized as potential inhibitors of the Plasmodium falciparum (Pf) and vivax (Pv) 6-oxopurine phosphoribosyltransferases.  The structural variability between these sym. ANbPs lies in the no. of atoms in the two acyclic linkers connecting the N9 atom of the purine base to each of two phosphonate groups and the branching point of the acyclic moiety relative to the purine base, which occurs at either the alpha or beta positions.  Within each series, six different 6-oxopurine bases have been attached.  In general, the ANbPs with either guanine or hypoxanthine have lower Ki values than for those contg. either the 8-bromo or 7-deaza 6-oxopurine bases.  The lowest Ki values obtained for the two parasite enzymes were 0.1 μM (Pf) and 0.2 μM (Pv) for this series of compds.  Two phosphoramidate prodrugs of these inhibitors exhibited antimalarial activity against Pf in infected erythrocyte cell culture with IC50 values of 0.8 and 1.5 μM.  These two compds. exhibited low cytotoxicity in human A549 cells having CC50 values of >300 μM resulting in an excellent selectivity index.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRylWYh-MpNLVg90H21EOLACvtfcHk0liv2HsMzkYiWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslGnur8%253D&md5=62891e50ca20c740844a44c1a7e8876b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.05.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.05.048%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Symmetric%2520Acyclic%2520Nucleoside%2520Bisphosphonates%2520as%2520Inhibitors%2520of%2520the%2520Plasmodium%2520Falciparum%252C%2520Plasmodium%2520Vivax%2520and%2520Human%25206-Oxopurine%2520Phosphoribosyltransferases%2520and%2520the%2520Antimalarial%2520Activity%2520of%2520Their%2520Prodrugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D4008%26epage%3D4030%26doi%3D10.1016%2Fj.bmc.2017.05.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Baszczyňski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dračínský, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Špaček, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span> </span><span class="NLM_article-title">An Efficient Oxa-Michael Addition to Diethyl Vinylphosphonate under Mild Reaction Conditions</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1282</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span><span class="refDoi"> DOI: 10.1039/C2RA00938B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1039%2FC2RA00938B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=1282-1284&issue=4&author=O.+Baszczy%C5%88skiauthor=P.+Jansaauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=M.+M.+Kaiserauthor=P.+%C5%A0pa%C4%8Dekauthor=Z.+Janeba&title=An+Efficient+Oxa-Michael+Addition+to+Diethyl+Vinylphosphonate+under+Mild+Reaction+Conditions&doi=10.1039%2FC2RA00938B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient oxa-Michael addition to diethyl vinylphosphonate under mild reaction conditions</span></div><div class="casAuthors">Baszczynski, Ondrej; Jansa, Petr; Dracinsky, Martin; Kaiser, Martin Maxmilian; Spacek, Petr; Janeba, Zlatko</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1282-1284</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">An oxa-Michael addn. of various secondary and branched primary alcs. to di-Et vinylphosphonate was systematically studied and optimized.  This efficient method avoids the use of harsh reaction conditions (e.g. strong bases, high temps.) and gains access to an important class of biol. active compds. in one step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkfK-6i55JqbVg90H21EOLACvtfcHk0lioUOKyUNra6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKlsLo%253D&md5=1d3be7a12bc68ed6531e08596bcd00a0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2FC2RA00938B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2RA00938B%26sid%3Dliteratum%253Aachs%26aulast%3DBaszczy%25C5%2588ski%26aufirst%3DO.%26aulast%3DJansa%26aufirst%3DP.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DM.%2BM.%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DJaneba%26aufirst%3DZ.%26atitle%3DAn%2520Efficient%2520Oxa-Michael%2520Addition%2520to%2520Diethyl%2520Vinylphosphonate%2520under%2520Mild%2520Reaction%2520Conditions%26jtitle%3DRSC%2520Adv.%26date%3D2012%26volume%3D2%26issue%3D4%26spage%3D1282%26epage%3D1284%26doi%3D10.1039%2FC2RA00938B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Thompson, D. H.; Boomer, J. A.; Haynes, R.</span><span> </span><span class="NLM_article-title">Vinyl Ether Lipids with Cleavable Hydrophlic Headgroups</span>. U.S. Patent 6,979,460 B1, Dec 27,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=D.+H.+Thompson&author=J.+A.+Boomer&author=R.+Haynes&title=Vinyl+Ether+Lipids+with+Cleavable+Hydrophlic+Headgroups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DD.%2BH.%26atitle%3DVinyl%2520Ether%2520Lipids%2520with%2520Cleavable%2520Hydrophlic%2520Headgroups%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Linn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J. L.</span><span> </span><span class="NLM_article-title">1,4-Diazabicyclo[2.2.2]octane (Dabco)-Catalysed Hydrolysis and Alcoholysis Reactions of 2-Amino-9-Benzyl-6-Chloro-9H-Purine</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">914</span><span class="refDoi"> DOI: 10.1039/c39940000913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1039%2Fc39940000913" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1994&pages=913-914&issue=8&author=J.+A.+Linnauthor=E.+W.+McLeanauthor=J.+L.+Kelley&title=1%2C4-Diazabicyclo%5B2.2.2%5Doctane+%28Dabco%29-Catalysed+Hydrolysis+and+Alcoholysis+Reactions+of+2-Amino-9-Benzyl-6-Chloro-9H-Purine&doi=10.1039%2Fc39940000913"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2Fc39940000913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39940000913%26sid%3Dliteratum%253Aachs%26aulast%3DLinn%26aufirst%3DJ.%2BA.%26aulast%3DMcLean%26aufirst%3DE.%2BW.%26aulast%3DKelley%26aufirst%3DJ.%2BL.%26atitle%3D1%252C4-Diazabicyclo%255B2.2.2%255Doctane%2520%2528Dabco%2529-Catalysed%2520Hydrolysis%2520and%2520Alcoholysis%2520Reactions%2520of%25202-Amino-9-Benzyl-6-Chloro-9H-Purine%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1994%26volume%3D8%26issue%3D8%26spage%3D913%26epage%3D914%26doi%3D10.1039%2Fc39940000913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">de Jersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holý, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">6-Oxopurine Phosphoribosyltransferase: A Target for the Development of Antimalarial Drugs</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">2085</span><span class="NLM_x">–</span> <span class="NLM_lpage">2102</span><span class="refDoi"> DOI: 10.2174/156802611796575911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.2174%2F156802611796575911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=21619515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=2085-2102&issue=16&author=J.+de+Jerseyauthor=A.+Hol%C3%BDauthor=D.+Hockov%C3%A1author=L.+Naesensauthor=D.+T.+Keoughauthor=L.+W.+Guddat&title=6-Oxopurine+Phosphoribosyltransferase%3A+A+Target+for+the+Development+of+Antimalarial+Drugs&doi=10.2174%2F156802611796575911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">6-oxopurine phosphoribosyltransferase: a target for the development of antimalarial drugs</span></div><div class="casAuthors">de Jersey, John; Holy, Antonin; Hockova, Dana; Naesens, Lieve; Keough, Dianne T.; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2085-2102</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria remains the most serious parasitic diseases affecting humans in the world today, resulting in 1-2 million fatalities each year.  Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) are the predominant causative agents.  Both are responsible for widespread mortality and morbidity and are a serious socio-economic burden, esp. for countries in the developing world.  One of the most important defences against malaria has been the use of chemotherapeutic drugs (e.g. chloroquine, artemisinins, pyrimethamine) but these have mainly been found by serendipity.  Their mechanisms was not understood at the time of their discovery and, even today, are still not unequivocal.  For many of these compds., the parasite is now resistant and, hence, there is an urgent need to develop new therapeutic drugs directed to validated targets.  One metabolic pathway crucial for the survival and replication and survival of the parasite is the synthesis of the purine nucleoside monophosphates essential for the prodn. of DNA/RNA mols.  A key enzyme in this pathway is the 6-oxopurine phosphoribosyltransferase (PRTase).  The focus of this review is on the identification and characterization of inhibitors of the enzymes from both Pf and Pv as antimalarial drug leads.  The acyclic nucleoside phosphonates (ANPs) appear to be excellent candidates because they are good inhibitors of the two Plasmodium enzymes, can be selective compared to the human enzyme, can arrest parasitemia in cell based assays, have low cytotoxicity to the human host cell and, because of their stable carbon-phosphorous bond, are stable within the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptM-lrmcqP2bVg90H21EOLACvtfcHk0lioUOKyUNra6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3E&md5=631fe3c94e8ff703031ea8d71afcc7c2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F156802611796575911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611796575911%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3D6-Oxopurine%2520Phosphoribosyltransferase%253A%2520A%2520Target%2520for%2520the%2520Development%2520of%2520Antimalarial%2520Drugs%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26issue%3D16%26spage%3D2085%26epage%3D2102%26doi%3D10.2174%2F156802611796575911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kaiser, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dračínský, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poštová-Slavětínská, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procházková, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edstein, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavchich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of <i>Plasmodium Falciparum</i> and Human 6-Oxopurine Phosphoribosyltransferases</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1707</span><span class="NLM_x">–</span> <span class="NLM_lpage">1723</span><span class="refDoi"> DOI: 10.1002/cmdc.201500322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1002%2Fcmdc.201500322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=26368337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyju77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1707-1723&issue=10&author=M.+M.+Kaiserauthor=D.+Hockov%C3%A1author=T.-H.+Wangauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=L.+Po%C5%A1tov%C3%A1-Slav%C4%9Bt%C3%ADnsk%C3%A1author=E.+Proch%C3%A1zkov%C3%A1author=M.+D.+Edsteinauthor=M.+Chavchichauthor=D.+T.+Keoughauthor=L.+W.+Guddatauthor=Z.+Janeba&title=Synthesis+and+Evaluation+of+Novel+Acyclic+Nucleoside+Phosphonates+as+Inhibitors+of+Plasmodium+Falciparum+and+Human+6-Oxopurine+Phosphoribosyltransferases&doi=10.1002%2Fcmdc.201500322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine Phosphoribosyltransferases</span></div><div class="casAuthors">Kaiser, Martin M.; Hockova, Dana; Wang, Tzu-Hsuan; Dracinsky, Martin; Postova-Slavetinska, Lenka; Prochazkova, Eliska; Edstein, Michael D.; Chavchich, Marina; Keough, Dianne T.; Guddat, Luke W.; Janeba, Zlatko</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1707-1723</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Acyclic nucleoside phosphonates (ANPs) are a promising class of antimalarial therapeutic drug leads that exhibit a wide variety of Ki values for Plasmodium falciparum (Pf) and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases [HG(X)PRTs].  A novel series of ANPs, analogs of previously reported 2-(phosphonoethoxy)ethyl (PEE) and (R,S)-3-hydroxy-2-(phosphonomethoxy)propyl (HPMP) derivs., were designed and synthesized to evaluate their ability to act as inhibitors of these enzymes and to extend our ongoing antimalarial structure-activity relationship studies.  In this series, (S)-3-hydroxy-2-(phosphonoethoxy)propyl (HPEP), (S)-2-(phosphonomethoxy)propanoic acid (CPME), or (S)-2-(phosphonoethoxy)propanoic acid (CPEE) are the acyclic moieties.  Of this group, (S)-3-hydroxy-2-(phosphonoethoxy)propylguanine (HPEPG) exhibits the highest potency for PfHGXPRT, with a Ki value of 0.1 μΜ and a Ki value for human HGPRT of 0.6 μΜ.  The crystal structures of HPEPG and HPEPHx (where Hx=hypoxanthine) in complex with human HGPRT were obtained, showing specific interactions with active site residues.  Prodrugs for the HPEP and CPEE analogs were synthesized and tested for in vitro antimalarial activity.  The lowest IC50 value (22 μΜ) in a chloroquine-resistant strain was obsd. for the bis-amidate prodrug of HPEPG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm9gVba_Sb_bVg90H21EOLACvtfcHk0litJ5ZfWuYnBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyju77N&md5=16d12091e7fbd1c4522f3c5c8b2f35c9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500322%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DM.%2BM.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.-H.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DPo%25C5%25A1tov%25C3%25A1-Slav%25C4%259Bt%25C3%25ADnsk%25C3%25A1%26aufirst%3DL.%26aulast%3DProch%25C3%25A1zkov%25C3%25A1%26aufirst%3DE.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26aulast%3DJaneba%26aufirst%3DZ.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Novel%2520Acyclic%2520Nucleoside%2520Phosphonates%2520as%2520Inhibitors%2520of%2520Plasmodium%2520Falciparum%2520and%2520Human%25206-Oxopurine%2520Phosphoribosyltransferases%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26issue%3D10%26spage%3D1707%26epage%3D1723%26doi%3D10.1002%2Fcmdc.201500322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Jansa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baszczyňski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dračínský, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votruba, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zídek, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahador, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cihlar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holý, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span> </span><span class="NLM_article-title">A Novel and Efficient One-Pot Synthesis of Symmetrical Diamide (Bis-Amidate) Prodrugs of Acyclic Nucleoside Phosphonates and Evaluation of Their Biological Activities</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3748</span><span class="NLM_x">–</span> <span class="NLM_lpage">3754</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2Fj.ejmech.2011.05.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3748-3754&issue=9&author=P.+Jansaauthor=O.+Baszczy%C5%88skiauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=I.+Votrubaauthor=Z.+Z%C3%ADdekauthor=G.+Bahadorauthor=G.+Stepanauthor=T.+Cihlarauthor=R.+MacKmanauthor=A.+Hol%C3%BDauthor=Z.+Janeba&title=A+Novel+and+Efficient+One-Pot+Synthesis+of+Symmetrical+Diamide+%28Bis-Amidate%29+Prodrugs+of+Acyclic+Nucleoside+Phosphonates+and+Evaluation+of+Their+Biological+Activities&doi=10.1016%2Fj.ejmech.2011.05.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DJansa%26aufirst%3DP.%26aulast%3DBaszczy%25C5%2588ski%26aufirst%3DO.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DVotruba%26aufirst%3DI.%26aulast%3DZ%25C3%25ADdek%26aufirst%3DZ.%26aulast%3DBahador%26aufirst%3DG.%26aulast%3DStepan%26aufirst%3DG.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DMacKman%26aufirst%3DR.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DJaneba%26aufirst%3DZ.%26atitle%3DA%2520Novel%2520and%2520Efficient%2520One-Pot%2520Synthesis%2520of%2520Symmetrical%2520Diamide%2520%2528Bis-Amidate%2529%2520Prodrugs%2520of%2520Acyclic%2520Nucleoside%2520Phosphonates%2520and%2520Evaluation%2520of%2520Their%2520Biological%2520Activities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26issue%3D9%26spage%3D3748%26epage%3D3754%26doi%3D10.1016%2Fj.ejmech.2011.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Shi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furneaux, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahill, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girvin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubmeyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almo, S. C.</span><span> </span><span class="NLM_article-title">The 2.0 Å Structure of Human Hypoxanthine-Guanine Phosphoribosyltransferase in Complex with a Transition-State Analog Inhibitor</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">588</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span><span class="refDoi"> DOI: 10.1038/9376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1038%2F9376" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=588-593&issue=6&author=W.+Shiauthor=C.+M.+Liauthor=P.+C.+Tylerauthor=R.+H.+Furneauxauthor=S.+M.+Cahillauthor=M.+E.+Girvinauthor=C.+Grubmeyerauthor=V.+L.+Schrammauthor=S.+C.+Almo&title=The+2.0+%C3%85+Structure+of+Human+Hypoxanthine-Guanine+Phosphoribosyltransferase+in+Complex+with+a+Transition-State+Analog+Inhibitor&doi=10.1038%2F9376"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F9376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F9376%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DC.%2BM.%26aulast%3DTyler%26aufirst%3DP.%2BC.%26aulast%3DFurneaux%26aufirst%3DR.%2BH.%26aulast%3DCahill%26aufirst%3DS.%2BM.%26aulast%3DGirvin%26aufirst%3DM.%2BE.%26aulast%3DGrubmeyer%26aufirst%3DC.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26aulast%3DAlmo%26aufirst%3DS.%2BC.%26atitle%3DThe%25202.0%2520%25C3%2585%2520Structure%2520of%2520Human%2520Hypoxanthine-Guanine%2520Phosphoribosyltransferase%2520in%2520Complex%2520with%2520a%2520Transition-State%2520Analog%2520Inhibitor%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1999%26volume%3D6%26issue%3D6%26spage%3D588%26epage%3D593%26doi%3D10.1038%2F9376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">McPhillips, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhillips, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phizackerley, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltis, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span> </span><span class="NLM_article-title"><i>Blu-Ice</i> and the <i>Distributed Control System</i>: Software for Data Acquisition and Instrument Control at Macromolecular Crystallography BeamLines</span> <span class="citation_source-journal">J. Synchrotron Radiat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.1107/S0909049502015170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1107%2FS0909049502015170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=12409628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotleluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=401-406&issue=6&author=T.+M.+McPhillipsauthor=S.+E.+McPhillipsauthor=H.-J.+Chiuauthor=A.+E.+Cohenauthor=A.+M.+Deaconauthor=P.+J.+Ellisauthor=E.+Garmanauthor=A.+Gonzalezauthor=N.+K.+Sauterauthor=R.+P.+Phizackerleyauthor=S.+M.+Soltisauthor=P.+Kuhn&title=Blu-Ice+and+the+Distributed+Control+System%3A+Software+for+Data+Acquisition+and+Instrument+Control+at+Macromolecular+Crystallography+BeamLines&doi=10.1107%2FS0909049502015170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines</span></div><div class="casAuthors">McPhillips, Timothy M.; McPhillips, Scott E.; Chiu, Hsiu Ju; Cohen, Aina E.; Deacon, Ashley M.; Ellis, Paul J.; Garman, Elspeth; Gonzalez, Ana; Sauter, Nicholas K.; Phizackerley, R. Paul; Soltis, S. Michael; Kuhn, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-406</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">The Blu-Ice and Distributed Control System (DCS) software packages were developed to provide unified control over the disparate hardware resources available at a macromol. crystallog. beamline.  Blu-Ice is a user interface that provides scientific experimenters and beamline support staff with intuitive graphical tools for collecting diffraction data and configuring beamlines for expts.  Blu-Ice communicates with the hardware at a beamline via DCS, an instrument-control and data-acquisition package designed to integrate hardware resources in a highly heterogeneous networked computing environment.  Together, Blu-Ice and DCS provide a flexible platform for increasing the ease of use, the level of automation and the remote accessibility of beamlines.  Blu-Ice and DCS are currently installed on four Stanford Synchrotron Radiation Lab. crystallog. beamlines and are being implemented at sister light sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVsQUIFJPBLVg90H21EOLACvtfcHk0litJ5ZfWuYnBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotleluro%253D&md5=c77228bd50890463f3e43e981a2e238a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0909049502015170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0909049502015170%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhillips%26aufirst%3DT.%2BM.%26aulast%3DMcPhillips%26aufirst%3DS.%2BE.%26aulast%3DChiu%26aufirst%3DH.-J.%26aulast%3DCohen%26aufirst%3DA.%2BE.%26aulast%3DDeacon%26aufirst%3DA.%2BM.%26aulast%3DEllis%26aufirst%3DP.%2BJ.%26aulast%3DGarman%26aufirst%3DE.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DPhizackerley%26aufirst%3DR.%2BP.%26aulast%3DSoltis%26aufirst%3DS.%2BM.%26aulast%3DKuhn%26aufirst%3DP.%26atitle%3DBlu-Ice%2520and%2520the%2520Distributed%2520Control%2520System%253A%2520Software%2520for%2520Data%2520Acquisition%2520and%2520Instrument%2520Control%2520at%2520Macromolecular%2520Crystallography%2520BeamLines%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2002%26volume%3D9%26issue%3D6%26spage%3D401%26epage%3D406%26doi%3D10.1107%2FS0909049502015170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&issue=2&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lhBcSXU_vMD2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D2%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkóczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title"><i>PHENIX</i>: A Comprehensive Python-Based System for Macromolecular Structure Solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&issue=2&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+A+Comprehensive+Python-Based+System+for+Macromolecular+Structure+Solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lhBcSXU_vMD2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520A%2520Comprehensive%2520Python-Based%2520System%2520for%2520Macromolecular%2520Structure%2520Solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D2%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&issue=4&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lhBcSXU_vMD2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D4%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Trager, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, J. B.</span><span> </span><span class="NLM_article-title">Human Malaria Parasites in Continuous Culture</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x"> (</span><span class="NLM_issue">4254</span><span class="NLM_x">) </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">675</span><span class="refDoi"> DOI: 10.1126/science.781840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1126%2Fscience.781840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=781840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A280%3ADyaE283ks1Wqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1976&pages=673-675&issue=4254&author=W.+Tragerauthor=J.+B.+Jensen&title=Human+Malaria+Parasites+in+Continuous+Culture&doi=10.1126%2Fscience.781840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Human malaria parasites in continuous culture</span></div><div class="casAuthors">Trager W; Jensen J B</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">4254</span>),
    <span class="NLM_cas:pages">673-5</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Plasmodium falciparum can now be maintained in continuous culture in human erythrocytes incubated at 38 degrees C in RPMI 1640 medium with human serum under an atmosphere with 7 percent carbon dioxide and low oxygen (1 or 5 percent).  The original parasite material, derived from an infected Aotus trivirgatus monkey, was diluted more than 100 million times by the addition of human erythrocytes at 3- or 4-day intervals.  The parasites continued to reproduce in their normal asexual cycle of approximately 48 hours but were no longer highly synchronous.  The have remained infective to Aotus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPnKdQ--_afmyYR5VtavbzfW6udTcc2eazeTxjrkHSTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE283ks1Wqug%253D%253D&md5=a7f43c2255b75d9841c36338433c78b8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscience.781840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.781840%26sid%3Dliteratum%253Aachs%26aulast%3DTrager%26aufirst%3DW.%26aulast%3DJensen%26aufirst%3DJ.%2BB.%26atitle%3DHuman%2520Malaria%2520Parasites%2520in%2520Continuous%2520Culture%26jtitle%3DScience%26date%3D1976%26volume%3D193%26issue%3D4254%26spage%3D673%26epage%3D675%26doi%3D10.1126%2Fscience.781840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Lambros, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderberg, J. P.</span><span> </span><span class="NLM_article-title">Synchronization of <i>Plasmodium falciparum</i> Erythrocytic Stages in Culture</span> <span class="citation_source-journal">J. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span><span class="refDoi"> DOI: 10.2307/3280287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.2307%2F3280287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=383936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A280%3ADyaL3c%252FgvVGmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1979&pages=418-420&issue=3&author=C.+Lambrosauthor=J.+P.+Vanderberg&title=Synchronization+of+Plasmodium+falciparum+Erythrocytic+Stages+in+Culture&doi=10.2307%2F3280287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synchronization of Plasmodium falciparum erythrocytic stages in culture</span></div><div class="casAuthors">Lambros C; Vanderberg J P</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of parasitology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">418-20</span>
        ISSN:<span class="NLM_cas:issn">0022-3395</span>.
    </div><div class="casAbstract">Synchronous development of the erythrocytic stages of a human malaria parasite, Plasmodium falciparum, in culture was accomplished by suspending cultured parasites in 5% D-sorbitol and subsequent reintroduction into culture.  Immediately after sorbitol treatment, cultures consisted mainly of single and multiple ring-form infections.  At the same time, varying degrees of lysis of erythrocytes infected with the more mature stages of the parasite was evident.  Approximately 95% of the parasites were in the ring stage of development at 48 and 96 hr after sorbitol treatment-likewise, a high percentage of trophozoite and schizont stages was observed at 24, 72, and 120 hr.  D-Mannitol produced similar, selective, lytic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8OaabOIODNFUIs6wFK5xJfW6udTcc2eazeTxjrkHSTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3c%252FgvVGmtg%253D%253D&md5=b1f79ae8156db4fdef9b290140de2298</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2307%2F3280287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F3280287%26sid%3Dliteratum%253Aachs%26aulast%3DLambros%26aufirst%3DC.%26aulast%3DVanderberg%26aufirst%3DJ.%2BP.%26atitle%3DSynchronization%2520of%2520Plasmodium%2520falciparum%2520Erythrocytic%2520Stages%2520in%2520Culture%26jtitle%3DJ.%2520Parasitol.%26date%3D1979%26volume%3D65%26issue%3D3%26spage%3D418%26epage%3D420%26doi%3D10.2307%2F3280287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Desjardins, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chulay, J. D.</span><span> </span><span class="NLM_article-title">Quantitative Assessment of Antimalarial Activity <i>in vitro</i> by a Semiautomated Microdilution Technique</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span><span class="refDoi"> DOI: 10.1128/AAC.16.6.710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1128%2FAAC.16.6.710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=394674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADyaL3cXktFyrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=710-718&issue=6&author=R.+E.+Desjardinsauthor=C.+J.+Canfieldauthor=J.+D.+Haynesauthor=J.+D.+Chulay&title=Quantitative+Assessment+of+Antimalarial+Activity+in+vitro+by+a+Semiautomated+Microdilution+Technique&doi=10.1128%2FAAC.16.6.710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique</span></div><div class="casAuthors">Desjardins, Robert E.; Canfield, Craig J.; Haynes, J. David; Chulay, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">710-18</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">A rapid, semiautomated microdilution method was developed for measuring the activity of potential antimalarial drugs against cultured intraerythrocytic asexual forms of the human malaria parasite Plasmodium falciparum.  Microtitration plates were used to prep. serial dilns. of the compds. to be tested.  Parasites, obtained from continuous stock cultures, were subcultured in these plates for 42 h.  Inhibition of uptake of a radiolabeled nucleic acid precursor by the parasites served as the indicator of antimalarial activity.  Results of repeased measurements of activity with chloroquine, quinine, and the new drug mefloquine demonstrated that the method is sensitive and precise.  Several addnl. antimalarial drugs and compds. of interest were tested in vitro, and the results were consistent with available in vivo data.  The use of P. falciparum isolates with known susceptibility to antimalarial drugs also permitted evaluation of the cross-resistance potential of each compd. tested.  The applications and expectations of this new test system within a drug development program are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9KHtWVyGh8LVg90H21EOLACvtfcHk0likJdhf1INLyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktFyrsL0%253D&md5=0b708f34bdee0fe03d6cae1e4d7c3598</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FAAC.16.6.710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.16.6.710%26sid%3Dliteratum%253Aachs%26aulast%3DDesjardins%26aufirst%3DR.%2BE.%26aulast%3DCanfield%26aufirst%3DC.%2BJ.%26aulast%3DHaynes%26aufirst%3DJ.%2BD.%26aulast%3DChulay%26aufirst%3DJ.%2BD.%26atitle%3DQuantitative%2520Assessment%2520of%2520Antimalarial%2520Activity%2520in%2520vitro%2520by%2520a%2520Semiautomated%2520Microdilution%2520Technique%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1979%26volume%3D16%26issue%3D6%26spage%3D710%26epage%3D718%26doi%3D10.1128%2FAAC.16.6.710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Dianne T. Keough, Shun Jie Wun, Ondřej Baszczyňski, Wai Soon Eng, Petr Špaček, Santosh Panjikar, Lieve Naesens, Radek Pohl, Dominik Rejman, Dana Hocková, Richard L. Ferrero, <span class="NLM_string-name hlFld-ContribAuthor">Luke W. Guddat</span>. </span><span class="cited-content_cbyCitation_article-title">Helicobacter pylori Xanthine–Guanine–Hypoxanthine Phosphoribosyltransferase—A Putative Target for Drug Discovery against Gastrointestinal Tract Infections. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5710-5729. <a href="https://doi.org/10.1021/acs.jmedchem.0c02184" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02184%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHelicobacter%252Bpylori%252BXanthine%2525E2%252580%252593Guanine%2525E2%252580%252593Hypoxanthine%252BPhosphoribosyltransferase%2525E2%252580%252594A%252BPutative%252BTarget%252Bfor%252BDrug%252BDiscovery%252Bagainst%252BGastrointestinal%252BTract%252BInfections%26aulast%3DKeough%26aufirst%3DDianne%2BT.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D17122020%26date%3D23042021%26volume%3D64%26issue%3D9%26spage%3D5710%26epage%3D5729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Er-Jun Hao, Gong-Xin Li, Yu-Ru Liang, Ming-Sheng Xie, Dong-Chao Wang, Xiao-Han Jiang, Jia-Yi Cheng, Zhi-Xian Shi, Yang Wang, <span class="NLM_string-name hlFld-ContribAuthor">Hai-Ming Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Activity Evaluation of Novel Acyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 2077-2109. <a href="https://doi.org/10.1021/acs.jmedchem.0c01717" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01717</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01717%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BActivity%252BEvaluation%252Bof%252BNovel%252BAcyclic%252BNucleosides%252Bas%252BPotential%252BAnticancer%252BAgents%252BIn%252BVitro%252Band%252BIn%252BVivo%26aulast%3DHao%26aufirst%3DEr-Jun%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30092020%26date%3D04022021%26volume%3D64%26issue%3D4%26spage%3D2077%26epage%3D2109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Thomas Cheviet, Sharon Wein, Gabriel Bourchenin, Manon Lagacherie, Christian Périgaud, Rachel Cerdan, <span class="NLM_string-name hlFld-ContribAuthor">Suzanne Peyrottes</span>. </span><span class="cited-content_cbyCitation_article-title">β-Hydroxy- and β-Aminophosphonate Acyclonucleosides as Potent Inhibitors of Plasmodium falciparum Growth. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8069-8087. <a href="https://doi.org/10.1021/acs.jmedchem.0c00131" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00131%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B2-Hydroxy-%252Band%252B%2525CE%2525B2-Aminophosphonate%252BAcyclonucleosides%252Bas%252BPotent%252BInhibitors%252Bof%252BPlasmodium%252Bfalciparum%252BGrowth%26aulast%3DCheviet%26aufirst%3DThomas%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23012020%26date%3D20072020%26volume%3D63%26issue%3D15%26spage%3D8069%26epage%3D8087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jan Skácel, Martin Dračínský, <span class="NLM_string-name hlFld-ContribAuthor">Zlatko Janeba</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Tetrasubstituted Thiophenes via Direct Metalation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (2)
                                     , 788-797. <a href="https://doi.org/10.1021/acs.joc.9b02803" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02803</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02803%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BTetrasubstituted%252BThiophenes%252Bvia%252BDirect%252BMetalation%26aulast%3DSk%25C3%25A1cel%26aufirst%3DJan%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D15102019%26date%3D03012020%26date%3D20122019%26volume%3D85%26issue%3D2%26spage%3D788%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Thomas Cheviet, Isabelle Lefebvre-Tournier, Sharon Wein, <span class="NLM_string-name hlFld-ContribAuthor">Suzanne Peyrottes</span>. </span><span class="cited-content_cbyCitation_article-title">Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (18)
                                     , 8365-8391. <a href="https://doi.org/10.1021/acs.jmedchem.9b00182" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00182%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPlasmodium%252BPurine%252BMetabolism%252Band%252BIts%252BInhibition%252Bby%252BNucleoside%252Band%252BNucleotide%252BAnalogues%26aulast%3DCheviet%26aufirst%3DThomas%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D29012019%26date%3D25042019%26date%3D09042019%26volume%3D62%26issue%3D18%26spage%3D8365%26epage%3D8391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Doleželová</span>, <span class="hlFld-ContribAuthor ">Tomáš  Klejch</span>, <span class="hlFld-ContribAuthor ">Petr  Špaček</span>, <span class="hlFld-ContribAuthor ">Martina  Slapničková</span>, <span class="hlFld-ContribAuthor ">Luke  Guddat</span>, <span class="hlFld-ContribAuthor ">Dana  Hocková</span>, <span class="hlFld-ContribAuthor ">Alena  Zíková</span>. </span><span class="cited-content_cbyCitation_article-title">Acyclic nucleoside phosphonates with adenine nucleobase inhibit Trypanosoma brucei adenine phosphoribosyltransferase in vitro. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-91747-6" title="DOI URL">https://doi.org/10.1038/s41598-021-91747-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-91747-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-91747-6%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAcyclic%252Bnucleoside%252Bphosphonates%252Bwith%252Badenine%252Bnucleobase%252Binhibit%252BTrypanosoma%252Bbrucei%252Badenine%252Bphosphoribosyltransferase%252Bin%252Bvitro%26aulast%3DDole%25C5%25BEelov%25C3%25A1%26aufirst%3DEva%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Frydrych</span>, <span class="hlFld-ContribAuthor ">Dianne T.  Keough</span>, <span class="hlFld-ContribAuthor ">Marina  Chavchich</span>, <span class="hlFld-ContribAuthor ">Jye  Travis</span>, <span class="hlFld-ContribAuthor ">Martin  Dračínský</span>, <span class="hlFld-ContribAuthor ">Michael D.  Edstein</span>, <span class="hlFld-ContribAuthor ">Luke W.  Guddat</span>, <span class="hlFld-ContribAuthor ">Dana  Hocková</span>, <span class="hlFld-ContribAuthor ">Zlatko  Janeba</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleotide analogues containing a pyrrolidine, piperidine or piperazine ring: Synthesis and evaluation of inhibition of plasmodial and human 6-oxopurine phosphoribosyltransferases and in vitro antimalarial activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113416. <a href="https://doi.org/10.1016/j.ejmech.2021.113416" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113416%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNucleotide%252Banalogues%252Bcontaining%252Ba%252Bpyrrolidine%25252C%252Bpiperidine%252Bor%252Bpiperazine%252Bring%25253A%252BSynthesis%252Band%252Bevaluation%252Bof%252Binhibition%252Bof%252Bplasmodial%252Band%252Bhuman%252B6-oxopurine%252Bphosphoribosyltransferases%252Band%252Bin%2525C2%2525A0vitro%252Bantimalarial%252Bactivity%26aulast%3DFrydrych%26aufirst%3DJan%26date%3D2021%26volume%3D219%26spage%3D113416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle H.  Townsend</span>, <span class="hlFld-ContribAuthor ">Claudia M.  Tellez Freitas</span>, <span class="hlFld-ContribAuthor ">Dallas  Larsen</span>, <span class="hlFld-ContribAuthor ">Stephen R.  Piccolo</span>, <span class="hlFld-ContribAuthor ">K. Scott  Weber</span>, <span class="hlFld-ContribAuthor ">Richard A.  Robison</span>, <span class="hlFld-ContribAuthor ">Kim L.  O’Neill</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxanthine Guanine Phosphoribosyltransferase expression is negatively correlated with immune activity through its regulation of purine synthesis. </span><span class="cited-content_cbyCitation_journal-name">Immunobiology</span><span> <strong>2020,</strong> <em>225 </em>
                                    (3)
                                     , 151931. <a href="https://doi.org/10.1016/j.imbio.2020.151931" title="DOI URL">https://doi.org/10.1016/j.imbio.2020.151931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.imbio.2020.151931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.imbio.2020.151931%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunobiology%26atitle%3DHypoxanthine%252BGuanine%252BPhosphoribosyltransferase%252Bexpression%252Bis%252Bnegatively%252Bcorrelated%252Bwith%252Bimmune%252Bactivity%252Bthrough%252Bits%252Bregulation%252Bof%252Bpurine%252Bsynthesis%26aulast%3DTownsend%26aufirst%3DMichelle%2BH.%26date%3D2020%26volume%3D225%26issue%3D3%26spage%3D151931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morag  Dagen</span>, <span class="hlFld-ContribAuthor ">Graham L.  Patrick</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of purine and pyrimidine pathways. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 513-546. <a href="https://doi.org/10.1016/B978-0-08-101210-9.00015-9" title="DOI URL">https://doi.org/10.1016/B978-0-08-101210-9.00015-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-101210-9.00015-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-101210-9.00015-9%26sid%3Dliteratum%253Aachs%26atitle%3DInhibitors%252Bof%252Bpurine%252Band%252Bpyrimidine%252Bpathways%26aulast%3DDagen%26aufirst%3DMorag%26date%3D2020%26spage%3D513%26epage%3D546%26pub%3DElsevier%26atitle%3DAntimalarial%252BAgents%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomáš  Klejch</span>, <span class="hlFld-ContribAuthor ">Dianne T.  Keough</span>, <span class="hlFld-ContribAuthor ">Marina  Chavchich</span>, <span class="hlFld-ContribAuthor ">Jye  Travis</span>, <span class="hlFld-ContribAuthor ">Jan  Skácel</span>, <span class="hlFld-ContribAuthor ">Radek  Pohl</span>, <span class="hlFld-ContribAuthor ">Zlatko  Janeba</span>, <span class="hlFld-ContribAuthor ">Michael D.  Edstein</span>, <span class="hlFld-ContribAuthor ">Vicky M.  Avery</span>, <span class="hlFld-ContribAuthor ">Luke W.  Guddat</span>, <span class="hlFld-ContribAuthor ">Dana  Hocková</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfide, sulfoxide and sulfone bridged acyclic nucleoside phosphonates as inhibitors of the Plasmodium falciparum and human 6-oxopurine phosphoribosyltransferases: Synthesis and evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111667. <a href="https://doi.org/10.1016/j.ejmech.2019.111667" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111667%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSulfide%25252C%252Bsulfoxide%252Band%252Bsulfone%252Bbridged%252Bacyclic%252Bnucleoside%252Bphosphonates%252Bas%252Binhibitors%252Bof%252Bthe%252BPlasmodium%252Bfalciparum%252Band%252Bhuman%252B6-oxopurine%252Bphosphoribosyltransferases%25253A%252BSynthesis%252Band%252Bevaluation%26aulast%3DKlejch%26aufirst%3DTom%25C3%25A1%25C5%25A1%26date%3D2019%26volume%3D183%26spage%3D111667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth M  Heidel</span>, <span class="hlFld-ContribAuthor ">Cynthia S  Dowd</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphonate prodrugs: an overview and recent advances. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (13)
                                     , 1625-1643. <a href="https://doi.org/10.4155/fmc-2018-0591" title="DOI URL">https://doi.org/10.4155/fmc-2018-0591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0591%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DPhosphonate%252Bprodrugs%25253A%252Ban%252Boverview%252Band%252Brecent%252Badvances%26aulast%3DHeidel%26aufirst%3DKenneth%2BM%26date%3D2019%26volume%3D11%26issue%3D13%26spage%3D1625%26epage%3D1643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin Maxmilian  Kaiser</span>, <span class="hlFld-ContribAuthor ">Pavel  Novák</span>, <span class="hlFld-ContribAuthor ">Šárka  Rosenbergová</span>, <span class="hlFld-ContribAuthor ">Lenka  Poštová-Slavětínská</span>, <span class="hlFld-ContribAuthor ">Ivan  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Zlatko  Janeba</span>. </span><span class="cited-content_cbyCitation_article-title">Acyclic Nucleoside Phosphonates Bearing (
              R
              )- or (
              S
              )-9-[3-Hydroxy-2-(phosphonoethoxy)propyl] (HPEP) Moiety as Monomers for the Synthesis of Modified Oligonucleotides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (37)
                                     , 5119-5126. <a href="https://doi.org/10.1002/ejoc.201800490" title="DOI URL">https://doi.org/10.1002/ejoc.201800490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201800490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201800490%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAcyclic%252BNucleoside%252BPhosphonates%252BBearing%252B%252528%252BR%252B%252529-%252Bor%252B%252528%252BS%252B%252529-9-%25255B3-Hydroxy-2-%252528phosphonoethoxy%252529propyl%25255D%252B%252528HPEP%252529%252BMoiety%252Bas%252BMonomers%252Bfor%252Bthe%252BSynthesis%252Bof%252BModified%252BOligonucleotides%26aulast%3DKaiser%26aufirst%3DMartin%2BMaxmilian%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D37%26spage%3D5119%26epage%3D5126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomáš  Klejch</span>, <span class="hlFld-ContribAuthor ">Radek  Pohl</span>, <span class="hlFld-ContribAuthor ">Zlatko  Janeba</span>, <span class="hlFld-ContribAuthor ">Minghan  Sun</span>, <span class="hlFld-ContribAuthor ">Dianne T.  Keough</span>, <span class="hlFld-ContribAuthor ">Luke W.  Guddat</span>, <span class="hlFld-ContribAuthor ">Dana  Hocková</span>. </span><span class="cited-content_cbyCitation_article-title">Acyclic nucleoside phosphonates with unnatural nucleobases, favipiravir and allopurinol, designed as potential inhibitors of the human and Plasmodium falciparum 6-oxopurine phosphoribosyltransferases. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (40)
                                     , 5886-5897. <a href="https://doi.org/10.1016/j.tet.2018.08.014" title="DOI URL">https://doi.org/10.1016/j.tet.2018.08.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.08.014%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAcyclic%252Bnucleoside%252Bphosphonates%252Bwith%252Bunnatural%252Bnucleobases%25252C%252Bfavipiravir%252Band%252Ballopurinol%25252C%252Bdesigned%252Bas%252Bpotential%252Binhibitors%252Bof%252Bthe%252Bhuman%252Band%252BPlasmodium%252Bfalciparum%252B6-oxopurine%252Bphosphoribosyltransferases%26aulast%3DKlejch%26aufirst%3DTom%25C3%25A1%25C5%25A1%26date%3D2018%26volume%3D74%26issue%3D40%26spage%3D5886%26epage%3D5897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reaction catalyzed by HGPRT/HGXPRT. R = H (hypoxanthine), R = NH<sub>2</sub> (guanine), R = OH (xanthine).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General structures of ANbP-based HGPRT/HGXPRT inhibitors: (A, B) previously published bisphosphonates;<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (C) new asymmetric inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. [(2-[(Guanin-9-yl)methyl]propane-1,3-diyl)bis(oxy)]bis(methylene)diphosphonic acid (<b>1a</b>) bound in the active site of human HGPRT (Protein Data Bank code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IJQ">4IJQ</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> A sulfate ion from the crystallization media is present in the complex along with two magnesium ions (purple spheres).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the crystal structure of the human HGPRT·<b>1a</b> complex<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> with the docked structure of the new guanine derivative <b>20</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) overlaid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) BrCH<sub>2</sub>P(O)(O<i>i</i>Pr)<sub>2</sub>, NaH, DMF, 0°C; (b) DOWEX (50WX8 H<sup>+</sup>), 90% MeOH, 50°C; (c) TBDMSCl, imidazole, DMF, rt; (d) diethyl vinylphosphonate, Cs<sub>2</sub>CO<sub>3</sub>, <i>t</i>-BuOH, rt; (e) DOWEX (50WX8 H<sup>+</sup>), 90% MeOH, 50°C.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) DIAD, PPh<sub>3</sub>, 6-chloropurine, 2-amino-6-chloropurine or corresponding 7-deazapurines, THF, −30°C; (b) CF<sub>3</sub>COOH, H<sub>2</sub>O, rt; (c) K<sub>2</sub>CO<sub>3</sub>, DABCO, H<sub>2</sub>O, 120°C; (d) Br<sub>2</sub>, CCl<sub>4</sub>, DMF, rt; (e) BrSi(CH<sub>3</sub>)<sub>3</sub>, CH<sub>3</sub>CN, rt.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Br<sub>2</sub>, CCl<sub>4</sub>, DMF, rt; (b) BrSi(CH<sub>3</sub>)<sub>3</sub>, CH<sub>3</sub>CN, rt.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0015.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (1) BrSi(CH<sub>3</sub>)<sub>3</sub>, CH<sub>3</sub>CN, rt, (2) PPh<sub>3</sub>, aldrithiol, (<span class="smallcaps smallerCapital">l</span>)-NH<sub>2</sub>CH(Bn)COOEt·HCl, Et<sub>3</sub>N, pyridine, 70°C; (b) NBS, 1,4-dioxane, microwave, 100 °C.</p></p></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of the tetrameric human HGPRT·<b>20</b> complex. Magenta highlights the location of the ordered regions adjacent to the large mobile loop, residues R100-D120, which are not visible in this complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Electron density map of [3-(guanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methylphosphonic acid (<b>20</b>) bound in subunit C. The pale blue sphere shows the location of the single magnesium ion in the active site. (B) Superimposition of subunits A, B, C, and D showing the location of <b>20</b> in each of the four active sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Interaction between the oxygen atom in one of the linkers and the bridging water molecule when <b>20</b> is bound in the active site of subunit B of human HGPRT. The hydrogen bond between the exocyclic amino group and the carbonyl of D193 occurs in all subunits.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Comparison of the binding mode of <b>20</b> and <b>1a</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IJQ">4IJQ</a>) in the active site of human HGPRT. Compound <b>1a</b> with the associated sulfate ion: dark blue. Compound <b>20</b>: colored by element.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0009.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Network of hydrogen bonds that the phosphonyl oxygen atoms of the phosphonate groups, which point into the PP<sub>i</sub> binding pocket, form at the active site of the human HGPRT·<b>20</b> complex. The green sphere is magnesium ion, and the red spheres are waters.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0010.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Superimposition of the human HGPRT·<b>20</b> complex with the human enzyme in complex with (2-[(guanin-9-yl)methyl]propane-1,3-diyl)bis(oxy)]bis(methylene)diphosphonic acid (<b>1a</b>) and sulfate (yellow)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IJQ">4IJQ</a>) and ImmGP and pyrophosphate (dark blue)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BZY">1BZY</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/medium/jm-2017-00926j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0011.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures and the numbering system for the assignment of NMR signals of compounds in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00926/20170908/images/large/jm-2017-00926j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00926&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73212" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73212" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span> <span class="citation_source-book">World Malaria Report 2016</span>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Malaria+Report+2016%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DWorld%2520Malaria%2520Report%25202016%26pub%3DWorld%2520Health%2520Organization%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Venkatesh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shastri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochar, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patankar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span> </span><span class="NLM_article-title">Proteomics of <i>Plasmodium Vivax</i> Malaria: New Insights, Progress and Potential</span> <span class="citation_source-journal">Expert Rev. Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">782</span><span class="refDoi"> DOI: 10.1080/14789450.2016.1210515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1080%2F14789450.2016.1210515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=27389635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Krtb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=771-782&issue=8&author=A.+Venkateshauthor=S.+K.+Patelauthor=S.+Rayauthor=J.+Shastriauthor=G.+Chatterjeeauthor=S.+K.+Kocharauthor=S.+Patankarauthor=S.+Srivastava&title=Proteomics+of+Plasmodium+Vivax+Malaria%3A+New+Insights%2C+Progress+and+Potential&doi=10.1080%2F14789450.2016.1210515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomics of Plasmodium vivax malaria: new insights, progress and potential</span></div><div class="casAuthors">Venkatesh, Apoorva; Patel, Sandip K.; Ray, Sandipan; Shastri, Jayanthi; Chatterjee, Gangadhar; Kochar, Sanjay K.; Patankar, Swati; Srivastava, Sanjeeva</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Proteomics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">771-782</span>CODEN:
                <span class="NLM_cas:coden">ERPXA3</span>;
        ISSN:<span class="NLM_cas:issn">1478-9450</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Plasmodium vivax has accounted for an enormous share of the global malaria burden in recent years, along with Plasmodium falciparum.  The wide distribution of P. vivax and recent evidences of severe and complicated vivax malaria across several endemic regions of the world suggest that this disease may have been more overlooked than benign.  While P. falciparum has been extensively studied, P. vivax has received limited research attention owing to its complex nature and absence of a continuous culture system.  This review briefly describes the epidemiol. of vivax malaria, analyzes challenges towards effective control and summarizes major insights provided by genomics and transcriptomics research in the area.  Subsequently, the review provides a detailed description of the applications of proteomics in vivax malaria research, focusing on both host responses and parasite proteomics studies to understand P. vivax biol.  In recent years, proteomics technologies are being used effectively to understand P. vivax biol. and the underlying pathogenesis.  Technol. advances in mass spectrometry configurations, multiomics investigations and emerging strategies such as targeted proteomics may also immensely aid in studying disease severity, improving existing diagnosis and identifying new drug and vaccine targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQsw7cGxQKHLVg90H21EOLACvtfcHk0lj5wo-PskFKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Krtb7E&md5=58859c5cc44360c85904b0bea281bdf3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1080%2F14789450.2016.1210515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14789450.2016.1210515%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatesh%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DS.%2BK.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DShastri%26aufirst%3DJ.%26aulast%3DChatterjee%26aufirst%3DG.%26aulast%3DKochar%26aufirst%3DS.%2BK.%26aulast%3DPatankar%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DS.%26atitle%3DProteomics%2520of%2520Plasmodium%2520Vivax%2520Malaria%253A%2520New%2520Insights%252C%2520Progress%2520and%2520Potential%26jtitle%3DExpert%2520Rev.%2520Proteomics%26date%3D2016%26volume%3D13%26issue%3D8%26spage%3D771%26epage%3D782%26doi%3D10.1080%2F14789450.2016.1210515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Spring, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanachayangkul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somethy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Se, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittiverakul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sia-ngam, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntawunginn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arsanok, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buathong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaorattanakawee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ta-aksorn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanarat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundrakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teja-isavadharm, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichyangkul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phann, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshnick, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chour, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanteri, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, D. L.</span><span> </span><span class="NLM_article-title">Dihydroartemisinin-piperaquine Failure Associated with a Triple Mutant Including <i>Kelch13 C580Y</i> in Cambodia: An Observational Cohort Study</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1016/S1473-3099(15)70049-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2FS1473-3099%2815%2970049-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=25877962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFSgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=683-691&author=M.+D.+Springauthor=J.+T.+Linauthor=J.+E.+Manningauthor=P.+Vanachayangkulauthor=S.+Somethyauthor=R.+Bunauthor=Y.+Seauthor=S.+Channauthor=M.+Ittiverakulauthor=P.+Sia-ngamauthor=W.+Kuntawunginnauthor=M.+Arsanokauthor=N.+Buathongauthor=S.+Chaorattanakaweeauthor=P.+Gosiauthor=W.+Ta-aksornauthor=N.+Chanaratauthor=S.+Sundrakesauthor=N.+Kongauthor=T.+K.+Hengauthor=S.+Nouauthor=P.+Teja-isavadharmauthor=S.+Pichyangkulauthor=S.+T.+Phannauthor=S.+Balasubramanianauthor=J.+J.+Julianoauthor=S.+R.+Meshnickauthor=C.+M.+Chourauthor=S.+Promauthor=C.+A.+Lanteriauthor=C.+Lonauthor=D.+L.+Saunders&title=Dihydroartemisinin-piperaquine+Failure+Associated+with+a+Triple+Mutant+Including+Kelch13+C580Y+in+Cambodia%3A+An+Observational+Cohort+Study&doi=10.1016%2FS1473-3099%2815%2970049-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study</span></div><div class="casAuthors">Spring, Michele D.; Lin, Jessica T.; Manning, Jessica E.; Vanachayangkul, Pattaraporn; Somethy, Sok; Bun, Rathvicheth; Se, Youry; Chann, Soklyda; Ittiverakul, Mali; Sia-ngam, Piyaporn; Kuntawunginn, Worachet; Arsanok, Montri; Buathong, Nillawan; Chaorattanakawee, Suwanna; Gosi, Panita; Ta-aksorn, Winita; Chanarat, Nitima; Sundrakes, Siratchana; Kong, Nareth; Heng, Thay Kheang; Nou, Samon; Teja-isavadharm, Paktiya; Pichyangkul, Sathit; Phann, Sut Thang; Balasubramanian, Sujata; Juliano, Jonathan J.; Meshnick, Steven R.; Chour, Char Meng; Prom, Satharath; Lanteri, Charlotte A.; Lon, Chanthap; Saunders, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">683-691</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Dihydroartemisinin-piperaquine has been adopted as first-line artemisinin combination therapy (ACT) for multidrug-resistant Plasmodium falciparum malaria in Cambodia because of few remaining alternatives.  We aimed to assess the efficacy of std. 3 day dihydroartemisinin-piperaquine treatment of uncomplicated P falciparum malaria, with and without the addn. of primaquine, focusing on the factors involved in drug resistance.  In this observational cohort study, we assessed 107 adults aged 18-65 years presenting to Anlong Veng District Hospital, Oddar Meanchey Province, Cambodia, with uncomplicated P falciparum or mixed P falciparum/Plasmodium vivax infection of between 1000 and 200 000 parasites per μL of blood, and participating in a randomized clin. trial in which all had received dihydroartemisinin-piperaquine for 3 days, after which they had been randomly allocated to receive either primaquine or no primaquine.  The trial was halted early due to poor dihydroartemisinin-piperaquine efficacy, and we assessed day 42 PCR-cor. therapeutic efficacy (proportion of patients with recurrence at 42 days) and evidence of drug resistance from the initial cohort.  We did analyses on both the intention to treat (ITT), modified ITT (withdrawals, losses to follow-up, and those with secondary outcomes [eg, new non-recrudescent malaria infection] were censored on the last day of follow-up), and per-protocol populations of the original trial.  The original trial was registered with ClinicalTrials.gov, no. NCT01280162.  Between Dec 10, 2012, and Feb 18, 2014, we had enrolled 107 patients in the original trial.  Enrolment was voluntarily halted on Feb 16, 2014, before reaching planned enrollment (n=150) because of poor efficacy.  We had randomly allocated 50 patients to primaquine and 51 patients to no primaquine groups.  PCR-adjusted Kaplan-Meier risk of P falciparum 42 day recrudescence was 54% (95% CI 45-63) in the modified ITT anal. population.  We found two kelch13 propeller gene mutations assocd. with artemisinin resistance-a non-synonymous Cys580Tyr substitution in 70 (65%) of 107 participants, an Arg539Thr substitution in 33 (31%), and a wild-type parasite in four (4%).  Unlike Arg539Thr, Cys580Tyr was accompanied by two other mutations assocd. with extended parasite clearance (MAL10:688956 and MAL13:1718319).  This combination triple mutation was assocd. with a 5·4 times greater risk of treatment failure (hazard ratio 5·4 [95% CI 2·4-12]; p<0·0001) and higher piperaquine 50% inhibitory concn. (triple mutant 34 nM [28-41]; non-triple mutant 24 nM [1-27]; p=0·003) than other infections had.  The drug was well tolerated, with gastrointestinal symptoms being the most common complaints.  The dramatic decline in efficacy of dihydroartemisinin-piperaquine compared with what was obsd. in a study at the same location in 2010 was strongly assocd. with a new triple mutation including the kelch13 Cys580Tyr substitution.  3 Days of artemisinin as part of an artemisinin combination therapy regimen might be insufficient.  Strict regulation and monitoring of antimalarial use, along with non-pharmacol. approaches to malaria resistance containment, must be integral parts of the public health response to rapidly accelerating drug resistance in the region.  Armed Forces Health Surveillance Center/Global Emerging Infections Surveillance and Response System, Military Infectious Disease Research Program, National Institute of Allergy and Infectious Diseases, and American Society of Tropical Medicine and Hygiene/Burroughs Wellcome Fund.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFjkvNekrUMrVg90H21EOLACvtfcHk0ljaAxd0OiXOWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFSgu78%253D&md5=6150b25babe19f91eb5971e030327681</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2815%2970049-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252815%252970049-6%26sid%3Dliteratum%253Aachs%26aulast%3DSpring%26aufirst%3DM.%2BD.%26aulast%3DLin%26aufirst%3DJ.%2BT.%26aulast%3DManning%26aufirst%3DJ.%2BE.%26aulast%3DVanachayangkul%26aufirst%3DP.%26aulast%3DSomethy%26aufirst%3DS.%26aulast%3DBun%26aufirst%3DR.%26aulast%3DSe%26aufirst%3DY.%26aulast%3DChann%26aufirst%3DS.%26aulast%3DIttiverakul%26aufirst%3DM.%26aulast%3DSia-ngam%26aufirst%3DP.%26aulast%3DKuntawunginn%26aufirst%3DW.%26aulast%3DArsanok%26aufirst%3DM.%26aulast%3DBuathong%26aufirst%3DN.%26aulast%3DChaorattanakawee%26aufirst%3DS.%26aulast%3DGosi%26aufirst%3DP.%26aulast%3DTa-aksorn%26aufirst%3DW.%26aulast%3DChanarat%26aufirst%3DN.%26aulast%3DSundrakes%26aufirst%3DS.%26aulast%3DKong%26aufirst%3DN.%26aulast%3DHeng%26aufirst%3DT.%2BK.%26aulast%3DNou%26aufirst%3DS.%26aulast%3DTeja-isavadharm%26aufirst%3DP.%26aulast%3DPichyangkul%26aufirst%3DS.%26aulast%3DPhann%26aufirst%3DS.%2BT.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DJuliano%26aufirst%3DJ.%2BJ.%26aulast%3DMeshnick%26aufirst%3DS.%2BR.%26aulast%3DChour%26aufirst%3DC.%2BM.%26aulast%3DProm%26aufirst%3DS.%26aulast%3DLanteri%26aufirst%3DC.%2BA.%26aulast%3DLon%26aufirst%3DC.%26aulast%3DSaunders%26aufirst%3DD.%2BL.%26atitle%3DDihydroartemisinin-piperaquine%2520Failure%2520Associated%2520with%2520a%2520Triple%2520Mutant%2520Including%2520Kelch13%2520C580Y%2520in%2520Cambodia%253A%2520An%2520Observational%2520Cohort%2520Study%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2015%26volume%3D15%26spage%3D683%26epage%3D691%26doi%3D10.1016%2FS1473-3099%2815%2970049-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Thanh, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuy-Nhien, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuyen, N. T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nha-Ca, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quang, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thwaites, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolbers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hien, T. T.</span><span> </span><span class="NLM_article-title">Rapid Decline in the Susceptibility of <i>Plasmodium falciparum</i> to Dihydroartemisinin-piperaquine in the South of Vietnam</span> <span class="citation_source-journal">Malar. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="refDoi"> DOI: 10.1186/s12936-017-1680-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1186%2Fs12936-017-1680-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=28086775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A280%3ADC%252BC1c7ls1Oltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=27&author=N.+V.+Thanhauthor=N.+Thuy-Nhienauthor=N.+T.+K.+Tuyenauthor=N.+T.+Tongauthor=N.+T.+Nha-Caauthor=L.+T.+Dongauthor=H.+H.+Quangauthor=J.+Farrarauthor=G.+Thwaitesauthor=N.+J.+Whiteauthor=M.+Wolbersauthor=T.+T.+Hien&title=Rapid+Decline+in+the+Susceptibility+of+Plasmodium+falciparum+to+Dihydroartemisinin-piperaquine+in+the+South+of+Vietnam&doi=10.1186%2Fs12936-017-1680-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam</span></div><div class="casAuthors">Thanh Ngo Viet; Thuy-Nhien Nguyen; Tuyen Nguyen Thi Kim; Tong Nguyen Thanh; Nha-Ca Nguyen Thuy; Farrar Jeremy; Thwaites Guy; Wolbers Marcel; Hien Tran Tinh; Dong Le Thanh; Quang Huynh Hong; Farrar Jeremy; Thwaites Guy; White Nicholas J; Wolbers Marcel; Hien Tran Tinh; White Nicholas J</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Artemisinin resistant Plasmodium falciparum has emerged in the countries of the Greater Mekong sub-region posing a serious threat to global malaria elimination efforts.  The relationship of artemisinin resistance to treatment failure has been unclear.  METHODS:  In annual studies conducted in three malaria endemic provinces in the south of Vietnam (Binh Phuoc, Ninh Thuan and Gia Lai) between 2011 and 2015, 489 patients with uncomplicated P. falciparum malaria were enrolled in detailed clinical, parasitological and molecular therapeutic response assessments with 42 days follow up.  Patients received the national recommended first-line treatment dihydroartemisinin-piperaquine for three days.  RESULTS:  Over the 5 years the proportion of patients with detectable parasitaemia on day 3 rose steadily from 38 to 57% (P < 0.001).  In Binh Phuoc province, the parasite clearance half-life increased from 3.75 h in 2011 to 6.60 h in 2015 (P < 0.001), while treatment failures rose from 0% in 2012 and 2013, to 7% in 2014 and 26% in 2015 (P < 0.001).  Recrudescence was associated with in vitro evidence of artemisinin and piperaquine resistance.  In the treatment failures cases of 2015, all 14 parasite isolates carried the C580Y Pfkelch 13 gene, marker of artemisinin resistance and 93% (13/14) of them carried exoE415G mutations, markers of piperaquine resistance.  CONCLUSIONS:  In the south of Vietnam recent emergence of piperaquine resistant P. falciparum strains has accelerated the reduced response to artemisinin and has led to treatment failure rates of up to 26% to dihydroartemisinin-piperaquine, Vietnam's current first-line ACT.  Alternative treatments are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGj2vwuYNqs7FU0A1HOshhfW6udTcc2ebhax8gqgFdvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7ls1Oltg%253D%253D&md5=cd3e7d89b8166b18acf7760d80073963</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2Fs12936-017-1680-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-017-1680-8%26sid%3Dliteratum%253Aachs%26aulast%3DThanh%26aufirst%3DN.%2BV.%26aulast%3DThuy-Nhien%26aufirst%3DN.%26aulast%3DTuyen%26aufirst%3DN.%2BT.%2BK.%26aulast%3DTong%26aufirst%3DN.%2BT.%26aulast%3DNha-Ca%26aufirst%3DN.%2BT.%26aulast%3DDong%26aufirst%3DL.%2BT.%26aulast%3DQuang%26aufirst%3DH.%2BH.%26aulast%3DFarrar%26aufirst%3DJ.%26aulast%3DThwaites%26aufirst%3DG.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26aulast%3DWolbers%26aufirst%3DM.%26aulast%3DHien%26aufirst%3DT.%2BT.%26atitle%3DRapid%2520Decline%2520in%2520the%2520Susceptibility%2520of%2520Plasmodium%2520falciparum%2520to%2520Dihydroartemisinin-piperaquine%2520in%2520the%2520South%2520of%2520Vietnam%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26spage%3D27%26doi%3D10.1186%2Fs12936-017-1680-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Cassera, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazleton, K. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">Purine and Pyrimidine Pathways as Targets in Plasmodium falciparum</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">2103</span><span class="NLM_x">–</span> <span class="NLM_lpage">2115</span><span class="refDoi"> DOI: 10.2174/156802611796575948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.2174%2F156802611796575948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=21619511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=2103-2115&issue=16&author=M.+B.+Casseraauthor=Y.+Zhangauthor=K.+Z.+Hazletonauthor=V.+L.+Schramm&title=Purine+and+Pyrimidine+Pathways+as+Targets+in+Plasmodium+falciparum&doi=10.2174%2F156802611796575948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Purine and pyrimidine pathways as targets in Plasmodium falciparum</span></div><div class="casAuthors">Cassera, Maria Belen; Zhang, Yong; Hazleton, Keith Z.; Schramm, Vern L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2103-2115</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria is a leading cause of morbidity and mortality in the tropics.  Chemotherapeutic and vector control strategies have been applied for more than a century but have not been efficient in disease eradication.  Increased resistance of malaria parasites to drug treatment and of mosquito vectors to insecticides requires the development of novel chemotherapeutic agents.  Malaria parasites exhibit rapid nucleic acid synthesis during their intraerythrocytic growth phase.  Plasmodium purine and pyrimidine metabolic pathways are distinct from those of their human hosts.  Thus, targeting purine and pyrimidine metabolic pathways provides a promising route for novel drug development.  Recent developments in enzymic transition state anal. have provided an improved route to inhibitor design targeted to specific enzymes, including those of purine and pyrimidine metab.  Modern transition state analog drug discovery has resulted in transition state analogs capable of binding to target enzymes with unprecedented affinity and specificity.  These agents can provide specific blocks in essential pathways.  The combination of tight binding with the high specificity of these logically designed inhibitors, results in low toxicity and minor side effects.  These features reduce two of the major problems with the current antimalarials.  Transition state analog design is being applied to generate new lead compds. to treat malaria by targeting purine and pyrimidine pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYWQhqSwJfg7Vg90H21EOLACvtfcHk0ljDNFasgg9EEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3F&md5=bbab95b24e5f86134ceb7aa7f9473bde</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F156802611796575948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611796575948%26sid%3Dliteratum%253Aachs%26aulast%3DCassera%26aufirst%3DM.%2BB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHazleton%26aufirst%3DK.%2BZ.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DPurine%2520and%2520Pyrimidine%2520Pathways%2520as%2520Targets%2520in%2520Plasmodium%2520falciparum%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26issue%3D16%26spage%3D2103%26epage%3D2115%26doi%3D10.2174%2F156802611796575948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Berman, P. A.; Human, L.</span><span> </span><span class="NLM_article-title">Hypoxanthine Depletion Induced by Xanthine Oxidase Inhibits Malaria Parasite Growth in Vitro</span>.  <span class="citation_source-book">Purine and Pyrimidine Metabolism in Man VII: Part A: Chemotherapy, ATP Depletion, and Gout</span>; <span class="NLM_contrib-group">Harkness, R. A.; Elion, G. B.; Zöllner, N.</span>, Eds.; <span class="NLM_publisher-name">Plenum Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1991</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1007%2F978-1-4899-2638-8_37" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1991&pages=165-168&author=P.+A.+Berman&author=L.+Humanauthor=R.+A.+Harkness&author=G.+B.+Elion&author=N.+Z%C3%B6llner&title=Purine+and+Pyrimidine+Metabolism+in+Man+VII%3A+Part+A%3A+Chemotherapy%2C+ATP+Depletion%2C+and+Gout"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2F978-1-4899-2638-8_37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4899-2638-8_37%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DP.%2BA.%26atitle%3DHypoxanthine%2520Depletion%2520Induced%2520by%2520Xanthine%2520Oxidase%2520Inhibits%2520Malaria%2520Parasite%2520Growth%2520in%2520Vitro%26btitle%3DPurine%2520and%2520Pyrimidine%2520Metabolism%2520in%2520Man%2520VII%253A%2520Part%2520A%253A%2520Chemotherapy%252C%2520ATP%2520Depletion%252C%2520and%2520Gout%26aulast%3DHarkness%26aufirst%3DR.%2BA.%26pub%3DPlenum%2520Press%26date%3D1991%26spage%3D165%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holý, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner-Adams, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Inhibition of Hypoxanthine-Guanine Phosphoribosyltransferase by Acyclic Nucleoside Phosphonates: A New Class of Antimalarial Therapeutics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4391</span><span class="NLM_x">–</span> <span class="NLM_lpage">4399</span><span class="refDoi"> DOI: 10.1021/jm900267n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900267n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Ons7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4391-4399&issue=14&author=D.+T.+Keoughauthor=D.+Hockov%C3%A1author=A.+Hol%C3%BDauthor=L.+M.+J.+Naesensauthor=T.+S.+Skinner-Adamsauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Inhibition+of+Hypoxanthine-Guanine+Phosphoribosyltransferase+by+Acyclic+Nucleoside+Phosphonates%3A+A+New+Class+of+Antimalarial+Therapeutics&doi=10.1021%2Fjm900267n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hypoxanthine-Guanine Phosphoribosyltransferase by Acyclic Nucleoside Phosphonates: A New Class of Antimalarial Therapeutics</span></div><div class="casAuthors">Keough, Dianne T.; Hockova, Dana; Holy, Antonin; Naesens, Lieve M. J.; Skinner-Adams, Tina S.; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4391-4399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The purine salvage enzyme hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT) is essential for purine nucleotide and hence nucleic acid synthesis in the malaria parasite, Plasmodium falciparum.  Acyclic nucleoside phosphonates (ANPs) are analogs of the nucleotide product of the reaction, comprising a purine base joined by a linker to a phosphonate moiety.  Ki values for 19 ANPs were detd. for Pf HGXPRT and the corresponding human enzyme, HGPRT.  Values for Pf HGXPRT were as low as 100 nM, with selectivity for the parasite enzyme of up to 58.  Structures of human HGPRT in complex with three ANPs are reported.  On binding, a large mobile loop in the free enzyme moves to partly cover the active site.  For three ANPs, the IC50 values for Pf grown in cell culture were 1, 14, and 46 μM, while the cytotoxic concn. for the first compd. was 489 μM.  These results provide a basis for the design of potent and selective ANP inhibitors of Pf HGXPRT as antimalarial drug leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn8rPcoy0EBbVg90H21EOLACvtfcHk0ljDNFasgg9EEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Ons7w%253D&md5=76746f78ec791a08ba2376beba86fa2b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm900267n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900267n%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DNaesens%26aufirst%3DL.%2BM.%2BJ.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DInhibition%2520of%2520Hypoxanthine-Guanine%2520Phosphoribosyltransferase%2520by%2520Acyclic%2520Nucleoside%2520Phosphonates%253A%2520A%2520New%2520Class%2520of%2520Antimalarial%2520Therapeutics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D14%26spage%3D4391%26epage%3D4399%26doi%3D10.1021%2Fjm900267n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Li, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furneaux, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kicska, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubmeyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girvin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">Transition-State Analogs as Inhibitors of Human and Malarial Hypoxanthine-Guanine Phosphoribosyltransferases</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">582</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span><span class="refDoi"> DOI: 10.1038/9367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1038%2F9367" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=582-587&author=C.+M.+Liauthor=P.+C.+Tylerauthor=R.+H.+Furneauxauthor=G.+Kicskaauthor=Y.+Xuauthor=C.+Grubmeyerauthor=M.+E.+Girvinauthor=V.+L.+Schramm&title=Transition-State+Analogs+as+Inhibitors+of+Human+and+Malarial+Hypoxanthine-Guanine+Phosphoribosyltransferases&doi=10.1038%2F9367"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F9367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F9367%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BM.%26aulast%3DTyler%26aufirst%3DP.%2BC.%26aulast%3DFurneaux%26aufirst%3DR.%2BH.%26aulast%3DKicska%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DGrubmeyer%26aufirst%3DC.%26aulast%3DGirvin%26aufirst%3DM.%2BE.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DTransition-State%2520Analogs%2520as%2520Inhibitors%2520of%2520Human%2520and%2520Malarial%2520Hypoxanthine-Guanine%2520Phosphoribosyltransferases%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D582%26epage%3D587%26doi%3D10.1038%2F9367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ducati, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namanja-Magliano, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">Transition-State Inhibitors of Purine Salvage and Other Prospective Enzyme Targets in Malaria</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1341</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span><span class="refDoi"> DOI: 10.4155/fmc.13.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.4155%2Ffmc.13.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=23859211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFWktL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1341-1360&issue=11&author=R.+G.+Ducatiauthor=H.+A.+Namanja-Maglianoauthor=V.+L.+Schramm&title=Transition-State+Inhibitors+of+Purine+Salvage+and+Other+Prospective+Enzyme+Targets+in+Malaria&doi=10.4155%2Ffmc.13.51"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria</span></div><div class="casAuthors">Ducati, Rodrigo G.; Namanja-Magliano, Hilda A.; Schramm, Vern L.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1341-1360</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria is a leading cause of human death within the tropics.  The gradual generation of drug resistance imposes an urgent need for the development of new and selective antimalarial agents.  Kinetic isotope effects coupled to computational chem. have provided the relevant details on geometry and charge of enzymic transition states to facilitate the design of transition-state analogs.  These features have been reproduced into chem. stable mimics through synthetic chem., generating inhibitors with dissocn. consts. in the pico- to femto-molar range.  Transition-state analogs are expected to contribute to the control of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1jm7Iu-SN7bVg90H21EOLACvtfcHk0li311l3cIXz-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFWktL%252FK&md5=a7f6768ef89b03de28fa984f7f153f93</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.51%26sid%3Dliteratum%253Aachs%26aulast%3DDucati%26aufirst%3DR.%2BG.%26aulast%3DNamanja-Magliano%26aufirst%3DH.%2BA.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DTransition-State%2520Inhibitors%2520of%2520Purine%2520Salvage%2520and%2520Other%2520Prospective%2520Enzyme%2520Targets%2520in%2520Malaria%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26issue%3D11%26spage%3D1341%26epage%3D1360%26doi%3D10.4155%2Ffmc.13.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Clinch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazleton, K. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, P. C.</span><span> </span><span class="NLM_article-title">Acyclic Phosph(on)ate Inhibitors of <i>Plasmodium Falciparum</i> Hypoxanthine-Guanine-Xanthine Phosphoribosyltransferase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5629</span><span class="NLM_x">–</span> <span class="NLM_lpage">5646</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.02.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2Fj.bmc.2013.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=23810424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWls73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=5629-5646&issue=17&author=K.+Clinchauthor=D.+R.+Crumpauthor=G.+B.+Evansauthor=K.+Z.+Hazletonauthor=J.+M.+Masonauthor=V.+L.+Schrammauthor=P.+C.+Tyler&title=Acyclic+Phosph%28on%29ate+Inhibitors+of+Plasmodium+Falciparum+Hypoxanthine-Guanine-Xanthine+Phosphoribosyltransferase&doi=10.1016%2Fj.bmc.2013.02.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Acyclic phosph(on)ate inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase</span></div><div class="casAuthors">Clinch, Keith; Crump, Douglas R.; Evans, Gary B.; Hazleton, Keith Z.; Mason, Jennifer M.; Schramm, Vern L.; Tyler, Peter C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5629-5646</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The pathogenic protozoa responsible for malaria lack enzymes for the de novo synthesis of purines and rely on purine salvage from the host.  In Plasmodium falciparum (Pf), hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT) converts hypoxanthine to inosine monophosphate and is essential for purine salvage making the enzyme an anti-malarial drug target.  We have synthesized a no. of simple acyclic aza-C-nucleosides and shown that some are potent inhibitors of Pf HGXPRT while showing excellent selectivity for the Pf vs. the human enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUUjPr4oHetrVg90H21EOLACvtfcHk0li311l3cIXz-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWls73I&md5=1a7be25d17441e003e48c568a3ba231c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DClinch%26aufirst%3DK.%26aulast%3DCrump%26aufirst%3DD.%2BR.%26aulast%3DEvans%26aufirst%3DG.%2BB.%26aulast%3DHazleton%26aufirst%3DK.%2BZ.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26aulast%3DTyler%26aufirst%3DP.%2BC.%26atitle%3DAcyclic%2520Phosph%2528on%2529ate%2520Inhibitors%2520of%2520Plasmodium%2520Falciparum%2520Hypoxanthine-Guanine-Xanthine%2520Phosphoribosyltransferase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D17%26spage%3D5629%26epage%3D5646%26doi%3D10.1016%2Fj.bmc.2013.02.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Terán, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Česnek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zíková, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Crystal Structures and Inhibition of <i>Trypanosoma brucei</i> Hypoxanthine–Guanine Phosphoribosyltransferase</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">35894</span><span class="refDoi"> DOI: 10.1038/srep35894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1038%2Fsrep35894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=27786284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKntrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=35894&author=D.+Ter%C3%A1nauthor=D.+Hockov%C3%A1author=M.+%C4%8Cesnekauthor=A.+Z%C3%ADkov%C3%A1author=L.+Naesensauthor=D.+T.+Keoughauthor=L.+W.+Guddat&title=Crystal+Structures+and+Inhibition+of+Trypanosoma+brucei+Hypoxanthine%E2%80%93Guanine+Phosphoribosyltransferase&doi=10.1038%2Fsrep35894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures and inhibition of Trypanosoma brucei hypoxanthine-guanine phosphoribosyltransferase</span></div><div class="casAuthors">Teran, David; Hockova, Dana; Cesnek, Michal; Zikova, Alena; Naesens, Lieve; Keough, Dianne T.; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35894</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human African Trypanosomiasis (HAT) is a life-threatening infectious disease caused by the protozoan parasite, Trypanosoma brucei (Tbr).  Due to the debilitating side effects of the current therapeutics and the emergence of resistance to these drugs, new medications for this disease need to be developed.  One potential new drug target is 6-oxopurine phosphoribosyltransferase (PRT), an enzyme central to the purine salvage pathway and whose activity is crit. for the prodn. of the nucleotides (GMP and IMP) required for DNA/RNA synthesis within this protozoan parasite.  Here, the first crystal structures of this enzyme have been detd., these in complex with GMP and IMP and with three acyclic nucleoside phosphonate (ANP) inhibitors.  The Ki values for GMP and IMP are 30.5 μM and 77 μM, resp.  Two of the ANPs have Ki values considerably lower than for the nucleotides, 2.3 μM (with guanine as base) and 15.8 μM (with hypoxanthine as base).  The crystal structures show that when two of the ANPs bind, they induce an unusual conformation change to the loop where the reaction product, pyrophosphate, is expected to bind.  This and other structural differences between the Tbr and human enzymes suggest selective inhibitors for the Tbr enzyme can be designed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe7k6Mh75xB7Vg90H21EOLACvtfcHk0li311l3cIXz-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKntrnN&md5=5704d506e6373d4de9e3a49b441162e0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fsrep35894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep35894%26sid%3Dliteratum%253Aachs%26aulast%3DTer%25C3%25A1n%26aufirst%3DD.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3D%25C4%258Cesnek%26aufirst%3DM.%26aulast%3DZ%25C3%25ADkov%25C3%25A1%26aufirst%3DA.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DCrystal%2520Structures%2520and%2520Inhibition%2520of%2520Trypanosoma%2520brucei%2520Hypoxanthine%25E2%2580%2593Guanine%2520Phosphoribosyltransferase%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D35894%26doi%3D10.1038%2Fsrep35894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Eng, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Špaček, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">First Crystal Structures of <i>Mycobacterium Tuberculosis</i> 6-Oxopurine Phosphoribosyltransferase: Complexes with GMP and Pyrophosphate and with Acyclic Nucleoside Phosphonates Whose Prodrugs Have Antituberculosis Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">4822</span><span class="NLM_x">–</span> <span class="NLM_lpage">4838</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00611</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00611" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4822-4838&issue=11&author=W.+S.+Engauthor=D.+Hockov%C3%A1author=P.+%C5%A0pa%C4%8Dekauthor=Z.+Janebaauthor=N.+P.+Westauthor=K.+Woodsauthor=L.+M.+J.+Naesensauthor=D.+T.+Keoughauthor=L.+W.+Guddat&title=First+Crystal+Structures+of+Mycobacterium+Tuberculosis+6-Oxopurine+Phosphoribosyltransferase%3A+Complexes+with+GMP+and+Pyrophosphate+and+with+Acyclic+Nucleoside+Phosphonates+Whose+Prodrugs+Have+Antituberculosis+Activity&doi=10.1021%2Facs.jmedchem.5b00611"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00611%26sid%3Dliteratum%253Aachs%26aulast%3DEng%26aufirst%3DW.%2BS.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DWest%26aufirst%3DN.%2BP.%26aulast%3DWoods%26aufirst%3DK.%26aulast%3DNaesens%26aufirst%3DL.%2BM.%2BJ.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DFirst%2520Crystal%2520Structures%2520of%2520Mycobacterium%2520Tuberculosis%25206-Oxopurine%2520Phosphoribosyltransferase%253A%2520Complexes%2520with%2520GMP%2520and%2520Pyrophosphate%2520and%2520with%2520Acyclic%2520Nucleoside%2520Phosphonates%2520Whose%2520Prodrugs%2520Have%2520Antituberculosis%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D11%26spage%3D4822%26epage%3D4838%26doi%3D10.1021%2Facs.jmedchem.5b00611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krečmerová, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Česnek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holý, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brereton, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzor, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title"><i>Plasmodium Vivax</i> Hypoxanthine-Guanine Phosphoribosyltransferase: A Target for Anti-Malarial Chemotherapy</span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span><span class="refDoi"> DOI: 10.1016/j.molbiopara.2010.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2Fj.molbiopara.2010.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=20595032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVCmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2010&pages=165-169&issue=2&author=D.+T.+Keoughauthor=D.+Hockov%C3%A1author=M.+Kre%C4%8Dmerov%C3%A1author=M.+%C4%8Cesnekauthor=A.+Hol%C3%BDauthor=L.+Naesensauthor=I.+M.+Breretonauthor=D.+J.+Winzorauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Plasmodium+Vivax+Hypoxanthine-Guanine+Phosphoribosyltransferase%3A+A+Target+for+Anti-Malarial+Chemotherapy&doi=10.1016%2Fj.molbiopara.2010.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium vivax hypoxanthine-guanine phosphoribosyltransferase: A target for anti-malarial chemotherapy</span></div><div class="casAuthors">Keough, Dianne T.; Hockova, Dana; Krecmerova, Marcela; Cesnek, Michal; Holy, Antonin; Naesens, Lieve; Brereton, Ian M.; Winzor, Donald J.; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-169</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">The malarial parasite, Plasmodium vivax (Pv), causes a serious infectious disease found primarily in Asia and the Americas.  For protozoan parasites, 6-oxopurine phosphoribosyltransferases (PRTases) provide the only metabolic pathway to synthesize the purine nucleoside monophosphates essential for DNA/RNA prodn.  We have purified the recombinant Pv 6-oxopurine (PRTase) and compared its properties with the human and Pf enzymes.  The Pv enzyme uses hypoxanthine and guanine with similar catalytic efficiency to the Pf enzyme but xanthine is not a substrate, hence we identify this enzyme as PvHGPRT.  Mass spectrometry suggests that PvHGPRT contains bound magnesium ions that are removed by EDTA resulting in loss of activity.  However, the addn. of Mg2+ restores activity.  Acyclic nucleoside phosphonates (ANPs) are good inhibitors of PvHGPRT having Ki values as low as 3 μM.  These compds. can form the basis for the design of new drugs aimed at combating malaria caused by Pv.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1uFwfI8LK6LVg90H21EOLACvtfcHk0li4Tedev_eoGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVCmt7o%253D&md5=027d3207a8530ca9c113412a0a976d6e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2010.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2010.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DKre%25C4%258Dmerov%25C3%25A1%26aufirst%3DM.%26aulast%3D%25C4%258Cesnek%26aufirst%3DM.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DBrereton%26aufirst%3DI.%2BM.%26aulast%3DWinzor%26aufirst%3DD.%2BJ.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DPlasmodium%2520Vivax%2520Hypoxanthine-Guanine%2520Phosphoribosyltransferase%253A%2520A%2520Target%2520for%2520Anti-Malarial%2520Chemotherapy%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2010%26volume%3D173%26issue%3D2%26spage%3D165%26epage%3D169%26doi%3D10.1016%2Fj.molbiopara.2010.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edstein, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavchich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Aza-Acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group as Inhibitors of the Human, <i>Plasmodium Falciparum</i> and <i>Vivax</i> 6-Oxopurine Phosphoribosyltransferases and Their Prodrugs as Antimalarial Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span><span class="refDoi"> DOI: 10.1021/jm501416t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501416t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=827-846&issue=2&author=D.+T.+Keoughauthor=D.+Hockov%C3%A1author=Z.+Janebaauthor=T.+H.+Wangauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=M.+Chavchichauthor=L.+W.+Guddat&title=Aza-Acyclic+Nucleoside+Phosphonates+Containing+a+Second+Phosphonate+Group+as+Inhibitors+of+the+Human%2C+Plasmodium+Falciparum+and+Vivax+6-Oxopurine+Phosphoribosyltransferases+and+Their+Prodrugs+as+Antimalarial+Agents&doi=10.1021%2Fjm501416t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Aza-acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group As Inhibitors of the Human, Plasmodium falciparum and vivax 6-Oxopurine Phosphoribosyltransferases and Their Prodrugs As Antimalarial Agents</span></div><div class="casAuthors">Keough, Dianne T.; Hockova, Dana; Janeba, Zlatko; Wang, Tzu-Hsuan; Naesens, Lieve; Edstein, Michael D.; Chavchich, Marina; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">827-846</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxanthine-guanine-[xanthine] phosphoribosyltransferase (HG[X]PRT) is considered an important target for antimalarial chemotherapy as it is the only pathway for the synthesis of the purine nucleoside monophosphates required for DNA/RNA prodn.  Thus, inhibition of this enzyme should result in cessation of replication.  The aza-acyclic nucleoside phosphonates (aza-ANPs) are good inhibitors of Plasmodium falciparum HGXPRT (PfHGXPRT), with Ki values as low as 0.08 and 0.01 μM for Plasmodium vivax HGPRT (PvHGPRT).  Prodrugs of these aza-ANPs exhibit antimalarial activity against Pf lines with IC50 values (0.8-6.0 μM) and have low cytotoxicity against human cells.  Crystal structures of six of these compds. in complex with human HGPRT have been detd.  These suggest that the different affinities of these aza-ANPs could be due to the flexibility of the loops surrounding the active site as well as the flexibility of the inhibitors, allowing them to adapt to fit into three binding pockets of the enzyme(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9eXB3S3z3v7Vg90H21EOLACvtfcHk0licB2qNn7LIdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrzF&md5=c7d1dad69f99a1b4928b2a65fa411670</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm501416t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501416t%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DT.%2BH.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DAza-Acyclic%2520Nucleoside%2520Phosphonates%2520Containing%2520a%2520Second%2520Phosphonate%2520Group%2520as%2520Inhibitors%2520of%2520the%2520Human%252C%2520Plasmodium%2520Falciparum%2520and%2520Vivax%25206-Oxopurine%2520Phosphoribosyltransferases%2520and%2520Their%2520Prodrugs%2520as%2520Antimalarial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D2%26spage%3D827%26epage%3D846%26doi%3D10.1021%2Fjm501416t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Špaček, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrbková, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krečmerová, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eng, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jans, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Inhibition of the <i>Escherichia Coli</i> 6-Oxopurine Phosphoribosyltransferases by Nucleoside Phosphonates: Potential for New Antibacterial Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">6967</span><span class="NLM_x">–</span> <span class="NLM_lpage">6984</span><span class="refDoi"> DOI: 10.1021/jm400779n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400779n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1ChsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6967-6984&issue=17&author=D.+T.+Keoughauthor=D.+Hockov%C3%A1author=D.+Rejmanauthor=P.+%C5%A0pa%C4%8Dekauthor=S.+Vrbkov%C3%A1author=M.+Kre%C4%8Dmerov%C3%A1author=W.+S.+Engauthor=H.+Jansauthor=N.+P.+Westauthor=L.+M.+J.+Naesensauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Inhibition+of+the+Escherichia+Coli+6-Oxopurine+Phosphoribosyltransferases+by+Nucleoside+Phosphonates%3A+Potential+for+New+Antibacterial+Agents&doi=10.1021%2Fjm400779n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Escherichia coli 6-Oxopurine Phosphoribosyltransferases by Nucleoside Phosphonates: Potential for New Antibacterial Agents</span></div><div class="casAuthors">Keough, Dianne T.; Hockova, Dana; Rejman, Dominik; Spacek, Petr; Vrbkova, Silvie; Krecmerova, Marcela; Eng, Wai Soon; Jans, Harmen; West, Nicholas P.; Naesens, Lieve M. J.; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6967-6984</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Escherichia coli (Ec) cells possess two purine salvage enzymes: xanthine-guanine phosphoribosyltransferase (XGPRT) and hypoxanthine phosphoribosyltransferase (HPRT).  EcXGPRT shares a common structural feature with other members of this family, a flexible loop that closes over the active site during catalysis.  The replacement of six of these amino acids by alanine has no effect on the Km for the two substrates.  However, the Ki for the nucleoside monophosphate increases by 27-fold, and the kcat is reduced by ∼200-fold.  Nucleoside phosphonates (NP) are good inhibitors of EcXGPRT and EcHPRT, with Ki values as low as 10 nM.  In the absence of the flexible loop, these values increase by 5- to 30-fold, indicating the importance of the loop for high-affinity inhibition.  Crystal structures of two NPs in complex with EcXGPRT explain the tight binding.  Prodrugs of NPs with low Ki values for EcXGPRT or EcHPRT exhibit IC50 values between 5 and 23 μM against Mycobacterium tuberculosis in cell-based assays, suggesting that these compds. are therapeutic leads against pathogenic bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjJGY9KeZWpbVg90H21EOLACvtfcHk0licB2qNn7LIdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1ChsL7M&md5=bc8016299374898032e7311d054ec883</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm400779n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400779n%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DRejman%26aufirst%3DD.%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DVrbkov%25C3%25A1%26aufirst%3DS.%26aulast%3DKre%25C4%258Dmerov%25C3%25A1%26aufirst%3DM.%26aulast%3DEng%26aufirst%3DW.%2BS.%26aulast%3DJans%26aufirst%3DH.%26aulast%3DWest%26aufirst%3DN.%2BP.%26aulast%3DNaesens%26aufirst%3DL.%2BM.%2BJ.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DInhibition%2520of%2520the%2520Escherichia%2520Coli%25206-Oxopurine%2520Phosphoribosyltransferases%2520by%2520Nucleoside%2520Phosphonates%253A%2520Potential%2520for%2520New%2520Antibacterial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D17%26spage%3D6967%26epage%3D6984%26doi%3D10.1021%2Fjm400779n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Špaček, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichý, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrbková, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slavětínská, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edstein, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavchich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group Are Potent Inhibitors of 6-Oxopurine Phosphoribosyltransferases and Have Antimalarial Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2513</span><span class="NLM_x">–</span> <span class="NLM_lpage">2526</span><span class="refDoi"> DOI: 10.1021/jm301893b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301893b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2513-2526&issue=6&author=D.+T.+Keoughauthor=P.+%C5%A0pa%C4%8Dekauthor=D.+Hockov%C3%A1author=T.+Tich%C3%BDauthor=S.+Vrbkov%C3%A1author=L.+Slav%C4%9Bt%C3%ADnsk%C3%A1author=Z.+Janebaauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=M.+Chavchichauthor=T.+H.+Wangauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Acyclic+Nucleoside+Phosphonates+Containing+a+Second+Phosphonate+Group+Are+Potent+Inhibitors+of+6-Oxopurine+Phosphoribosyltransferases+and+Have+Antimalarial+Activity&doi=10.1021%2Fjm301893b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group Are Potent Inhibitors of 6-Oxopurine Phosphoribosyltransferases and Have Antimalarial Activity</span></div><div class="casAuthors">Keough, Dianne T.; Spacek, Petr; Hockova, Dana; Tichy, Tomas; Vrbkova, Silvie; Slavetinska, Lenka; Janeba, Zlatko; Naesens, Lieve; Edstein, Michael D.; Chavchich, Marina; Wang, Tzu-Hsuan; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2513-2526</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyclic nucleoside phosphonates (ANPs) that contain a 6-oxopurine base are good inhibitors of the Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) 6-oxopurine phosphoribosyltransferases (PRTs).  Chem. modifications based on the crystal structure of 2-(phosphonoethoxy)ethylguanine (PEEG) in complex with human HGPRT have led to the design of new ANPs.  These novel compds. contain a second phosphonate group attached to the ANP scaffold.  {[(2-[(Guanine-9H-yl)methyl]propane-1,3-diyl)bis(oxy)]bis(methylene)}diphosphonic acid (I) exhibited a Ki value of 30 nM for human HGPRT and 70 nM for Pf HGXPRT.  The crystal structure of this compd. in complex with human HGPRT shows that it fills or partially fills three crit. locations in the active site: the binding sites of the purine base, the 5'-phosphate group, and pyrophosphate.  This is the first HG(X)PRT inhibitor that has been able to achieve this result.  Prodrugs have been synthesized resulting in IC50 values as low as 3.8 μM for Pf grown in cell culture, up to 25-fold lower compared to the parent compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOIyMCQRsPnrVg90H21EOLACvtfcHk0licB2qNn7LIdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWgsrw%253D&md5=f57c4cfd4f9bcb94e6ce93894bfd4d0f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm301893b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301893b%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DTich%25C3%25BD%26aufirst%3DT.%26aulast%3DVrbkov%25C3%25A1%26aufirst%3DS.%26aulast%3DSlav%25C4%259Bt%25C3%25ADnsk%25C3%25A1%26aufirst%3DL.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DT.%2BH.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DAcyclic%2520Nucleoside%2520Phosphonates%2520Containing%2520a%2520Second%2520Phosphonate%2520Group%2520Are%2520Potent%2520Inhibitors%2520of%25206-Oxopurine%2520Phosphoribosyltransferases%2520and%2520Have%2520Antimalarial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D6%26spage%3D2513%26epage%3D2526%26doi%3D10.1021%2Fjm301893b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Česnek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holý, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dračínský, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baszczyňski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Synthesis of 9-Phosphonoalkyl and 9-Phosphonoalkoxyalkyl Purines: Evaluation of Their Ability to Act as Inhibitors of <i>Plasmodium Falciparum, Plasmodium Vivax</i> and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">1076</span><span class="NLM_x">–</span> <span class="NLM_lpage">1089</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.11.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2Fj.bmc.2011.11.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=22178188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFSisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1076-1089&issue=2&author=M.+%C4%8Cesnekauthor=D.+Hockov%C3%A1author=A.+Hol%C3%BDauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=O.+Baszczy%C5%88skiauthor=J.+de+Jerseyauthor=D.+T.+Keoughauthor=L.+W.+Guddat&title=Synthesis+of+9-Phosphonoalkyl+and+9-Phosphonoalkoxyalkyl+Purines%3A+Evaluation+of+Their+Ability+to+Act+as+Inhibitors+of+Plasmodium+Falciparum%2C+Plasmodium+Vivax+and+Human+Hypoxanthine-Guanine-%28Xanthine%29+Phosphoribosyltransferases&doi=10.1016%2Fj.bmc.2011.11.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 9-phosphonoalkyl and 9-phosphonoalkoxyalkyl purines: Evaluation of their ability to act as inhibitors of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases</span></div><div class="casAuthors">Cesnek, Michal; Hockova, Dana; Holy, Antonin; Dracinsky, Martin; Baszczynski, Ondrej; de Jersey, John; Keough, Dianne T.; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1076-1089</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purine salvage enzyme, hypoxanthine-guanine-(xanthine) phosphoribosyltransferase [HG(X)PRT], catalyzes the synthesis of the purine nucleoside monophosphates, IMP, GMP or XMP essential for DNA/RNA prodn.  In protozoan parasites, such as Plasmodium, this is the only route available for their synthesis as they lack the de novo pathway which is present in human cells.  Acyclic nucleoside phosphonates (ANPs), analogs of the purine nucleoside monophosphates, have been found to inhibit Plasmodium falciparum (Pf) HGXPRT and Plasmodium vivax (Pv) HGPRT with Ki values as low as 100 nM.  They arrest parasitemia in cell based assays with IC50 values of the order of 1-10 μM.  ANPs with phosphonoalkyl and phosphonoalkoxyalkyl moieties linking the purine base and phosphonate group were designed and synthesized to evaluate the influence of this linker on the potency and/or selectivity of the ANPs for the human and malarial enzymes.  This data shows that variability in the linker, as well as the positioning of the oxygen in this linker, influences binding.  The human enzyme binds the ANPs with Ki values of 0.5 μM when the no. of atoms in the linker was 5 or 6 atoms.  However, the parasite enzymes have little affinity for such long chains unless oxygen is included in the three-position.  In comparison, all three enzymes have little affinity for ANPs where the no. of atoms linking the base and the phosphonate group is of the order of 2-3 atoms.  The chem. nature of the purine base also effects the Ki values.  This data shows that both the linker and the purine base play an important role in the binding of the ANPs to these three enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpquLDpWV2ftrVg90H21EOLACvtfcHk0lhPQgiRTlqxyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFSisA%253D%253D&md5=9e75cc4dcd0fd16d1c34844fc00cf818</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.11.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.11.034%26sid%3Dliteratum%253Aachs%26aulast%3D%25C4%258Cesnek%26aufirst%3DM.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DBaszczy%25C5%2588ski%26aufirst%3DO.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DSynthesis%2520of%25209-Phosphonoalkyl%2520and%25209-Phosphonoalkoxyalkyl%2520Purines%253A%2520Evaluation%2520of%2520Their%2520Ability%2520to%2520Act%2520as%2520Inhibitors%2520of%2520Plasmodium%2520Falciparum%252C%2520Plasmodium%2520Vivax%2520and%2520Human%2520Hypoxanthine-Guanine-%2528Xanthine%2529%2520Phosphoribosyltransferases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26issue%3D2%26spage%3D1076%26epage%3D1089%26doi%3D10.1016%2Fj.bmc.2011.11.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Thornton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miccoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehellou, Y.</span><span> </span><span class="NLM_article-title">Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">10400</span><span class="NLM_x">–</span> <span class="NLM_lpage">10410</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00523</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00523" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWntLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10400-10410&issue=23&author=P.+J.+Thorntonauthor=H.+Kadriauthor=A.+Miccoliauthor=Y.+Mehellou&title=Nucleoside+Phosphate+and+Phosphonate+Prodrug+Clinical+Candidates&doi=10.1021%2Facs.jmedchem.6b00523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates</span></div><div class="casAuthors">Thornton, Peter J.; Kadri, Hachemi; Miccoli, Ageo; Mehellou, Youcef</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10400-10410</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nucleoside monophosphates and monophosphonates have been known for a long time to exert favorable pharmacol. effects upon intracellular delivery.  However, their development as drug mols. has been hindered by the inherent poor druglike properties of the monophosphate and monophosphonate groups.  These include inefficient cellular uptake and poor in vivo stability, with this latter drawback being most relevant to monophosphates than monophosphonates.  To address these limitations, numerous monophosphate and monophosphonate prodrug strategies have been developed and applied in the discovery of nucleoside monophosphate and monophosphonate prodrugs that can treat viral infections and cancer.  The approval of sofosbuvir, a nucleoside monophosphate prodrug, highlighted the success to be had by employing these prodrug technologies in the discovery of nucleotide therapeutics.  In this Miniperspective, we discuss the different key monophosphate and monophosphonate nucleoside prodrugs that entered clin. development, some of which may in the future be approved to treat various human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps_oIoE-3R_rVg90H21EOLACvtfcHk0lhPQgiRTlqxyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWntLjE&md5=f00f13fb82caa27b88a87d2d337dcad4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00523%26sid%3Dliteratum%253Aachs%26aulast%3DThornton%26aufirst%3DP.%2BJ.%26aulast%3DKadri%26aufirst%3DH.%26aulast%3DMiccoli%26aufirst%3DA.%26aulast%3DMehellou%26aufirst%3DY.%26atitle%3DNucleoside%2520Phosphate%2520and%2520Phosphonate%2520Prodrug%2520Clinical%2520Candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D23%26spage%3D10400%26epage%3D10410%26doi%3D10.1021%2Facs.jmedchem.6b00523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edstein, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavchich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">Antimalarial Activity of Prodrugs of N-Branched Acyclic Nucleoside Phosphonate Inhibitors of 6-Oxopurine Phosphoribosyltransferases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5502</span><span class="NLM_x">–</span> <span class="NLM_lpage">5510</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2Fj.bmc.2015.07.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5502-5510&issue=17&author=D.+Hockov%C3%A1author=Z.+Janebaauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=M.+Chavchichauthor=D.+T.+Keoughauthor=L.+W.+Guddat&title=Antimalarial+Activity+of+Prodrugs+of+N-Branched+Acyclic+Nucleoside+Phosphonate+Inhibitors+of+6-Oxopurine+Phosphoribosyltransferases&doi=10.1016%2Fj.bmc.2015.07.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.038%26sid%3Dliteratum%253Aachs%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DAntimalarial%2520Activity%2520of%2520Prodrugs%2520of%2520N-Branched%2520Acyclic%2520Nucleoside%2520Phosphonate%2520Inhibitors%2520of%25206-Oxopurine%2520Phosphoribosyltransferases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26issue%3D17%26spage%3D5502%26epage%3D5510%26doi%3D10.1016%2Fj.bmc.2015.07.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Špaček, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavchich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dračínský, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edstein, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Symmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of the <i>Plasmodium Falciparum, Plasmodium Vivax</i> and Human 6-Oxopurine Phosphoribosyltransferases and the Antimalarial Activity of Their Prodrugs</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4008</span><span class="NLM_x">–</span> <span class="NLM_lpage">4030</span><span class="refDoi"> DOI: 10.1016/j.bmc.2017.05.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2Fj.bmc.2017.05.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=28601510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslGnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=4008-4030&author=P.+%C5%A0pa%C4%8Dekauthor=D.+T.+Keoughauthor=M.+Chavchichauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=Z.+Janebaauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=L.+W.+Guddatauthor=D.+Hockov%C3%A1&title=Synthesis+and+Evaluation+of+Symmetric+Acyclic+Nucleoside+Bisphosphonates+as+Inhibitors+of+the+Plasmodium+Falciparum%2C+Plasmodium+Vivax+and+Human+6-Oxopurine+Phosphoribosyltransferases+and+the+Antimalarial+Activity+of+Their+Prodrugs&doi=10.1016%2Fj.bmc.2017.05.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of symmetric acyclic nucleoside bisphosphonates as inhibitors of the Plasmodium falciparum, Plasmodium vivax and human 6-oxopurine phosphoribosyltransferases and the antimalarial activity of their prodrugs</span></div><div class="casAuthors">Spacek, Petr; Keough, Dianne T.; Chavchich, Marina; Dracinsky, Martin; Janeba, Zlatko; Naesens, Lieve; Edstein, Michael D.; Guddat, Luke W.; Hockova, Dana</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4008-4030</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two new series of sym. acyclic nucleoside bisphosphonates (ANbPs) have been synthesized as potential inhibitors of the Plasmodium falciparum (Pf) and vivax (Pv) 6-oxopurine phosphoribosyltransferases.  The structural variability between these sym. ANbPs lies in the no. of atoms in the two acyclic linkers connecting the N9 atom of the purine base to each of two phosphonate groups and the branching point of the acyclic moiety relative to the purine base, which occurs at either the alpha or beta positions.  Within each series, six different 6-oxopurine bases have been attached.  In general, the ANbPs with either guanine or hypoxanthine have lower Ki values than for those contg. either the 8-bromo or 7-deaza 6-oxopurine bases.  The lowest Ki values obtained for the two parasite enzymes were 0.1 μM (Pf) and 0.2 μM (Pv) for this series of compds.  Two phosphoramidate prodrugs of these inhibitors exhibited antimalarial activity against Pf in infected erythrocyte cell culture with IC50 values of 0.8 and 1.5 μM.  These two compds. exhibited low cytotoxicity in human A549 cells having CC50 values of >300 μM resulting in an excellent selectivity index.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRylWYh-MpNLVg90H21EOLACvtfcHk0lhC5LMPP6aLTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslGnur8%253D&md5=62891e50ca20c740844a44c1a7e8876b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.05.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.05.048%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Symmetric%2520Acyclic%2520Nucleoside%2520Bisphosphonates%2520as%2520Inhibitors%2520of%2520the%2520Plasmodium%2520Falciparum%252C%2520Plasmodium%2520Vivax%2520and%2520Human%25206-Oxopurine%2520Phosphoribosyltransferases%2520and%2520the%2520Antimalarial%2520Activity%2520of%2520Their%2520Prodrugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D4008%26epage%3D4030%26doi%3D10.1016%2Fj.bmc.2017.05.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Baszczyňski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dračínský, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Špaček, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span> </span><span class="NLM_article-title">An Efficient Oxa-Michael Addition to Diethyl Vinylphosphonate under Mild Reaction Conditions</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1282</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span><span class="refDoi"> DOI: 10.1039/C2RA00938B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1039%2FC2RA00938B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=1282-1284&issue=4&author=O.+Baszczy%C5%88skiauthor=P.+Jansaauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=M.+M.+Kaiserauthor=P.+%C5%A0pa%C4%8Dekauthor=Z.+Janeba&title=An+Efficient+Oxa-Michael+Addition+to+Diethyl+Vinylphosphonate+under+Mild+Reaction+Conditions&doi=10.1039%2FC2RA00938B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient oxa-Michael addition to diethyl vinylphosphonate under mild reaction conditions</span></div><div class="casAuthors">Baszczynski, Ondrej; Jansa, Petr; Dracinsky, Martin; Kaiser, Martin Maxmilian; Spacek, Petr; Janeba, Zlatko</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1282-1284</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">An oxa-Michael addn. of various secondary and branched primary alcs. to di-Et vinylphosphonate was systematically studied and optimized.  This efficient method avoids the use of harsh reaction conditions (e.g. strong bases, high temps.) and gains access to an important class of biol. active compds. in one step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkfK-6i55JqbVg90H21EOLACvtfcHk0lhC5LMPP6aLTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKlsLo%253D&md5=1d3be7a12bc68ed6531e08596bcd00a0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2FC2RA00938B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2RA00938B%26sid%3Dliteratum%253Aachs%26aulast%3DBaszczy%25C5%2588ski%26aufirst%3DO.%26aulast%3DJansa%26aufirst%3DP.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DM.%2BM.%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DJaneba%26aufirst%3DZ.%26atitle%3DAn%2520Efficient%2520Oxa-Michael%2520Addition%2520to%2520Diethyl%2520Vinylphosphonate%2520under%2520Mild%2520Reaction%2520Conditions%26jtitle%3DRSC%2520Adv.%26date%3D2012%26volume%3D2%26issue%3D4%26spage%3D1282%26epage%3D1284%26doi%3D10.1039%2FC2RA00938B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Thompson, D. H.; Boomer, J. A.; Haynes, R.</span><span> </span><span class="NLM_article-title">Vinyl Ether Lipids with Cleavable Hydrophlic Headgroups</span>. U.S. Patent 6,979,460 B1, Dec 27,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=D.+H.+Thompson&author=J.+A.+Boomer&author=R.+Haynes&title=Vinyl+Ether+Lipids+with+Cleavable+Hydrophlic+Headgroups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DD.%2BH.%26atitle%3DVinyl%2520Ether%2520Lipids%2520with%2520Cleavable%2520Hydrophlic%2520Headgroups%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Linn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J. L.</span><span> </span><span class="NLM_article-title">1,4-Diazabicyclo[2.2.2]octane (Dabco)-Catalysed Hydrolysis and Alcoholysis Reactions of 2-Amino-9-Benzyl-6-Chloro-9H-Purine</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">914</span><span class="refDoi"> DOI: 10.1039/c39940000913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1039%2Fc39940000913" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1994&pages=913-914&issue=8&author=J.+A.+Linnauthor=E.+W.+McLeanauthor=J.+L.+Kelley&title=1%2C4-Diazabicyclo%5B2.2.2%5Doctane+%28Dabco%29-Catalysed+Hydrolysis+and+Alcoholysis+Reactions+of+2-Amino-9-Benzyl-6-Chloro-9H-Purine&doi=10.1039%2Fc39940000913"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2Fc39940000913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39940000913%26sid%3Dliteratum%253Aachs%26aulast%3DLinn%26aufirst%3DJ.%2BA.%26aulast%3DMcLean%26aufirst%3DE.%2BW.%26aulast%3DKelley%26aufirst%3DJ.%2BL.%26atitle%3D1%252C4-Diazabicyclo%255B2.2.2%255Doctane%2520%2528Dabco%2529-Catalysed%2520Hydrolysis%2520and%2520Alcoholysis%2520Reactions%2520of%25202-Amino-9-Benzyl-6-Chloro-9H-Purine%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1994%26volume%3D8%26issue%3D8%26spage%3D913%26epage%3D914%26doi%3D10.1039%2Fc39940000913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">de Jersey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holý, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span> </span><span class="NLM_article-title">6-Oxopurine Phosphoribosyltransferase: A Target for the Development of Antimalarial Drugs</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">2085</span><span class="NLM_x">–</span> <span class="NLM_lpage">2102</span><span class="refDoi"> DOI: 10.2174/156802611796575911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.2174%2F156802611796575911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=21619515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=2085-2102&issue=16&author=J.+de+Jerseyauthor=A.+Hol%C3%BDauthor=D.+Hockov%C3%A1author=L.+Naesensauthor=D.+T.+Keoughauthor=L.+W.+Guddat&title=6-Oxopurine+Phosphoribosyltransferase%3A+A+Target+for+the+Development+of+Antimalarial+Drugs&doi=10.2174%2F156802611796575911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">6-oxopurine phosphoribosyltransferase: a target for the development of antimalarial drugs</span></div><div class="casAuthors">de Jersey, John; Holy, Antonin; Hockova, Dana; Naesens, Lieve; Keough, Dianne T.; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2085-2102</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria remains the most serious parasitic diseases affecting humans in the world today, resulting in 1-2 million fatalities each year.  Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) are the predominant causative agents.  Both are responsible for widespread mortality and morbidity and are a serious socio-economic burden, esp. for countries in the developing world.  One of the most important defences against malaria has been the use of chemotherapeutic drugs (e.g. chloroquine, artemisinins, pyrimethamine) but these have mainly been found by serendipity.  Their mechanisms was not understood at the time of their discovery and, even today, are still not unequivocal.  For many of these compds., the parasite is now resistant and, hence, there is an urgent need to develop new therapeutic drugs directed to validated targets.  One metabolic pathway crucial for the survival and replication and survival of the parasite is the synthesis of the purine nucleoside monophosphates essential for the prodn. of DNA/RNA mols.  A key enzyme in this pathway is the 6-oxopurine phosphoribosyltransferase (PRTase).  The focus of this review is on the identification and characterization of inhibitors of the enzymes from both Pf and Pv as antimalarial drug leads.  The acyclic nucleoside phosphonates (ANPs) appear to be excellent candidates because they are good inhibitors of the two Plasmodium enzymes, can be selective compared to the human enzyme, can arrest parasitemia in cell based assays, have low cytotoxicity to the human host cell and, because of their stable carbon-phosphorous bond, are stable within the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptM-lrmcqP2bVg90H21EOLACvtfcHk0lhC5LMPP6aLTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3E&md5=631fe3c94e8ff703031ea8d71afcc7c2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F156802611796575911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611796575911%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3D6-Oxopurine%2520Phosphoribosyltransferase%253A%2520A%2520Target%2520for%2520the%2520Development%2520of%2520Antimalarial%2520Drugs%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26issue%3D16%26spage%3D2085%26epage%3D2102%26doi%3D10.2174%2F156802611796575911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kaiser, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocková, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dračínský, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poštová-Slavětínská, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procházková, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edstein, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavchich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keough, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guddat, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of <i>Plasmodium Falciparum</i> and Human 6-Oxopurine Phosphoribosyltransferases</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1707</span><span class="NLM_x">–</span> <span class="NLM_lpage">1723</span><span class="refDoi"> DOI: 10.1002/cmdc.201500322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1002%2Fcmdc.201500322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=26368337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyju77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1707-1723&issue=10&author=M.+M.+Kaiserauthor=D.+Hockov%C3%A1author=T.-H.+Wangauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=L.+Po%C5%A1tov%C3%A1-Slav%C4%9Bt%C3%ADnsk%C3%A1author=E.+Proch%C3%A1zkov%C3%A1author=M.+D.+Edsteinauthor=M.+Chavchichauthor=D.+T.+Keoughauthor=L.+W.+Guddatauthor=Z.+Janeba&title=Synthesis+and+Evaluation+of+Novel+Acyclic+Nucleoside+Phosphonates+as+Inhibitors+of+Plasmodium+Falciparum+and+Human+6-Oxopurine+Phosphoribosyltransferases&doi=10.1002%2Fcmdc.201500322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine Phosphoribosyltransferases</span></div><div class="casAuthors">Kaiser, Martin M.; Hockova, Dana; Wang, Tzu-Hsuan; Dracinsky, Martin; Postova-Slavetinska, Lenka; Prochazkova, Eliska; Edstein, Michael D.; Chavchich, Marina; Keough, Dianne T.; Guddat, Luke W.; Janeba, Zlatko</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1707-1723</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Acyclic nucleoside phosphonates (ANPs) are a promising class of antimalarial therapeutic drug leads that exhibit a wide variety of Ki values for Plasmodium falciparum (Pf) and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases [HG(X)PRTs].  A novel series of ANPs, analogs of previously reported 2-(phosphonoethoxy)ethyl (PEE) and (R,S)-3-hydroxy-2-(phosphonomethoxy)propyl (HPMP) derivs., were designed and synthesized to evaluate their ability to act as inhibitors of these enzymes and to extend our ongoing antimalarial structure-activity relationship studies.  In this series, (S)-3-hydroxy-2-(phosphonoethoxy)propyl (HPEP), (S)-2-(phosphonomethoxy)propanoic acid (CPME), or (S)-2-(phosphonoethoxy)propanoic acid (CPEE) are the acyclic moieties.  Of this group, (S)-3-hydroxy-2-(phosphonoethoxy)propylguanine (HPEPG) exhibits the highest potency for PfHGXPRT, with a Ki value of 0.1 μΜ and a Ki value for human HGPRT of 0.6 μΜ.  The crystal structures of HPEPG and HPEPHx (where Hx=hypoxanthine) in complex with human HGPRT were obtained, showing specific interactions with active site residues.  Prodrugs for the HPEP and CPEE analogs were synthesized and tested for in vitro antimalarial activity.  The lowest IC50 value (22 μΜ) in a chloroquine-resistant strain was obsd. for the bis-amidate prodrug of HPEPG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm9gVba_Sb_bVg90H21EOLACvtfcHk0lj40SCzzwqbhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyju77N&md5=16d12091e7fbd1c4522f3c5c8b2f35c9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500322%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DM.%2BM.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.-H.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DPo%25C5%25A1tov%25C3%25A1-Slav%25C4%259Bt%25C3%25ADnsk%25C3%25A1%26aufirst%3DL.%26aulast%3DProch%25C3%25A1zkov%25C3%25A1%26aufirst%3DE.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26aulast%3DJaneba%26aufirst%3DZ.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Novel%2520Acyclic%2520Nucleoside%2520Phosphonates%2520as%2520Inhibitors%2520of%2520Plasmodium%2520Falciparum%2520and%2520Human%25206-Oxopurine%2520Phosphoribosyltransferases%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26issue%3D10%26spage%3D1707%26epage%3D1723%26doi%3D10.1002%2Fcmdc.201500322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Jansa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baszczyňski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dračínský, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votruba, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zídek, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahador, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cihlar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holý, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeba, Z.</span><span> </span><span class="NLM_article-title">A Novel and Efficient One-Pot Synthesis of Symmetrical Diamide (Bis-Amidate) Prodrugs of Acyclic Nucleoside Phosphonates and Evaluation of Their Biological Activities</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3748</span><span class="NLM_x">–</span> <span class="NLM_lpage">3754</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1016%2Fj.ejmech.2011.05.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3748-3754&issue=9&author=P.+Jansaauthor=O.+Baszczy%C5%88skiauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=I.+Votrubaauthor=Z.+Z%C3%ADdekauthor=G.+Bahadorauthor=G.+Stepanauthor=T.+Cihlarauthor=R.+MacKmanauthor=A.+Hol%C3%BDauthor=Z.+Janeba&title=A+Novel+and+Efficient+One-Pot+Synthesis+of+Symmetrical+Diamide+%28Bis-Amidate%29+Prodrugs+of+Acyclic+Nucleoside+Phosphonates+and+Evaluation+of+Their+Biological+Activities&doi=10.1016%2Fj.ejmech.2011.05.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DJansa%26aufirst%3DP.%26aulast%3DBaszczy%25C5%2588ski%26aufirst%3DO.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DVotruba%26aufirst%3DI.%26aulast%3DZ%25C3%25ADdek%26aufirst%3DZ.%26aulast%3DBahador%26aufirst%3DG.%26aulast%3DStepan%26aufirst%3DG.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DMacKman%26aufirst%3DR.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DJaneba%26aufirst%3DZ.%26atitle%3DA%2520Novel%2520and%2520Efficient%2520One-Pot%2520Synthesis%2520of%2520Symmetrical%2520Diamide%2520%2528Bis-Amidate%2529%2520Prodrugs%2520of%2520Acyclic%2520Nucleoside%2520Phosphonates%2520and%2520Evaluation%2520of%2520Their%2520Biological%2520Activities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26issue%3D9%26spage%3D3748%26epage%3D3754%26doi%3D10.1016%2Fj.ejmech.2011.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Shi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furneaux, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahill, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girvin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubmeyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almo, S. C.</span><span> </span><span class="NLM_article-title">The 2.0 Å Structure of Human Hypoxanthine-Guanine Phosphoribosyltransferase in Complex with a Transition-State Analog Inhibitor</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">588</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span><span class="refDoi"> DOI: 10.1038/9376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1038%2F9376" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=588-593&issue=6&author=W.+Shiauthor=C.+M.+Liauthor=P.+C.+Tylerauthor=R.+H.+Furneauxauthor=S.+M.+Cahillauthor=M.+E.+Girvinauthor=C.+Grubmeyerauthor=V.+L.+Schrammauthor=S.+C.+Almo&title=The+2.0+%C3%85+Structure+of+Human+Hypoxanthine-Guanine+Phosphoribosyltransferase+in+Complex+with+a+Transition-State+Analog+Inhibitor&doi=10.1038%2F9376"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F9376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F9376%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DC.%2BM.%26aulast%3DTyler%26aufirst%3DP.%2BC.%26aulast%3DFurneaux%26aufirst%3DR.%2BH.%26aulast%3DCahill%26aufirst%3DS.%2BM.%26aulast%3DGirvin%26aufirst%3DM.%2BE.%26aulast%3DGrubmeyer%26aufirst%3DC.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26aulast%3DAlmo%26aufirst%3DS.%2BC.%26atitle%3DThe%25202.0%2520%25C3%2585%2520Structure%2520of%2520Human%2520Hypoxanthine-Guanine%2520Phosphoribosyltransferase%2520in%2520Complex%2520with%2520a%2520Transition-State%2520Analog%2520Inhibitor%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1999%26volume%3D6%26issue%3D6%26spage%3D588%26epage%3D593%26doi%3D10.1038%2F9376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">McPhillips, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhillips, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phizackerley, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltis, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span> </span><span class="NLM_article-title"><i>Blu-Ice</i> and the <i>Distributed Control System</i>: Software for Data Acquisition and Instrument Control at Macromolecular Crystallography BeamLines</span> <span class="citation_source-journal">J. Synchrotron Radiat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.1107/S0909049502015170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1107%2FS0909049502015170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=12409628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotleluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=401-406&issue=6&author=T.+M.+McPhillipsauthor=S.+E.+McPhillipsauthor=H.-J.+Chiuauthor=A.+E.+Cohenauthor=A.+M.+Deaconauthor=P.+J.+Ellisauthor=E.+Garmanauthor=A.+Gonzalezauthor=N.+K.+Sauterauthor=R.+P.+Phizackerleyauthor=S.+M.+Soltisauthor=P.+Kuhn&title=Blu-Ice+and+the+Distributed+Control+System%3A+Software+for+Data+Acquisition+and+Instrument+Control+at+Macromolecular+Crystallography+BeamLines&doi=10.1107%2FS0909049502015170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines</span></div><div class="casAuthors">McPhillips, Timothy M.; McPhillips, Scott E.; Chiu, Hsiu Ju; Cohen, Aina E.; Deacon, Ashley M.; Ellis, Paul J.; Garman, Elspeth; Gonzalez, Ana; Sauter, Nicholas K.; Phizackerley, R. Paul; Soltis, S. Michael; Kuhn, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-406</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">The Blu-Ice and Distributed Control System (DCS) software packages were developed to provide unified control over the disparate hardware resources available at a macromol. crystallog. beamline.  Blu-Ice is a user interface that provides scientific experimenters and beamline support staff with intuitive graphical tools for collecting diffraction data and configuring beamlines for expts.  Blu-Ice communicates with the hardware at a beamline via DCS, an instrument-control and data-acquisition package designed to integrate hardware resources in a highly heterogeneous networked computing environment.  Together, Blu-Ice and DCS provide a flexible platform for increasing the ease of use, the level of automation and the remote accessibility of beamlines.  Blu-Ice and DCS are currently installed on four Stanford Synchrotron Radiation Lab. crystallog. beamlines and are being implemented at sister light sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVsQUIFJPBLVg90H21EOLACvtfcHk0lj40SCzzwqbhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotleluro%253D&md5=c77228bd50890463f3e43e981a2e238a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0909049502015170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0909049502015170%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhillips%26aufirst%3DT.%2BM.%26aulast%3DMcPhillips%26aufirst%3DS.%2BE.%26aulast%3DChiu%26aufirst%3DH.-J.%26aulast%3DCohen%26aufirst%3DA.%2BE.%26aulast%3DDeacon%26aufirst%3DA.%2BM.%26aulast%3DEllis%26aufirst%3DP.%2BJ.%26aulast%3DGarman%26aufirst%3DE.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DPhizackerley%26aufirst%3DR.%2BP.%26aulast%3DSoltis%26aufirst%3DS.%2BM.%26aulast%3DKuhn%26aufirst%3DP.%26atitle%3DBlu-Ice%2520and%2520the%2520Distributed%2520Control%2520System%253A%2520Software%2520for%2520Data%2520Acquisition%2520and%2520Instrument%2520Control%2520at%2520Macromolecular%2520Crystallography%2520BeamLines%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2002%26volume%3D9%26issue%3D6%26spage%3D401%26epage%3D406%26doi%3D10.1107%2FS0909049502015170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&issue=2&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgIdKjgCcD8UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D2%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkóczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title"><i>PHENIX</i>: A Comprehensive Python-Based System for Macromolecular Structure Solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&issue=2&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+A+Comprehensive+Python-Based+System+for+Macromolecular+Structure+Solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lhAwOhLAyFMPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520A%2520Comprehensive%2520Python-Based%2520System%2520for%2520Macromolecular%2520Structure%2520Solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D2%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&issue=4&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lhAwOhLAyFMPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D4%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Trager, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, J. B.</span><span> </span><span class="NLM_article-title">Human Malaria Parasites in Continuous Culture</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x"> (</span><span class="NLM_issue">4254</span><span class="NLM_x">) </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">675</span><span class="refDoi"> DOI: 10.1126/science.781840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1126%2Fscience.781840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=781840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A280%3ADyaE283ks1Wqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1976&pages=673-675&issue=4254&author=W.+Tragerauthor=J.+B.+Jensen&title=Human+Malaria+Parasites+in+Continuous+Culture&doi=10.1126%2Fscience.781840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Human malaria parasites in continuous culture</span></div><div class="casAuthors">Trager W; Jensen J B</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">4254</span>),
    <span class="NLM_cas:pages">673-5</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Plasmodium falciparum can now be maintained in continuous culture in human erythrocytes incubated at 38 degrees C in RPMI 1640 medium with human serum under an atmosphere with 7 percent carbon dioxide and low oxygen (1 or 5 percent).  The original parasite material, derived from an infected Aotus trivirgatus monkey, was diluted more than 100 million times by the addition of human erythrocytes at 3- or 4-day intervals.  The parasites continued to reproduce in their normal asexual cycle of approximately 48 hours but were no longer highly synchronous.  The have remained infective to Aotus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPnKdQ--_afmyYR5VtavbzfW6udTcc2eZ3ufEAB4uSVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE283ks1Wqug%253D%253D&md5=a7f43c2255b75d9841c36338433c78b8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscience.781840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.781840%26sid%3Dliteratum%253Aachs%26aulast%3DTrager%26aufirst%3DW.%26aulast%3DJensen%26aufirst%3DJ.%2BB.%26atitle%3DHuman%2520Malaria%2520Parasites%2520in%2520Continuous%2520Culture%26jtitle%3DScience%26date%3D1976%26volume%3D193%26issue%3D4254%26spage%3D673%26epage%3D675%26doi%3D10.1126%2Fscience.781840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Lambros, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderberg, J. P.</span><span> </span><span class="NLM_article-title">Synchronization of <i>Plasmodium falciparum</i> Erythrocytic Stages in Culture</span> <span class="citation_source-journal">J. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span><span class="refDoi"> DOI: 10.2307/3280287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.2307%2F3280287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=383936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A280%3ADyaL3c%252FgvVGmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1979&pages=418-420&issue=3&author=C.+Lambrosauthor=J.+P.+Vanderberg&title=Synchronization+of+Plasmodium+falciparum+Erythrocytic+Stages+in+Culture&doi=10.2307%2F3280287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synchronization of Plasmodium falciparum erythrocytic stages in culture</span></div><div class="casAuthors">Lambros C; Vanderberg J P</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of parasitology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">418-20</span>
        ISSN:<span class="NLM_cas:issn">0022-3395</span>.
    </div><div class="casAbstract">Synchronous development of the erythrocytic stages of a human malaria parasite, Plasmodium falciparum, in culture was accomplished by suspending cultured parasites in 5% D-sorbitol and subsequent reintroduction into culture.  Immediately after sorbitol treatment, cultures consisted mainly of single and multiple ring-form infections.  At the same time, varying degrees of lysis of erythrocytes infected with the more mature stages of the parasite was evident.  Approximately 95% of the parasites were in the ring stage of development at 48 and 96 hr after sorbitol treatment-likewise, a high percentage of trophozoite and schizont stages was observed at 24, 72, and 120 hr.  D-Mannitol produced similar, selective, lytic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8OaabOIODNFUIs6wFK5xJfW6udTcc2eZ3ufEAB4uSVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3c%252FgvVGmtg%253D%253D&md5=b1f79ae8156db4fdef9b290140de2298</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2307%2F3280287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F3280287%26sid%3Dliteratum%253Aachs%26aulast%3DLambros%26aufirst%3DC.%26aulast%3DVanderberg%26aufirst%3DJ.%2BP.%26atitle%3DSynchronization%2520of%2520Plasmodium%2520falciparum%2520Erythrocytic%2520Stages%2520in%2520Culture%26jtitle%3DJ.%2520Parasitol.%26date%3D1979%26volume%3D65%26issue%3D3%26spage%3D418%26epage%3D420%26doi%3D10.2307%2F3280287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Desjardins, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chulay, J. D.</span><span> </span><span class="NLM_article-title">Quantitative Assessment of Antimalarial Activity <i>in vitro</i> by a Semiautomated Microdilution Technique</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span><span class="refDoi"> DOI: 10.1128/AAC.16.6.710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=10.1128%2FAAC.16.6.710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=394674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;key=1%3ACAS%3A528%3ADyaL3cXktFyrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=710-718&issue=6&author=R.+E.+Desjardinsauthor=C.+J.+Canfieldauthor=J.+D.+Haynesauthor=J.+D.+Chulay&title=Quantitative+Assessment+of+Antimalarial+Activity+in+vitro+by+a+Semiautomated+Microdilution+Technique&doi=10.1128%2FAAC.16.6.710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique</span></div><div class="casAuthors">Desjardins, Robert E.; Canfield, Craig J.; Haynes, J. David; Chulay, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">710-18</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">A rapid, semiautomated microdilution method was developed for measuring the activity of potential antimalarial drugs against cultured intraerythrocytic asexual forms of the human malaria parasite Plasmodium falciparum.  Microtitration plates were used to prep. serial dilns. of the compds. to be tested.  Parasites, obtained from continuous stock cultures, were subcultured in these plates for 42 h.  Inhibition of uptake of a radiolabeled nucleic acid precursor by the parasites served as the indicator of antimalarial activity.  Results of repeased measurements of activity with chloroquine, quinine, and the new drug mefloquine demonstrated that the method is sensitive and precise.  Several addnl. antimalarial drugs and compds. of interest were tested in vitro, and the results were consistent with available in vivo data.  The use of P. falciparum isolates with known susceptibility to antimalarial drugs also permitted evaluation of the cross-resistance potential of each compd. tested.  The applications and expectations of this new test system within a drug development program are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9KHtWVyGh8LVg90H21EOLACvtfcHk0lj2-IJtG5Dn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktFyrsL0%253D&md5=0b708f34bdee0fe03d6cae1e4d7c3598</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FAAC.16.6.710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.16.6.710%26sid%3Dliteratum%253Aachs%26aulast%3DDesjardins%26aufirst%3DR.%2BE.%26aulast%3DCanfield%26aufirst%3DC.%2BJ.%26aulast%3DHaynes%26aufirst%3DJ.%2BD.%26aulast%3DChulay%26aufirst%3DJ.%2BD.%26atitle%3DQuantitative%2520Assessment%2520of%2520Antimalarial%2520Activity%2520in%2520vitro%2520by%2520a%2520Semiautomated%2520Microdilution%2520Technique%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1979%26volume%3D16%26issue%3D6%26spage%3D710%26epage%3D718%26doi%3D10.1128%2FAAC.16.6.710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IJQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IJQ','PDB','4IJQ'); return false;">PDB: 4IJQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BZY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BZY','PDB','1BZY'); return false;">PDB: 1BZY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RAB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RAB','PDB','4RAB'); return false;">PDB: 4RAB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W8V" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W8V','PDB','5W8V'); return false;">PDB: 5W8V</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i60"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00926">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_64162"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00926">10.1021/acs.jmedchem.7b00926</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SMILES strings of target ANbPs and their prodrugs (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00926/suppl_file/jm7b00926_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00926/suppl_file/jm7b00926_si_001.csv">jm7b00926_si_001.csv (3.26 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors of human HGPRT in complex with compound <b>20</b> have been deposited with the Protein Data Bank as entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W8V">5W8V</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00926%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-17%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00926" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799620a0fa93cbe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
